

















The Dissertation Committee for Constantine Chrysostomou Certifies that this is the 
approved version of the following dissertation: 
 
 









George Georgiou, Supervisor 
Brent L. Iverson 
Jennifer A. Maynard 
Hal S. Alper 
Charles B. Mullins 










Presented to the Faculty of the Graduate School of  
The University of Texas at Austin 
in Partial Fulfillment  
of the Requirements 
for the Degree of  
 
Doctor of Philosophy 
 
 




This dissertation is dedicated my parents, Evanthia and Andreas, and my brother, Charles.  
I owe all of my accomplishments to their continual support and guidance throughout my 




I would like to acknowledge my advisor, Professor George Georgiou, who has 
always been a constant source for advice both scientifically and professionally.  I will 
always be fortunate to have had him as an advisor and his continual support.  In addition 
to Professor Georgiou, I have also had the pleasure of learning from multiple scientists who 
have served as advisors to me, including Professor Brent Iverson and Dr. Scott Hunicke-
Smith. 
I would like to thank Dr. Karthik Veeravalli who spent the time to train me and 
introduce me to the lab.  I am also grateful for the opportunity to learn from a large number 
of great scientists including Dr. Sai Reddy, Dr. Xin Ge, Dr. Mark Pogson, Dr. Gregory 
Ippolito, and Dr. Everett Stone.   
With respect to my work in bacteriology, I am greatly appreciative of my 
collaboration with fellow scientists Erik Quandt and Dr. Nicholas Marshall.  I gained a 
great deal of knowledge from working with both very talented researchers.  I would also 
like to thank two undergraduate researchers who aided my research in redox pathways: 
Blagoje Djordjevic and Quoc Bao Nguyen.          
In my work in immunology I am indebted to the assistance provided by Benjamin 
Goetz, Andrew Horton, Gabriel Wu, and Dr. Sebastian Schaetzle.  However, the one person 
who I want to thank the most is Kam Hon Hoi.  Working with him has been one of the 
most enjoyable experiences of my graduate studies and he was intimately involved in the 
work discussed in almost every chapter within this dissertation.   
Finally, and most importantly, graduate school has provided me with a close 
network of fellow researchers and friends.  I greatly appreciate their constant presence and 
 vi
advice as I matured as a scientist.  They have left me with unforgettable memories as a 
graduate student and their advice throughout the years was invaluable.   
 vii
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Antibodies are essential molecules that help to provide immunity against a vast 
population of environmental pathogens.  This antibody conferred protection is dependent 
upon genetic diversification mechanisms that produce an impressive repertoire of 
lymphocytes expressing unique B-cell receptors.  The advent of high throughput 
sequencing has enabled researchers to sequence populations of B-cell receptors at an 
unprecedented depth.  Such investigations can be used to expand our understanding of 
mechanistic processes governing adaptive immunity, characterization of immunity related 
disorders, and the discovery of antibodies specific to antigens of interest.  However, next 
generation sequencing of immunological repertoires is not without its challenges.  For 
example, it is especially difficult to identify biologically relevant features within large 
datasets.  Additionally, within the immunology community, there is a severe lack of 
standardized and easily accessible bioinformatics analysis pipelines.  In this work, we 
present methods which address many of these concerns.  First, we present robust statistical 
methods for the comparison of immunoglobulin repertoires.  Specifically, we quantified 
the overlap between the antibody heavy chain variable domain (VH) repertoire of antibody 
secreting plasma cells isolated from the bone marrow, lymph nodes, and spleen lymphoid 
tissues of immunized mice.  Statistical analysis showed significantly more overlap between 
 viii
the bone marrow and spleen VH repertoires as compared to the lymph node repertoires.  
Moreover, we identified and synthesized antigen-specific antibodies from the repertoire of 
a mouse that showed a convergence of highly frequent VH sequences in all three tissues.  
Second, we introduce a novel algorithm for the rapid and accurate alignment of VH 
sequences to their respective germline genes.  Our tests show that gene assignments 
reported from this algorithm were more than 99% identical to assignments determined 
using the well-validated IMGT software, and yet the algorithm is five times faster than an 
IgBlast based analysis.  Finally, in an effort to introduce methods for the standardization, 
transparency, and replication of future repertoire studies, we have built a cloud-based 
pipeline of bioinformatics tools specific to immunoglobulin repertoire studies.  These tools 
provide solutions for data curation and long-term storage of immunological sequencing 
data in a database, annotation of sequences with biologically relevant features, and analysis 
of repertoire experiments.   
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Chapter 1: Introduction 
THE PROGRESSION OF RESEARCH IN IMMUNOLOGY 
The immune system has evolved both innate and adaptive defense mechanisms 
against an ever-changing population of potentially lethal microorganisms such as bacteria 
and viruses.  The innate immune system serves as the first level of defense which employs 
a system of genetically pre-encoded defensive elements against commonly encountered 
microbes.  The adaptive immune system, on the other hand, responds more slowly but 
produces an immensely diverse repertoire of defensive elements.  Moreover, the adaptive 
immune system can induce immunological memory thereby conferring prolonged or even 
lifelong immunity.  Thus, upon infection, both the innate and adaptive systems work 
cooperatively to identify and precisely target previously encountered or unanticipated 
foreign pathogens.  
This study of the immune response to infection has been a topic of interest for more 
than 200 years.  Even at its onset, simple observations of humoral immunity led to dramatic 
improvements in health care and quality of life.  Pioneers such as Edward Jenner and Louis 
Pasteur demonstrated that inoculating individuals with attenuated strains of the virus could 
provide apparently life-long immunity against the rampant small pox virus and rabies[1].  
This revelation eventually led to the eradication of smallpox worldwide[2].  Discovery at 
the cellular level, however, progressed more slowly.  It took another hundred years after 
Jenner’s smallpox vaccination before Emil von Behring and Shibasaburo Kitasato 
demonstrated that resistance to pathogens was conferred by “anti-toxic” agents in the 
serum of immunized animals[1]. 
The emergence of modern biological technologies in the latter half of the 20th 
century drastically changed the tools and the pace of progress in understanding 
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immunology.  Arguably one of the most important discoveries was that the “anti-toxic” 
agents observed in serum were in fact antibodies produced by specialized antibody 
secreting immune cells known as B cells.  Newfound knowledge of antibodies and their 
ability to both bind with high specificity to antigens and recruit other immune cells has 
expanded the potential of future therapeutics.  The field of antibody discovery has resulted 
in the development of hundreds of novel antibodies with potential therapeutic ability[3]–
[5].  Despite such successes, there are still many aspects of the immune system that remain 
poorly understood and inhibit our advancements in next generation antibody development. 
 The adaptive immune response against pathogen challenge is highly sensitive to 
both signaling factors in extracellular environment and communication between multitudes 
of immune cell types.  A better understanding of how these signals are integrated and how 
the diversity of circulating antibodies affect adaptive immunity is essential for both 
antibody discovery and vaccine development against more complex diseases such as 
AIDS[6], [7].  Until recently, large scale analysis of the entire antibody repertoire elicited 
in the course of the immune response was impractical given the standard molecular biology 
tools and instruments available.     
Fortunately, the introduction of next generation sequencing at the beginning of the 
21st century has again changed the landscape of immunological research.  Whereas 
previous technology revealed extensive information concerning the cellular machinery that 
controls individual elements of adaptive immunity, next generation sequencing technology 
permits researchers to simultaneously study, at an unprecedented depth, the entire 
repertoire of humoral immunity at rest or following infection.  Already, this technology 
has provided insights into the diversity of the immune repertoires, improved methods for 
the isolation of antigen-specific antibodies, and enabled proteomic analysis of circulating 
antibodies[8]–[12].   
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However, next generation sequencing has also introduced many challenges.  
Namely, the ability to sequence repertoires at great depth has presented researchers with 
the difficulty of not knowing how to utilize the plethora of data that is generated.  In order 
to gain biological and therapeutic insights, there is an acute need for the development of 
experimental methodologies and informatics tools for acquisition and interpretation of 
antibody repertoire sequence data.  The work described in this dissertation seeks to address 
this need.   
FEATURES OF THE ADAPTIVE IMMUNE SYSTEM  
Lymphocyte development 
All cells which constitute the innate and adaptive immune systems are known as 
leukocytes or white blood cells.  More specifically, the two main subsets of leukocytes  
comprising the adaptive immune system are known as B lymphocytes (B cells) and T 
lymphocytes (T cells).  While, B cells will eventually give rise to antibody secreting cells 
known as plasma cells, their differentiation is highly dependent upon the mutual 
stimulation and maturation of T cells.  T cell lymphocytes provide co-stimulatory signals 
to B cells in turn leading to the evolution and selection of B cells expressing antigen 
specific antibodies.  Circulation and interaction between lymphocytes is facilitated by a 
specialized circulatory system known as the lymphatic system.  Together, it has been 
estimated that there are approximately 4x1011 circulating B and T lymphocytes in 
humans[13].  Each mature lymphocyte expresses a highly variable B cell receptor (BCR) 
or T cell receptor (TCR) designed to bind foreign antigen.  The number and clonal diversity 
of this vast repertoire of lymphocytes encoding for unique immune receptors influences an 




B and T cells originate in the bone marrow and thymus, respectively.  During 
development in the central, or primary, lymphoid tissues, lymphocytes undergo similar 
differentiation pathways in which the genes encoding the BCR and TCR undergo various 
diversification processes.  Differentiated cells expressing functional yet non self-reactive 
Figure 1.1: Development of lymphocytes in the lymphatic system 
B and T cell lymphocytes differentiate from precursor cells in the bone marrow and 
thymus lymphoid tissues, respectively.  Differentiated naïve cells exit central
lymphoid tissues via specialized lymphatic vessels and enter peripheral lymphoid
tissues where they survey for antigen challenge.  Stimulation between activated T 
and B cells results in B cell proliferation and maturation.  Matured B cells can
circulate back and take residence in the bone marrow.         
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BCR and TCR are termed naïve B cells and naïve T cells, respectively.  Following 
differentiation, the primary repertoire of naïve T cells and B cells egress from their 
respective compartments, the thymus and bone marrow, and circulate to peripheral 
lymphoid tissues where antigen specific lymphocytes can become activated and proliferate 
(Figure 1.1).  
Foreign substances and microorganisms drain into peripheral, or secondary, 
lymphoid tissues via lymphatic vessels.  Secondary lymphoid tissues, which include the 
lymph nodes, spleen, and mucosal tissues, are composed of densely organized layers of 
leukocytes that survey for pathogenic species present in lymph.  Interactions between cells 
from both the innate and adaptive immune system in secondary lymphoid tissues are 
required for an effective immune response.  For example, in secondary lymphoid tissues, 
antigen presenting cells of the innate immune system, known as dendritic cells, display 
epitopes from engulfed microorganisms on their cell surface[14].  T cells expressing 
antigen specific TCR can be activated by antigen presented on dendritic cell surface 
receptors and differentiate into either killer T cells, regulatory T cells, or helper T cells.  
Activated helper T cells are responsible for activating the maturation of antigen specific B 
cells in peripheral lymphoid tissues. 
B cells that bind antigen while receiving proliferative co-stimulatory signals from 
helper T cells can further develop into long-lived memory B cells or antibody-secreting 
cells with either a transient or protracted lifespan.  Memory cells survive for very long 
times and provide immunological memory, ready to proliferate rapidly in response to re-
challenge with pathogen.  Mature B cells such as plasma cells and plasma blasts produce 
and secrete copious amounts of the soluble form of the BCR which corresponds to the 
antibodies found in secretions and in circulation.  Antibodies secreted into blood are tasked 
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with both binding to foreign objects with high specificity, and with initiating an effector 
response against the target by interacting with leukocytes of the innate immune response.    
Antibody structure and function 
 
Figure 1.2: Structure of antibodies 
A) Crystal structure of an antibody (PDB: 1IGT) B) Cartoon representation of 
antibody structure.  The N-terminal “Y-shaped arms” of the antibody bind antigen. 
The heavy chain encodes for the C-terminal “stem” responsible for effector 
function.  Antibodies express five main classes of constant chains. C) Both heavy 
chain and light chains are composed of a variable region and constant region.  The
heavy chain variable region is encoded by three gene segments, V, D, and J. The
light chain variable region is encoded by a V and J gene segment.    
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Antibodies are described as “Y” shaped molecules containing two identical heavy 
(50 kDa) and light (25 kDa) chains linked together by disulfide bonds (Figure 1.2 A&B).  
The “arms” of the antibody are responsible for binding antigen tightly whereas the C-
terminal “stem” is responsible for determining the immune system response to the bound 
antigen.  The presence of two identical binding sites at the N-terminus increases the 
effective affinity for the antigen. 
Structurally, both the heavy and light chain are comprised of multiple homologous 
protein domains.  The overall conformation of each domain is known as an 
immunoglobulin fold[15].  The immunoglobulin folds contain a canonical secondary 
structure formed from two beta sheets linked via disulfide bond; anti-parallel beta strands 
that constitute the beta sheets are connected together by flexible loops[16].  The N-terminal 
domains of each chain are known as the variable heavy (VH) and variable light (VL) 
domains.  The remaining domains comprise the constant regions.  Heavy chain antibodies 
contain between four and five immunoglobulin domains (CH) whereas the light chain is 
composed of two such domains (CL) (Figure 1.2B).   
In humans, the VH region of an antibody can be associated with any of the five CH 
domains encoded by the separate , , , and  heavy chain gene clusters (Figure 1.2 
A)[5].  Each CH class confers different characteristics to an antibody such as antibody half-
life, effector functions (i.e. ability to recruit innate cells against the bound pathogen), and 
location within the body; these characteristics determine the antibody’s isotype.  For 
example, naïve B cells egressing from the bone marrow will express two classes of B cell 
receptors, IgM and IgD, encoded by the  and  gene CH clusters, respectively.  IgM 
expressing cells can form pentamers, significantly increasing the overall avidity of naïve 
cells with low affinity for the antigen[5].  Furthermore, once a naïve cell matures into 
highly specific antibody secreting cells, a process known as class-switch recombination 
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(CSR) swaps the  CH gene cluster for a orCH gene cluster[17].  Most affinity 
matured antibodies present in the blood and extracellular fluid belong to the IgG isotype 
and thus express a  CH constant region.  The IgG class of antibodies is highly efficient at 
recruiting innate leukocytes to eliminate bound antigen via antibody dependent cell 
phagocytosis (ADCP) or cytotoxicity (ADCC)[18].  IgA and IgE isotypes are 
predominantly responsible for countering pathogens present in the mucosal and epithelial 
layers[19], [20].  
While the constant heavy chain determines antibody isotype, the variable heavy 
(VH) and light (VL) domains are responsible for antigen binding.  Specifically, the VH 
region is encoded by three gene segments, a variable (V), diversity (D), and a joining (J) 
gene segment, and the VL region is encoded by only a germline V and J gene segment 
(Figure 1.2 C)[21].  Sequence variability in the VH and VL is not evenly distributed, but 
concentrated in three hypervariable regions called the complementary determining regions 
(CDRs 1, 2, and 3)[21], [22].  CDRs 1 and 2 are found in the variable gene segment whereas 
CDR3 is formed by the junctions of the V-D-J and V-J gene segments comprising the VH 
and VL, respectively[23].  The CDRs correspond to the flexible loops between anti-parallel 
beta strands of the immunoglobulin fold and provide the vast majority of contact with 
antigen[16].  The less variable protein sequences which flank the CDR regions are called 
the framework regions (FR 1, 2, 3, and 4)[21].  
Genetic diversification processes that guide repertoire diversity  
The true diversity of an individual’s immune repertoire is currently unknown.          
Although there are more than 1011 circulating lymphocytes in humans, genetic 
diversification processes introduced during the development of a pro-B cell into an affinity 
matured B cell can theoretically produce a significantly larger number of variants 
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expressing unique surface receptors.  Specifically, the diversity of an antibody is regulated 
by four genetic mechanisms: (1) V(D)J recombination, (2) N/P nucleotide addition 
between the V(D)J junctions, (3) paring of heavy and light chains, and (4) somatic 
hypermutation introduced during affinity maturation of antigen specific lymphocytes in 
germinal centers[21]. 
V(D)J Recombination  
The gene segments which encode heavy and light chains are organized into three 
separate chromosomal clusters.  In humans, the VH, DH, and JH gene segments are found in 
chromosome 14[24].  While there is only one genetic locus for the heavy chain, two 
independent loci, located on chromosomes 22 and 2, give rise to lamda () and kappa () 
light chains[25], [26].  In precursor lymphocyte cells, these germline encoded loci contain 
multiple, non-identical copies of each V, D, and J gene segment[27].  Specifically, 140 
unique VH genes, 27 unique DH genes, and 6 unique JH genes have been identified in the 
VH locus of chromosome 14 in humans; similarly, the lamda and kappa genetic loci of 
human precursor cells encode for 75 V and 82  V genes, and 7 unique J and 5  J 
genes[28].  During lymphocyte differentiation, the supposed random recombination of 
these germline gene segments, termed V(D)J recombination, can produce a highly diverse, 
>107, population of naïve lymphocytes.   
V(D)J somatic recombination is initiated by lymphocytes undergoing 
differentiation in primary lymphoid tissues.  During this process, one VH[/, one DH, and 
one JH[/ germline gene are recombined into a single VH or VL exon[21].  Briefly, 
lymphocyte precursor cells express two recombinase enzymes, known as RAG-1 and 
RAG-2, that catalyze the random cleavage of DNA segments between specific signal 
sequences that flank VH and VL genes[29], [30].  In early stage B lymphocytes, the RAG-
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1/2 complex directs the random selection and cleavage of chromosomal DNA between the 
DH and JH germline genes (DJ recombination) [31].  Next, a random VH gene is recombined 
with the DJ gene segment in cells that have differentiated into the pre-B stage (Figure 
1.3)[31].  
 
Figure 1.3 Somatic recombination of the VH gene segment in a Pro-Pre-B cell 
The germline of precursor lymphocytes encodes for multiple copies of a VH, DH, 
and JH gene segment.  During differentiation, lymphocytes select one VH, DH, and 
JH from the germline (V(D)J recombination).  First, DJ recombination occurs 
during differentiation into a Pro B cell.  Next, differentiation into a Pre B cell
results in a VDJ recombined VH gene.  During VDJ recombination, random N/P 
nucleotide addition and subtraction introduced at the VD and DJ junctions 
(illustrated by colored diamonds above) results in the formation of a highly unique
region of the antibody termed the CDR3.  
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Identical recombination of the VJ or VJ gene segments into a VL exon occurs during 
the differentiation of a pre B cell into an immature B-cell[31].  While somatic 
recombination of germline genes can theoretically encode for more than 107 combinations 
of unique VH/VL pairs, V(D)J recombination is accompanied by an additional 
diversification process that introduces significant sequence variation at the V(D)J 
junctions, as discussed in the next section.   
N/P nucleotide addition contributes to CDR3 diversity 
In naïve B cells that have not been exposed to antigen, the CDR1 and CDR2 
complementary determining variable regions are encoded entirely by the variable VH and 
V[ germline gene segments.  The CDR3, on the other hand, is formed by the action of 
DNA repair mechanisms that are recruited after V(D)J recombination.  RAG-1/2 directed 
joining of the gene segments creates hairpins which must be resolved by the nuclease 
enzyme, Artemis.  Resolution of these hairpins results in the random addition of 
palindromic nucleotide sequences (P addition) at the ends of the joining region[32].  In 
addition to P addition, a lymphoid-specific enzyme, terminal deoxynucleotide transferase 
(TdT), randomly adds nucleotides to the ends of the V(D)J gene segments resulting in 
random non-templated nucleotide addition and subtraction (N addition)  (Figure 1.3).   
Because of random nucleotide N/P addition at the V(D)J joining ends of both heavy 
and light chains, the CDR3 is the most unique and variable region of an antibody.  For 
example, in humans, the length of the CDR3 sequence in the heavy chain can vary between 
5 and 30 amino acids.  Introduction of this random junctional diversity is the reason CDR3 
sequences are often used as fingerprints to identify groups of B cells that are clonally 
expanded from the same parent naïve cell that encodes for a unique CDR3.  Precursor B 
cells which express non-self-reactive and functional IgM and IgD B-cell receptors are 
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known as mature B cells.  This repertoire of mature B cells is also considered naïve since 
it is not yet known which B cells can successfully engage future pathogens.   
Affinity maturation in germinal centers 
Naïve cells leave primary lymphoid tissues and circulate through blood and 
lymphatic vessels to secondary lymphoid tissues, surveying for potential antigens.    Only 
antigen specific B cells that receive the proper signals from helper T cells and cytokines 
are programmed for survival and proliferation.  These selected B cells can further 
differentiate into either short-lived plasma cells, memory B cells, or long-lived plasma 
cells[33].  Short-lived plasma cells , or plasmablasts, live for several days and produce low 
affinity antibodies early on during an immune response, whereas differentiated memory or 
plasma cells can express much higher affinity B cell receptors and antibodies[34], [35].  
More importantly, selected memory B cells are capable of rapidly responding to repeated 
exposures to the pathogen.  While the fate of B cell differentiation is not governed by one 
process, a major source of high affinity memory B cells and long-lived plasma cells is 
within specialized sites of peripheral lymphoid tissues called germinal centers[34], [36].   
Germinal centers start as a small cluster of dividing antigen-stimulated B and T 
cells.  Histological staining of germinal centers shows that, after a few days,  dividing cells 
expand into two well defined compartments of light and dark stained zones[22].  These 
two distinct zones are believed to play a key role in affinity maturation and selection.  
According to the cyclic re-entry model of affinity maturation within germinal centers, B-
cell clones enter the dark zone where they undergo division and another chromosomal 
diversification process known as somatic hypermutation (SHM)[36].  This high density of 
proliferating B cells gives the compartment its “dark” appearance after histological 
staining[37].  Somatic hypermutation is catalyzed by the enzyme, activation-induced 
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cytidine deaminase (AID), which randomly creates base-pair mismatches via the 
deamination of cystosine into uridine[38].  Introduction of these base-pair mismatches 
signals DNA repair pathways, but in the process also introduces semi-random nucleotide 
changes ( approximately 10-3 to 10-5 mutations per base) at sites near the deamination 
site[39], [40].  After SHM, B cells encoding diversified BCRs are interspersed into the 
germinal light zone where they undergo selection.  Clones with increased affinity for the 
antigen are selected for further diversification or differentiation whereas low affinity 
mutants are programmed for apoptosis[36] (Figure 1.4).   
Figure 1.4 The cyclic reentry model of affinity maturation 
T cell activated B cells form germinal centers (GC) in peripheral lymphoid tissues.  In
the dark zone of a GC, B cells undergo clonal expansion and SHM of their respective
BCRs.  Expanded B cells enter light zone where they are presented with antigen.  BCR
displaying affinity for the antigen can re-enter dark zone for further SHM.  BCR with 
low antigen affinity are programmed for apoptosis.   
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In summary, studies in molecular genetics have revealed that the adaptive immune 
system can encode for an astronomical number of unique B cell receptors which arise as 
the result of multiple diversification and antigen-selection processes.  During an immune 
response, unique B cell lymphocytes capable of recognizing the pathogen with high affinity 
are produced and deployed to block the infectious agent and mediate its clearance through 
the engagement of innate killer cells.  Such mechanistic studies, however, can only provide 
a partial picture of adaptive immunity during infection and little is known about the true 
diversity and interaction of the circulating immune repertoire as a whole. 
 
HIGH THROUGHPUT TECHNOLOGIES IN IMMUNOLOGY 
Significant improvements in high-throughput technologies have allowed for “high-
resolution” system level analysis of the immune receptor repertoire.  The combination of 
cell cytometry (for the isolation of desired lymphocyte subsets), single cell analysis and/or 
next generation sequencing can enable both the quantification of the percentage of antigen 
specific lymphocytes and identification of the nucleic acid sequence of their respective 
BCR or secreted antibodies.  Table 1.1 summarizes current technologies that have been 
used by immunologists for sequencing and investigating the functional analysis of 










































































































































Single Cell Analysis  
Early studies of B cells and antibody discovery relied upon hybridoma technology 
in which individual B cells were immortalized by fusion with tumor cells[41], [42], [43], 
[44].  The discovery of hybridoma technology was a milestone for immunology research, 
Table 1.1: Current technologies in immunology  
Comparison of the technological capabilities of hybridoma, single cell analysis, and
next generation sequencing in immunology.  Table adapted from review by Reddy
and Georgiou, 2011.   
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antibody discovery, and the understanding of B cell fate and regulation[45]–[47].  
However, reliance upon hybridomas for in-depth studies of immune repertoires is 
impractical because successful formation of immortalized cells occurs at a very low 
frequency.  More importantly, not all B cell types, such as terminally differentiated plasma 
cells, are amenable to immortalization[48].  The subsequent introduction of single cell 
cloning overcame some of these limitations.  Single cell cloning involves four general 
steps: (1) isolation of specifically differentiated lymphocyte cell populations with the help 
of antibodies that recognize the appropriate cluster of differentiation (CD) cell surface 
protein markers using fluorescence activated cell sorting (FACS); (2) plating of cells on 
microtiter plates at limiting dilutions such that each well contains at most cell; (3) 
depending upon the purpose of the study, optional screening for cells with antigen 
specificity; (4) cloning of VH and VL genes into vectors for sequencing and, when needed, 
expression of the respective antibody protein[45].   
Single cell analysis has assisted in the discovery of novel therapeutic 
antibodies[49]–[52].  For example, single cell analysis has been used extensively to 
identify broadly neutralizing antibodies against rapidly evolving viruses such as HIV and 
flu[49], [53]–[56].  Unfortunately, single cell cloning has two major limitations.  First, the 
throughput of analysis is limited to a few hundred cells per experiment.  Second, single cell 
cloning is very time and materials intensive.  To some extent, these limitations can be 
addressed by applying microfluidic and lithographic techniques which can increase cell 
throughput by three orders of magnitude[45], [48], [57].  However, such methods are costly 
and materials are not always readily available to all research institutions.   
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Next Generation Sequencing 
Before the 21st century, DNA sequencing relied upon the method developed by 
Fred Sanger and then automated by Applied Biosystems and other companies[58].  
Automated systems using Sanger sequencing could, at best, process only a few hundred 
sequences simultaneously[59].  In 2005, so called next generation sequencing (NGS) was 
introduced by 454 Life Sciences.  This and other technologies for high throughput 
sequencing that soon followed enabled the parallel sequencing of 100s of thousands of 
DNA strands at a relatively low cost[60]–[62].  With NextGen sequencing, throughput has 
increased from 102 kbp/day in the late 20th century to more than 1012 kbp/day today[61].  
Scientifically, next generation sequencing has facilitated the ability to perform high 
throughput genome sequencing, transcriptional analysis, epigenetic marker detections, and 
identification of genetic markers that correlate with disease[59].   
Application of NGS methods provides a means for characterizing, at sufficient 
depth, a large fraction of sequences encoded by B cells comprising the immunoglobulin 
repertoire [8], [9], [11], [63]–[66].  In principle, NGS methods can theoretically yield 
sequence information from 106 B lymphocytes.  In contrast to single cell cloning methods, 
sequencing B cell receptors by NextGen sequencing is rapid, requires relatively little 
material and cost, and is a powerful tool in both fundamental immunology research, and 
for therapeutic and antibody discovery purposes (Figure 1.5).  The overall approach for 
deep sequencing immunoglobulin repertoires is as follows.  First, a desired B cell subset is 
isolated by FACS from either blood or a particular tissue of interest.  Second, cells are 
lysed and cDNA is synthesized from mRNA encoding B cell receptors.  Third, V genes 
within the cDNA pool are PCR amplified and prepared for next generation sequencing.  
Finally, bioinformatics methods are required to analyze the sequenced repertoire.  While 
most steps in this pipeline are standardized, the final task of bioinformatics analysis will 
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vary greatly for each experimental study.  Common methods of analysis can require the 
use of algorithms which perform multiple sequence alignments, nucleotide and amino acid 
sequence clustering, and robust statistical analyses[67]–[70] 
 
Deep sequencing the immunoglobulin expression profile from millions of B cells 
of different species has led to in depth quantifiable analysis of germline usage, CDR3 
length, and amino acid composition[63], [71]–[75].  For instance, one of first applications 
of next generation sequencing in immunology was the determination of the 
Figure 1.5: High throughput sequencing of immune repertoires 
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immunoglobulin repertoire in zebra fish[11].  Using next generation sequencing, they were 
able to characterize the patterns of VDJ usage in the naïve zebra fish repertoire and, 
moreover, identify immunoglobulin sequences that were present across multiple fish[11].  
These investigations have expanded our current knowledge concerning the distribution and 
mechanisms associated with the immune repertoire from both healthy and unhealthy 
individuals[76]–[78].  Additionally, high-resolution analysis of repertoires may be applied 
in the identification of biomarkers indicative of viral infection such as Dengue or cancer 
malignancies[79], [80].  Finally, next generation sequencing has proven useful for the 
identification of antigen specific antibodies following immunization[9].   
Since this shift in immunology towards genomic analyses using next generation 
sequencing, various sequencing platforms have emerged, each proclaiming benefits of 
improved sequencing and accuracy.  The choice of NGS platform will define the 
technological limitations of an experiment, how the data must be processed before analysis, 
and the types of non-biological errors that will be introduced after sequencing.  The 
following section discusses NGS technologies commonly used for sequencing 
immunological repertoires. 
 
METHODS AND PLATFORMS FOR NEXT GENERATION SEQUENCING 
While each individual platform varies with respect to number of sequences 
generated per run, read length, error rate, and total cost, all next generation sequencing 
platforms have three steps in common: (1) Library generation and amplification without 
bacterial cloning; (2) Conjugation of DNA library to a solid support such as glass slide or 
microbead; (3) Application of a method for parallel DNA synthesis and the identification 
of incorporated bases during synthesis[61], [62].       
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Library preparation 
The first step in most next generation sequencing platforms, such as Roche 454 or 
Illumina MiSeq, is the addition of small adapter nucleotide sequences to the ends of the 
amplicons which act as primers for downstream polymerase and extension reactions.  
Depending on the technology, template libraries for sequencing can either be directly 
sequenced (single molecule detection) or clonally amplified.  Clonal amplification methods 
are more readily used because they afford a lower error rate[61].  Two common techniques 
for clonal amplification are emulsion PCR and solid phase amplification (Figure 1.6)[61].  
Figure 1.6: HTS methods for clonal amplification 
A) Emulsion PCR: DNA is captured on beads and encapsulated in oil-water 
emulsion mixture containing all reagents (i.e. dNTP and polymerase) necessary for
PCR amplification.  PCR amplification is performed within droplets, generating
beads containing thousands of copies of the original amplicon.  Emulsion is broken 
and individual beads are deposited in picotiter plates or glass slides for downstream
sequencing. B) Individual amplicons are deposited sparsely on solid support.
Amplicons are used to prime clusters and immobilize template on surface.  Clusters
of DNA strands are created using bridge amplification of immobilized template
with neighboring primers. 
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In emulsion PCR, individual template DNA molecules are ligated with adapter 
sequences and then placed in oil-water emulsion mixtures.  Within the emulsion mixture, 
single stranded DNA molecules, via their ligated adapters, are captured onto beads under 
conditions that favor one DNA molecule per bead.  PCR amplification is performed in 
individual emulsion droplets.  After PCR amplification, EmPCR beads will contain 
thousands of identical copies the original captured DNA strand[81].  After amplification, 
the emulsion is broken and EmPCR beads containing PCR amplified sequences are 
immobilized either in a picotiter plate or on a solid glass surface for DNA sequencing and 
detection.   
In contrast to emulsion PCR, solid phase amplification generates clonally amplified 
DNA clusters directly on the glass surface of the flow cell.  Initially, this glass surface is 
coated with a high density of oligonucleotides that are complementary to the adapter 
sequences that were ligated to template DNA strands.  The oligonucleotides will 
immobilize adapter-ligated DNA strands deposited distantly on the glass slide[61].  The 
captured DNA strand is subsequently used as a template for the elongation of its 
complementary strand via PCR.  The high density of neighboring oligonucleotides, 
covalently bound to the glass surface serve as primers for further amplification of the DNA 
template and its complementary strand.  Therefore, bridge amplification results in the 
generation of a dense clusters of amplicons seeded by the original template strand.  In 
principle, because the templates are deposited in spatially distinct areas along the slide, 
there is no contamination by clusters of neighboring templates.   Amplified “template 
clusters” are subsequently subjected to DNA sequencing.  
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Sequencing and Detection 
 
Figure 1.7: HTS methods for sequencing and imaging clonally amplified templates 
A) Pyrosequencing: Indirect detection of nucleotide incorporation via
pyrophosphate reaction with Sulphurylase and Luciferase. B) CRT: Direct detection
of nucleotide incorporation via fluorescent dNTPs.  C) Sequencing by ligation:
Hybridization of fluorescent probes. 
 23
NGS platforms use a variety of techniques for DNA sequencing.  These techniques 
include, but are not limited to the indirect detection of nucleotide incorporation, direct 
detection of nucleotide incorporation via fluorescent dye, and sequencing by ligation 
(Figure 1.7)[61].  Pyrosequencing is an example of a method where sequencing relies on 
indirect detection of nucleotide incorporation[61].  During pyrosequencing, each 
nucleotide is individually washed over the library of amplicons.  Successful, incorporation 
of a complementary nucleotide into the growing DNA sequence results in the release of a 
pyrophosphate group.  ATP sulfurylase and luciferase enzymes present in the solution 
detect the release of pyrophosphate and emit light whose intensity is directly proportional 
to the number of nucleotides incorporated during that cycle.    
A common method of direct detection of nucleotide incorporation is called cyclic 
reversible termination (CRT)[61].  During CRT, DNA polymerase incorporates a 
fluorescent nucleotide that is complementary to the current base of the primed template.  
Each fluorescent nucleotide contains a reversible terminator group which prevents any 
other nucleotide from hybridizing to the template.  Upon incorporation, a detector records 
which fluorescently labeled nucleotide hybridized to the template base.  Next, the 
terminator and dye are removed from the incorporated base, and the cycle continues 
iteratively for the remaining bases. 
Finally, sequencing by ligation does not utilize a polymerase for DNA sequencing.  
Instead, this method relies upon DNA ligase which inserts fluorescently labeled DNA 
probes that hybridize to complementary sequences adjacent to the primed template.  Probes 
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Table 1.2: Comparison of currently available NGS sequencing platforms 
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Table 1.2 summarizes NextGen sequencing platforms that are currently available 
and lists their respective advantages and disadvantages.  Since 2005, two platforms have 
dominated mainstream DNA sequencing: 454 pyrosequencing by Roche and Illumina 
HiSeq and MiSeq sequencing.  454 sequencers return longer sequence reads with an overall 
lower error rate of base-pair mismatches at the expense of higher sequencing costs, lower 
processivity, and a higher probability of errors when sequencing homopolymer strands of 
DNA.  Illumina is currently the leading technology in next generation sequence because it 
can support more than 106 reads per plate at a low cost.  However, regardless of the 
technology, there are still many challenges that must be overcome when applying NGS in 
immunoglobulin repertoire analysis.   
 
CHALLENGES INTRODUCED IN NEXT GENERATION SEQUENCING OF ANTIBODY 
REPERTOIRES 
Although highly promising, many challenges must be addressed when using next 
generation sequencing for the analysis of immunoglobulin repertoires.  A common 
experimental aim in this field is the identification of immunoglobulin sequences that 
correspond to unique somatic variations of the BCR.  However, non-biological variation 
in the sequence can also be introduced by next generation sequencers which have intrinsic 
error rates ranging from 10-2 to 10-4 mutations per base pair[82].  Furthermore, PCR 
amplification of the cDNA library prior to sequencing introduces base pair mismatch error, 
insertion and deletion errors, and can skew the cDNA transcriptome.  The latter is caused 
by the inability to amplify individual transcripts which do not anneal preferentially to the 
mixture of degenerate primers[83].  Thus, distinguishing biologically relevant sequence 
variation from experimental error can be difficult. 
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Proper experimental design can address some of these challenges.  Sequencing 
technical replicates of cDNA libraries amplified with two or more primer sets can be useful 
for determining the statistical significance of differences observed in downstream analyses 
of non-technical replicates[11].  Additionally, sequence error introduced during PCR 
amplification and high throughput sequencing can be minimized by annealing random 
oligonucleotide barcodes to cDNA transcripts before PCR amplification.  These barcodes 
are used, post-sequencing, to align amplicons derived from the same template, and correct 
for any non-biological sequencing errors that were introduced[84].  Finally, spiking known 
immunoglobulin DNA sequences into samples can be used to establish the sensitivity and 
sequencing depth of a repertoire study[85].          
Regardless of experimental design, bioinformatics analysis is essential for 
deconvoluting the humoral immune response.  Researchers are heavily reliant upon 
analysis using openly available software packages or custom-made bioinformatics 
pipelines.  This requirement poses a significant challenge for researchers who lack strong 
computational backgrounds, and yet have an overabundance of sequence information.  
Many algorithms for immunology research are not designed to handle the information 
currently generated by next generation sequencing.  More importantly, the lack of 
standardization in this field makes it difficult to select the proper methods of bioinformatics 
analysis, and carry out meta-analyses of data compiled from various laboratories.   
The following chapters presents tools which address such challenges in big data 
and repertoire analysis.  First, in chapter 2, methods are presented for the statistical analysis 
and comparison of similarity between multiple immunoglobulin repertoires.  Second, 
chapter 3 introduces a novel algorithm for rapidly aligning immunoglobulin sequences to 
their respective VH genes.  Finally, in chapter 4, a cloud-based immunoglobulin analysis 
pipeline has been designed to address the lack of a validation, transparency and 
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reproducibility of repertoire studies.  In addition, this pipeline has been designed around a 
database for the deposition and sharing of computational resources across the 
immunological community.           
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Chapter 2:  A systems analysis of immunoglobulin repertoires in the 
lymphoid tissues of immunized mice  
INTRODUCTION 
The ability of the adaptive immune system to produce antigen specific antibodies 
following antigen challenge is critical for the elimination of pathogenic cells, and is of 
great interest for antibody discovery.  The humoral adaptive immune response is dependent 
upon the successful selection and maturation of antigen specific immune cells from a 
diverse population of B cells that originate from developing precursor pro-pre-B cells in 
the bone marrow [86], [87].  During differentiation in the bone marrow, pro-pre-B cells 
undergo diversification of their B cell receptors (BCRs) by mechanisms such as the somatic 
recombination of the variable (V), diversity (D), and joining (J) gene segments, and the 
introduction of junctional diversity between recombined gene segments[88].   
Once differentiated, naïve B cells migrate to peripheral lymphoid tissues and survey 
for “non-self” molecules that are present in lymphatic fluid or presented on the cell surface 
of antigen-presenting cells.  Antigen-activated B cells form germinal centers and undergo 
rounds of division and affinity maturation via somatic hypermutation of their B cell 
receptors.  These clonally expanded antigen-experienced B cells differentiate into either 
memory B cells or terminally differentiated antibody secreting plasma cells (PC), which 
secrete copious amounts of antibodies in serum[88]–[97].  Thus, especially in the case of 
an immunized individual, the immune repertoire of B lymphocytes post affinity maturation 
can become skewed towards clonally related B cells, termed clonotypes, that presumably 
originated from a particular naïve B cell precursor[86], [87], [98]–[100]. 
B lymphocytes circulate extensively through blood and lymphoid tissues.  
However, the distribution of these circulating lymphocytes within individual tissue 
compartments is not well understood.  For example, it has not been determined whether 
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populations of clonally related B lymphocytes reside preferentially within a single 
lymphoid tissue, or are distributed evenly across multiple tissues.  Further, it is not known 
whether differentiated plasmablasts distribute within secondary lymphoid tissues or rapidly 
home to the bone marrow for long term survival. Therefore, a particularly interesting issue 
is whether B clones encoding identical or highly similar antibody sequences are distributed 
equally among lymphoid tissues.   
These questions may be addressed by employing next generation sequencing to 
survey the antibody repertoires of individual lymphoid tissues.  Rigorous statistical 
methods can be used to compare the “degree of polarization” (i.e. prevalence of highly 
expanded clones) within specific tissues, as well as the overlap among the immunoglobulin 
repertoires of lymphoid organs following immunization[101]–[104].  It should be noted, 
however, that the comparison of B cell repertoires in various organs will be influenced by 
the immunization protocol.  For example, the immune system’s response to antigen can be 
affected by the route of immunization, the nature of the antigen and adjuvants used during 
immunization, and the time following immunization when organs are harvested for 
analysis.    
Here we investigated the antibody repertoires encoded by antibody secreting cells 
(CD138+ plasmablasts and plasma cells) from the bone marrow, spleen, and lymph nodes 
of five different BALB/c mice immunized with the antigen hen-egg-lysozyme (HEL).   We 
present methods for the comparative analysis of VH gene expression in each population.  
Particular emphasis of the work presented here illustrates analytical approaches for 
discerning relevant features of a repertoire from large sets of sequence data.  In addition 
we present data visualizations methods for conveying the biological relevance of the 
analysis.  Finally, we report that in animals where the same antibody sequences were 
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present at a high frequency in all tissue compartments, the top most expanded VH sequences 
encode for antigen-specific antibodies.  
DEFINITION OF TERMS USED IN THIS STUDY 
The following describes the meaning of terms used throughout this study: 
a) VH gene sequence: Refers to a unique full length immunoglobulin sequence. 
b) Sequence counts: Refers to the number of times we observe a unique VH gene 
sequence in our data. 
c) VH Clonotype-cluster:  For this study, a clonotype-cluster refers to a group of 
VH gene sequences that encode for the same V gene segment and CDRH3 
amino acid sequence.  Biologically these sequences are believed to be clonally 
related B cells that differentiated from the same parent naïve B cell.  
d) Unique clonotype: The unique clonotype refers to the unique CDRH3 sequence 
used to cluster VH gene sequences into clonotype-clusters.  The number of 
unique clonotypes corresponds to the total number of clonotype-clusters. 
e) Clonotype-cluster size: Refers to the total number of sequence counts that are 
grouped into the respective clonotype-cluster. 
f) Singleton: Refers to clonotype-clusters or unique VH gene sequences with a 
respective clonotype-cluster size or sequence count of one.  
g) Non-Singleton: Refers to clonotype-clusters or unique VH gene sequences with 
a respective clonotype-cluster size or sequence count greater than one. 
h) Tissue-specific clonotype: Refers to a clonotype-cluster comprised of VH 
sequences identified in only a single lymphoid tissue. 
i) Tissue-shared clonotype: Refers to a clonotype-cluster comprised of VH 
sequences from two or more lymphoid tissues. 
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j) Tissue Polarization: A tissue that is highly polarized would be indicative of a 
repertoire containing a small number of unique clonotype-clusters that are 
observed at a very high frequency; conversely, a non-polarized tissue or highly 
diverse population would be indicative of a repertoire consisting of numerous 
unique clonotypes present at very low frequencies.   
MATERIALS AND METHODS 
Experimental bench work 
The wet lab experimental methods described in this section were performed by 
Kam Hon Hoi.   
Immunization regime 
Five female BALB/c mice were obtained at six weeks of age from The Jackson 
Laboratory (Bar Harbor, ME).  The mice were housed in the Animal Resource Center for 
the University of Texas at Austin. All experimental procedures were conducted under the 
guidelines of the university’s Institutional Animal Care and Use Committee (IACUC # 
AUP-2010-00089). Six-week old female BALB/c mice were primed with 30 µg of Hen-
Egg-Lysozyme (HEL) (Sigma Cat# L6876-25G) and 25 µL of Complete Freund’s 
Adjuvant (CFA) (Thermo Scientific Prod# 77140) subcutaneously.  Twenty-one days post 
primary immunization, the mice were boosted with 25 µg of HEL and 25 µL of Incomplete 
Freund’s Adjuvant (IFA) (Thermo Scientific Prod# 77145) intraperitoneally.  Seven days 
after the boost, the mice were injected with a further 25 µg of HEL and 25 µL of IFA 
intraperitoneally. 
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Immune cell isolation and plasma cells enrichment 
Seven days after the second immunization boost, the mice were euthanized with 
carbon dioxide asphyxiation.  Spleen, femur and tibia bone marrow, and a total of 6-8 
lymph nodes (2 brachial, 2-4 lumbar, and 2 mesenteric) were collected for immune cell 
isolation.   Single cell suspensions of secondary lymphoid organs were prepared in ice-cold 
buffer no.1 (sterile-filtered PBS with 0.1% BSA and 2 mM EDTA) separately for each 
lymphoid organs from each animal.  A detailed description of bone marrow isolation was 
shown in a previous report[101].  Isolation of single cells from the spleen and lymph nodes 
were performed as follows.  Tissues were mechanically teased apart.  To separate single 
cells from connective tissue, teased samples were ground on a 70 μM mesh filter.  PBS 
was used to resuspend single cells and subsequently filter ground cells through the mesh 
filter.  Plasma cells and plasmablasts are the only B cell subsets that express CD138.  
Therefore, to isolate plasma cells and plasma blasts from other B cells,  CD138+ cells were 
enriched using anti-mouse CD138-biotin (BD Pharmingen Cat# 553713) and Dynabeads 
M-280 streptavidin (Invitrogen Cat# 112.05D). 
RNA extraction and cDNA generation 
CD138+ enriched cells from each lymphoid tissue were lysed separately using the 
TRI Reagent (Ambion Cat# AM9738).  Total RNA was isolated according to the 
manufacturer’s RiboPure Kit protocol (Ambion Cat# AM1924).  First strand cDNA of IgG 
specific immunoglobulin sequences were generated from a minimum of 100 ng of isolated 
total RNA using SuperScript RT II kit (Invitrogen Cat# 18064-022) and primers that bind 
specifically to the CH1 region of the IgG constant chain.  PCR amplification of the first 
strand cDNA was performed using conditions described previously[101] and a validated 
VH gene primer mix [105].  PCR products were gel-purified and subsequently submitted 
for 454 next generation sequencing. 
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ELISA assays of serum titer 
For at least 16 hours at 4 oC, Polystyrene 96 well plates (Costar #3590) were coated 
with 100 μl of Hel at a concentration of 8 µg/mL.  To separate plasma cells from blood, 20 
µL of blood from the terminal bleed of the mice was centrifuged on a bench-top centrifuge 
at 5000 RPM for five minutes.  Anti-HEL serum antibodies in the supernatant were 
determined by ELISA.  Goat anti-mouse IgG HRP (Invitrogen Cat# 62-6520) conjugated 
antibody was used as the secondary antibody and TMB substrate (Thermo Scientific Prod# 
34028) was used to develop the plate. Serum titers were determined by identifying the 
dilution level where absorbance at 450nm diminished to background levels. 
Antibody expression 
The VH gene amino acid sequences corresponding to the top five most highly 
abundant clonotypes in the highest titer mouse (Mouse 23), were used to construct 
synthetic genes (based on E. coli optimized codon sequences).  The five synthetic VH genes 
(Table B.5) were cloned into individual pFAB-S plasmids.  Cloned VH genes were 
combinatorially paired with the cDNA library of VL light chains isolated from CD138+ 
cells in the mouse 23 bone marrow.  The combinatorial VH-VL paired library was 
transformed into Jude-1 E. coli cells.  Subsequently, 96 colonies were individually picked 
and grown in 96 well plates and screened by ELISA.  ELISA assays were performed by 
coating polystyrene plates (Costar #3590) overnight at 4 oC with 8 µg/mL of HEL or 8 
µg/mL of BSA (as an unrelated antigen control).  After initial screening of potential 
antigen-specific binders, competitive ELISAs were performed to confirm antigen-
specificity of the heavy/light chain pairings.  For competitive ELISA, antigen-specific 
binders were preincubated with 80 µg/mL of soluble HEL for one hour.  After washing 
away soluble HEL and other molecules in plate solution, the amount of bound antibody 
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remaining in the well was measured using ELISA as described above.  Samples with loss-
in-signal after competitive ELISA suggested heavy-light pairs with strong affinity for HEL.      
In-silica sequence analysis 
Raw data processing 
In total, 15 cDNA samples were submitted for 454 pyrosequencing (Table 2.2).  We 
assumed sequences less than 350 base pairs were not full length heavy chain sequences 
containing a VH, DH, and JH gene segment.  Therefore, sequences less than 350 base pairs 
were removed from the analysis.  Sequences  that were  longer than 350 base pairs  and 
also passed internal Roche 454 quality filters were analyzed using IMGT High V-Quest 
immunoglobulin analysis software[67].  First, full length DNA sequences containing stop 
codons or lacking an identifiable VH, DH, and JH gene were considered non-productive 
sequences and filtered out.    Full length immunoglobulin sequences were analyzed for the 
following features using results extracted from the IMGT High V-Quest output files: VH 
gene family, CDRH1, CDRH2 and CDRH3 amino acid sequences, full length nucleotide 
sequences, and the degree of somatic hypermutation as compared to the sequence’s 
predicted germline assignment.   
VH Gene family usage 
In mice, the VH germline genes are grouped by sequence similarity into 16 gene 
families.  For each lymphoid tissue, we calculated the distribution of VH gene family usage 
across sequences.  Chi-square analysis was used to calculate the similarity of VH gene 
family usage across multiple lymphoid tissues.  For each mouse, VH families observed at 
very low frequencies (sequence count < 5) were binned together before comparing usage 
between lymphoid tissues.  Pairwise tissues with a reduced χ2 value < 3.8 (p-value <0.05) 
were assumed to demonstrate an identical distribution of VH gene usage.   
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Clonotype correlation analysis 
Pearson correlation analysis was used to compare the frequency of clonotype-
clusters shared between pairwise tissues.  For each pairwise tissue comparison, a Pearson 
correlation coefficient was calculated from clonotype-clusters present in both lymphoid 
tissues.  Finally, using Fisher r-to-z transformations, we calculated the statistical 
significance of correlation coefficients between different pairwise tissue comparisons.  
Clonotype diversity analysis 
We wanted to quantify clonotype-cluster diversity or, conversely, polarization in 
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Table 2.1: Common indices of diversity and normalized true diversities 
Diversity index quantifies population diversity.  Sensitivity of diversity to 
frequency, fi, is represented by the order of diversity, q.  True diversity is the 
normalized representation of the diversity index.  Table adapted from Jost, 2006. 
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biological diversity of populations.  Table 2.1 provides a list of diversity indices (described 
in detail in Appendix B) commonly used to characterize diversity.   
Diversity indices are monotonic functions in which a larger diversity index 
indicates a more diverse population.  However, as explained in Appendix B, one caveat in 
using diversity indices is that, while they are monotonically increasing, they are not all 
linear.  This non-linearity could be misleading when comparing populations because a 
population whose Shannon entropy diversity index is 10 is not twice as diverse as a 
population whose index is 5.  Instead, it is useful to first normalize or linearize the diversity 
index into a term referred to as “true diversity” [106] (Table 2.1).  The units of true diversity 
represent the “effective number of species” in a theoretical population consisting of an even 
distribution of species present at equal frequencies, and whose diversity index is equivalent 
to the diversity index in the non-normalized population (Appendix B).  Most importantly, 
using this definition of effective number of species, a population whose true diversity is 10 
can be considered to be twice as diverse as a population with a true diversity of 5.   Equation 
2.1 describes a generalized form of true diversity, DT, as a function of both species 





( ) ( )  [Eq 2.1]
:
  D  =  True diversity/"Effective number of species"
  q =  The diversity order
  S = The total number of unique species














In Equation 2.1, diversity is defined by the sum of species frequencies raised to the 
power of q.  Hence, for each diversity index, the order of diversity, q, defines the sensitivity 
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of diversity to species frequency.  Obtaining diversity measurements that do not bias 
diversity disproportionately by species frequency requires calculating true diversity using 
the first order of diversity (q=1).  In this case, the diversity contributed by both rare and 
highly common species will be weighted directly by their frequency (i.e. each frequency is 
raised to a power of one)[106].  Equation 2.1 is undefined for q = 1, but its limit at q =1 is 
equivalent to the exponential of the Shannon entropy diversity index (Table 2.1 row 3).   
For the purpose of this study, the diversity of each lymphoid tissue is defined by 
the number unique clonotype-clusters and their corresponding frequency in each tissue.  
Precisely, true diversity is calculated using Equation 2.1 where: 1) S is the number unique 
clonotype-clusters, 2) fi is clonotype-cluster frequency in a specific tissue, and 3) q = 0 
(which uses a species richness diversity index) or q = 1 (which uses a Shannon entropy 
diversity index).  We used species richness q = 0 to demonstrate the number of unique 
clonotypes observed in each tissue; Shannon entropy was used to quantify diversity by 
accounting for clonotype-cluster frequency.  
RESULTS 
Experimental pipeline 
We sought to investigate, in a quantitative manner, the VH repertoires in the bone 
marrow (BM), spleen (SP), and lymph nodes (LN) of mice that demonstrated a varied 
degree of immune response against a model protein antigen.  Figure 2.1 illustrates the 
experimental pipeline for comparing the VH repertoire between different lymphoid tissues.  
Briefly, mice were immunized with the antigen Hen-egg-lysozyme (HEL), and 21 days 
later, given two subsequent rounds of booster immunization one week apart.  Because of 
the high cost of antibody sequencing and the relatively large number of samples that were 
required for this study, a total of five mice were selected for analysis in this study.   
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ELISA analysis of mouse serum titers to the antigen HEL revealed that the immune 
response varied greatly between mice (Table B.3).  Specifically, mouse 23, with a serum 
titer of (1/625000), had the strongest response against HEL, mouse 13 showed an 
intermediate response titer (1/125000), and mice 5, 8, and 9 showed a weak titer (1/25,000) 
Figure 2.1: Schematic of the experimental approach used in analysis.  
A) Tissues were harvested seven days post-secondary booster immunization. 
B) For each tissue, CD138+ plasma cells were isolated using MACS with anti-
mouse CD138-biotin.  RNA was extracted, cDNA was prepared, and VH 
genes were amplified and submitted for NextGen 454 sequencing.  Quality 
processed raw reads were grouped into clonotype-clusters, defined as full 
length VH genes that express the same V gene segment and CDRH3 amino 
acid sequence. C) Bioinformatics analyses characterized the distribution and 
overlap of the tissue repertoires.  
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(Table 2.2).  Mice were sacrificed seven days post-secondary booster immunization and 
CD138+ cells were isolated from each lymphoid tissue using magnetic sorting.  Sorted CD 
138+ cells were lysed and mRNA was isolated to synthesize cDNA and subsequently 
amplify IgG specific VH genes using well validated primer sets that anneal upstream to the 
5’ end of the VH gene and a 3’ primer that anneals to the CH1 region of IgG (Tables B.1 




















) BM 20770 8659 1080 617 
LN 21668 9566 834 416 
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) BM 16177 6374 833 477 
LN 20343 9199 707 369 












BM 24876 14361 1579 1006 
LN 17609 7220 539 269 












BM 9767 4274 766 366 
LN 18287 7383 605 220 
SP 9452 3405 742 337 
Table 2.2: Sequence reads returned by 454 sequencing 
15 samples were submitted for 454 NGS.  Full length VH sequence were grouped 
into clonotype-clusters. Non-singleton clonotype-clusters contain >1 VH 
sequence. Mouse 23 showed highest titer, shown in parentheses, against HEL. 
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In total, 15 VH gene libraries were sequenced using 454 pyrosequencing and 
2.2x105 sequence reads were obtained.  After removing truncated VH genes, approximately 
1.3 x 105 sequence reads contained productive VH genes without stop codons and a CDRH3 
sequence greater than three amino acids (Table 2.2).  Finally, full length VH genes that 
encode for the same V gene segment and CDRH3 amino acid sequence were grouped into 
clonotype-clusters.   
Similarities in the VH Repertoires of Mice 
We first investigated the relationship between serum titer analysis for antigen-
specific antibodies and potential bias in underlying biological mechanisms that encode the 
B cell receptor repertoire for antibody secreting CD138+ B cells.  Specifically, the 
distribution of germline VH family genes, average CDRH3 length, and the degree of 
somatic hypermutation (SHM) were evaluated to help discern how V(D)J recombination, 
N/P addition, and SHM directed affinity maturation shape the repertoire.  Average 
variation in these VH repertoire features, such as genes containing very low or high amounts 
of hypermutation could indicate factors contributing to a weak or strong immune response, 
respectively.   
As a first analysis of the data, we pooled together all VH gene sequences encoded 
by CD138+ antibody secreting plasma cells from the spleen, bone marrow, and lymph 
nodes of an individual mouse.  On average, the statistical distributions of these biologically 
relevant parameters in the repertoires of the immunized mice were similar to previously 
reported observations of a mouse repertoire.  More importantly, the parameters did not 
appear to have any relationship with serum titer.  The distribution of CDRH3 length for all 
VH sequences within an individual mouse was found to have a mean length of 11.61 amino 
acids and a standard deviation of 2.65 amino acids (Figure 2.2 A).  SHM was calculated as 
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the number of amino acid differences between the V gene segment and its respective VH 
germline sequence.  The degree of SHM in the mouse ranged from 4-8 amino acid 
substitutions or between 1-3% of the V gene segment (Figure 2.2B).  A non-parametric 
Kruskal-Wallis one-way analysis of variance statistical test, which determines whether at 
least one sample within a group is statistically different, indicated that there was no 
significant difference among all mice animals with respect to CDRH3 length and degree 
of somatic hypermutation.  A non-parametric test was preferred for this analysis because, 
unlike ANOVA, it does not require the samples follow a normal distribution.   
 
The germline VH gene segments of VH sequences encoded by the CD138+ repertoire 
were determined based on IMGT[67] assignment.  We looked at the frequency of VH 
sequences assigned to each of the possible 15 mouse families of VH gene segments.    The 
Figure 2.2: Comparison of CDRH3 length distribution and SHM across all mice 
A) Box and whisker plot of CDRH3 length in each tissue. B) Average number 
of mutations in VH genes as compared to its respective VH germline gene. 
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rank-order (Spearman) correlation of VH family usage was strongly correlated (>0.9) 
across all mice.  The most commonly used VH families were VH1, VH14, VH5, and VH2, 
which collectively contributed to at least 70% of the total sequences identified in each 
tissue sample set (Figure 2.3).  VH families found at a frequency < 0.5% in every mouse 
included VH families 9, 11, 12, 13, and 15.  No VH 16 families were found in any mouse. 
Comparison of the VH repertoires within different tissues 
Interestingly, pairwise comparison of the distributions of VH gene family usage 
between the three lymphoid organs revealed potential biases in gene usage.  One consistent 
trend observed in Figure 2.3 is that the bone marrow (BMPC) and spleen (SPPC) 
repertoires showed the smallest differences in VH family usage in all mice.  Specifically, 
chi-square analysis between the frequency of BMPC VH family usage and SPPC VH family 
usage indicated an average reduced Σχ2 value of 27.7 +/- 16.3; in comparison, the average 
reduced Σχ2 between the bone marrow and lymph node repertoires of all mice was 178.1 
+/- 113.5 (Table 2.3).  A Mann-Whitney rank test confirmed that this observation was 
statistically significant (p-value <0.01) and therefore the VH family usage between the bone 
marrow and spleen were more similar as compared to the lymph node repertoire.  The 
Figure 2.3: Comparison of VH gene family distribution  
Heat map of germline VH gene family usage in each mouse tissue.  Line brackets 
are proportional to square root of chi-square (Σχ2) distance between pairwise 
tissues. 
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spleen is a highly vascularized organ and B cells within this tissue are likely to migrate and 
equilibrate within other compartments such as the bone marrow.  However, the distinct 
germline VH gene frequency found among lymph node CD138+ cells indicates that a 
population of differentiated B cells may remain resident within the lymph node, and not 
circulate to the bone marrow or spleen.   
 
 
Pairwise Tissue Comparison (Σχ2) 
BMPC vs. SPPC BMPC vs. LNPC LNPC vs. SPPC 
Mouse 5 51.4 85.3 116 
Mouse 8 6.5 142.3 132.1 
Mouse 9 23.5 354.5 332 
Mouse 13 32.5 222.5 214.8 
Mouse 23 21 85.7 162.4 
Post immunization, antigen-activated B cells enter germinal centers within 
secondary lymphoid tissues and undergo clonal amplification and affinity maturation.  
Therefore, it is not surprising to find lymphoid tissue repertoires of immunized mice 
dominated by only a few clonally related VH genes represented at very high frequencies.  
Initial analysis of the observed number of unique VH sequences (sequence counts) in our 
datasets identified only a few non-singleton (sequence count > 1) VH sequences (Figure 
B.1 A).  Specifically, the distribution of unique VH genes in each mouse had a median value 
of one count per VH sequence (singleton reads); we did not identify an identical VH 
sequence more than 11 times in any mouse.  This infrequency of non-singleton sequences 
was most likely due to random sequencing errors introduced during PCR amplification and 
Table 2.3: Chi-square analysis of VH gene family usage between tissues 
This table lists the reduced sum of chi-square error when comparing the 
frequency of VH gene families between pairwise lymphoid tissues. 
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high throughput sequencing.    We clustered together sequences that encoded for the same 
germline VH gene segment and CDRH3 amino acid sequence.  We assumed that variation 
in the nucleotide sequence of clustered VH sequences was either due to experimental 
sequence error or somatic variation among the antibodies expressed by clonally related B 
cells.  Therefore, these clusters, which may represent groups of clonally related B cells 
having originated from the same parent naïve B cell, are referred to in this study as 
clonotype-clusters.  In contrast to unique VH sequences, we were able to identify numerous 
non-singleton clonotype-clusters in all mice.  We next investigated how these clonotype-
clusters were distributed throughout the bone marrow, lymph node, and spleen tissues.   
The degree of polarization towards clonally expanded clonotypes was quantified in 
each of the lymphoid tissues.  We expected that, post-immunization, biological processes 
such as affinity maturation would result in significant polarization of VH gene repertoires 
towards a few clonally expanded clonotypes that show specificity for the antigen.  In this 
study, polarization was defined by the diversity of VH clonotype-clusters in each tissue.  A 
highly polarized population would be representative of a VH repertoire dominated by only 
a small population of clonotype-clusters and, thus, would not be considered very diverse.   
Clonotype cluster diversity was calculated using “true diversity” defined above by 
Equation 2.1 (materials and methods).  As described in the materials and methods, the 
diversity of a population can be quantified using a number of indices for diversity (Table 
2.2).  The equation for true diversity can transform each of these diversity indices into a 
function whose diversity index scales linearly with diversity (materials and methods).  In 
Equation 2.1, true diversity is a function of both the species frequency, fi, and the order of 
diversity, q.  In this study, clonotype-cluster frequency (the ratio of the number of VH 
sequences from a specific tissue grouped into a cluster to the total number of VH sequences 
in the tissue) will represent species frequency, fi.   Moreover, as discussed in the methods, 
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the order of diversity, q, characterizes the sensitivity of true diversity to species frequency, 
or in this instance, clonotype-cluster frequency.   
For example, we first calculated diversity using a zero order measurement for true 
diversity (q = 0).  In this instance, diversity is simply the number of clonotype clusters we 
identified in each tissue, and is insensitive to clonotype cluster frequency.  For the set of 
the five animals studied here, the zero order true diversity, was approximately 1065 +/- 
320, 762 +/- 232, and 961 +/- 241 respectively for the bone marrow, lymph nodes, and 
spleen (Figure 2.4A).  A Mann Whitney rank test revealed that zero-order true diversity 
did not differ in a statistically significant manner among the three lymphoid tissues (p-
value >0.05).  This analysis indicates that the number of clonotype-clusters did not vary 
significantly between lymphoid tissues.    This measurement of diversity, however, weights 
both small and very large clonotype-clusters equally.  Consequently, small clonotype-
Figure 2.4: Diversity of each mouse lymphoid tissue with respect to VH clonotypes 
A) Zero order true diversity B) First order true diversity.  This is also known as 
the exponential of Shannon entropy.    
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clusters will contribute to the measurement of diversity disproportionately to their 
respective frequency in the tissue compartments.   
First order true diversity (q=1), on the other hand, is considered a more informative 
diversity measurement because it is not biased by highly promiscuous or rare clonotype-
clusters (Equation 2.2).   
 
1
Exp[ ln( )] [Eq 2.2]
Where:
 S  = Number clonotype clusters











Equation 2.2 is equivalent to the exponential of the Shannon entropy diversity index 
(Materials and Methods, Table 2.1). Taking into account clonotype-cluster frequency in 
each tissue compartment and using first order true diversity (Equation 2.2) showed that, on 
average, the lymph nodes were half as diverse as the bone marrow or spleen (Figure 2.4B).  
This observation is supported by a Mann-Whitney rank test showing that the differences 
between true clonotype-cluster diversity in the lymph node to clonotype-cluster diversity 
in both the bone marrow and spleen are significant (p value=0.05 and 0.02, respectively)  
(Table B.4).  There was no difference in clonotype-cluster diversity between the bone 
marrow and spleen tissues (p-value ~1).  Based on this analysis, the lymph node repertoire 
is more polarized than both the spleen and bone marrow repertoires.  More importantly, 
the majority of VH gene sequences residing within the lymph nodes, which demonstrate 





Clonotype-clusters observed within multiple tissues (“tissue-shared clonotypes”) 
may represent clonally related B cells that circulated between multiple lymphoid tissues.  
On average, 25% of all non-singleton clonotype-clusters comprised VH genes identified in 
multiple tissues (“tissue-shared clusters”) (Figure 2.5 A).  Following previous analyses, the 
repertoire of clonotype-clusters in the lymph nodes contained the least overlap with both 
the bone marrow and spleen repertoires.  The majority of “tissue-shared” clonotype-
clusters were comprised of VH genes present in all three tissues, or VH genes found only in 
the bone marrow and spleen repertoires, but not the lymph nodes (Figure 2.5B).     
Figure 2.5: Distribution of non-singleton clonotype-clusters across lymphoid tissues 
A) The area of each circle represents the total number of non-singleton 
clonotype- clusters that comprise a specific tissue compartment.  The fraction of 
clonotype-clusters found only in that respective tissue (tissue specific) are 
colored gray.  B) Area proportional Venn diagram of the overlap of clonotype-
clusters shared between tissues.  The area of each of the seven subsets is 
proportional to the number of clonotype-clusters within a subset.  C) Scatter plot 
representing Pearson correlation coefficients of clonotype frequency between 
pairwise lymphoid tissues.  Horizontal lines represents the mean pairwise 
correlation across all mice. 
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Consequently, it was not surprising to find that the expression of VH genes comprising 
“tissue-shared” clonotype clusters were, on average, more correlated in the bone marrow 
and spleen repertoires.  Specifically, when comparing spleen to bone marrow (SPvsBM), 
lymph node to bone marrow (LNvsBM), and spleen to lymph node (SPvsLN), the average 
Pearson correlation coefficients of clonotype frequency was 0.75 +/- 0.12, 0.38 +/- 0.39, 
and 0.48 +/- 0.31 respectively (Figure 2.5 C).   
 
 Relative rank of Pearson correlation coefficients 
Mouse BMPC vs. SPPC BMPC vs. LNPC LNPC vs. SPPC 
Mouse 5 1 2.5 2.5 
Mouse 8 1.5 1.5 3 
Mouse 9 1 3 2 
Mouse 13 1 2.5 2.5 
Mouse 23 1 1 1 
 This trend, in which the VH repertoires from the bone marrow are spleen appear 
more correlated, is statistically significant across all mice.  For each analysis, we used the 
Fisher R-to-Z-transformation to determine whether the Pearson correlation coefficients 
observed between the bone marrow and spleen VH repertoires could be considered 
statistically greater than comparison with the lymph node VH repertoire.  For example, with 
respect to mouse 5, Pearson correlation between SPvsBM was 0.63 whereas the Pearson 
Table 2.4: Ranking of Pearson correlation coefficients from pairwise comparisons 
We used the Fisher R-to-Z transformation test to determine whether correlation 
coefficients between pairwise comparisons were statistically different.  The 
table shown summarizes the ranking of correlation coefficients based on the 
results of this analysis. A ranking of 1 represents the tissue pair with the best 
correlation. If the p-value of the r-to-z test was > 0.01 then the rankings for the 
two groups of pairwise tissues were averaged (i.e. 1.5 or 2.5). 
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correlations for LNvsBM and SPvsLN were 0.26 and 0.44, respectively (Figure 2.5 C).  
The Fisher R-to-Z transformation shows that SPvsBM correlation (r=0.63) is significantly 
higher (p-value ~ 0.007) than the correlation between the spleen and lymph nodes (r=0.44).  
On the other hand, the correlation between the spleen and lymph nodes (r=0.44) is not 
significantly higher (p-value ~ 0.08) than the correlation between the bone marrow and 
lymph nodes LNvsBM (r =0.26).  Fisher transformation analysis revealed that, with 
exception to mouse 23 and mouse 8, the VH repertoires of the bone marrow and spleen 
(SPvsBM) were consistently the most correlated lymphoid tissues (Table 2.4).  
Highly abundant VH clonotype-clusters, represented by a large cluster size, might 
reflect antibodies elicited in response to recent immunization with the antigen HEL.  
Therefore, we investigated further the distribution of the 30 most prevalent clonotype-
clusters in the bone marrow, lymph nodes, or spleen.  In mice 5, 8, 9, and 13 we found that 
approximately 28/66 (42%), 29/65 (44%), 21/69 (30%), and 22/71 (31%) clonotype 
clusters are comprised of VH sequences from all lymphoid tissue datasets. 
Notably, in mouse 23, which displayed the highest serum titer for HEL antigen, 
36/48 (75%) of the most abundant clonotype clusters are comprised of VH sequences from 
all lymphoid tissues datasets.  The frequency of clonotype-clusters varied between 
lymphoid compartments.  Figure 2.6 succinctly summarizes both the overlap and respective 
frequency of highly prevalent VH clonotype clusters within the bone marrow, lymph node, 
and spleen repertoires.
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Figure 2.6: Tri-Venn Diagram of lymphoid tissue repertoires   
Analagously to a venn-digram, this diagram maps the overlap of the top-30 most highly frequent clonotype-clusters across bone 
marrow (BM), lymph nodes (LN) and spleen (SP) (nodes i-vii).  In addition to overlap, each node is plotted as a heatmap of concentric 




Figure 2.6 is similar to a Venn-diagram in the sense that each clonotype-cluster is 
mapped to one of seven possible subsets (represented as nodes): (i) clonotypes only found 
in the bone marrow, (ii) clonotypes only found in the lymph nodes, (iii) clonotypes only 
found in the spleen, (iv) clonotypes found in both the bone marrow and lymph nodes but 
not spleen, (v) clonotypes found in the bone marrow and spleen but not lymph nodes, (vi) 
clonotypes found in the lymph nodes and spleen but not bone marrow, and (vii) clonotypes 
found in all tissues.  Each clonotype within a particular node is plotted as a concentric 
circle, and thus the total number of clonotypes (Nc) within each node is linearly 
proportional to the radius of the corresponding node.  In addition, the color and shading of 
each concentric circle is proportional to its respective clonotype frequency in a lymphoid 
tissue.  The shade of red, green, and blue for each concentric circle reflects that clonotype’s 
frequency in the bone marrow, lymph nodes, and spleen respectively.  Most importantly, 
concentric circles, comprising node vii, that are colored equally by dark red, dark green, 
and dark blue lines represents a clonotype cluster found at high frequency in all lymphoid 
tissues.  Hence, each node in Figure 2.6 can be described as a heatmap of clonotype-cluster 
frequency for a particular subset of a Venn diagram.      
Figure 2.6 illustrates that, unlike the other four animals examined here, the VH 
repertoire of CD138+ antibody secreting cells in mouse 23, which displayed a significantly 
higher titer to HEL (1:625000) than any other mouse, was very similar among the three 
lymphoid organs examined.  In this animal, the majority of VH sequences within the 
repertoire were represented by a few highly prevalent clonotypes that were distributed 
equally among the bone marrow, lymph nodes, and spleen (Figure 2.6, mouse 23 node vii).  




a limited set of antigen-specific B cells which subsequently distributed across all three 
tissues.    
Isolation of Antigen Specific Antibodies 
As mentioned above, the presence of the same highly abundant VH genes in 
different tissues suggests that these VH genes encode antigen-specific antibodies.  To 
examine this hypothesis, we evaluated the most abundant clonotype-clusters shared in all 
three lymphoid tissues of mouse 23.  At the time this study was performed, it was not 
possible to determine the paired repertoire of VH and VL sequences which are encoded by 
different mRNA strands.  Therefore, in order to determine the antigen specificity of the 
antibodies encoding the VH genes of interest (i.e. the most abundant VH clonotype clusters), 
it was necessary to identify cognate VL chains that could pair with the VH sequence of 
interest to yield functional antibodies.  For this purpose, the five VH sequences were 
synthesized using the consensus DNA sequences of the top five clonotype-clusters shared 
between all three lymphoid tissues in mouse 23 (Table B.5).  Each VH gene was paired 
with a library of potential VL genes sequenced from the cDNA of mouse 23 Bone marrow 
CD138+ cells.  The resulting five libraries of VH:VL combinations were expressed as 
fragment antigen binding (FAb) proteins in E. coli.  Colonies expressing different FAbs 
were picked at random, grown in 96 well plates, and tested for specificity to HEL.  Ten 96-
well plates were examined for each of the 5 libraries.   
ELISA showed that three of the five synthetic VH gene candidates had at least four-
fold signal above BSA background binding, suggesting specificity towards the HEL 
antigen.  It should be noted that our inability to identify antigen specific antibodies for 2/5 
highly abundant VH genes does not necessarily imply that these VH genes do not encode 




functional antibody could not be found via screening of a small number of VH:VL 
combinations.  Using competitive ELISA, we analyzed the binding equilibrium between 
HEL and the three synthetic Fab candidates.  Specifically, each Fab was incubated with 80 
μg/mL of soluble HEL prior to ELISA analysis.  After incubation, the plate was washed 
such that any FAb bound to the HEL in solution at equilibrium would be washed away.  
For two candidate FAb genes, competitive ELISA resulted in a more than 48% loss in 
signal due to the fraction of FAb that was bound to soluble HEL and subsequently washed.  
Notably, the third candidate (VH gene variant 2_1), which initially showed a 70 fold 
increase in signal above BSA binding, resulted in a 70% loss of signal after competitive 
ELISA (Table 2.5).  Therefore, we show that the three most highly abundant VH clonotype-
clusters in all lymphoid tissues of mouse 23 show strong binding specificity against the 
immunized antigen, Hen-egg-lysozyme.  
 
Unique CDRH3 








ELISA BMPC LNPC SPPC 
AREYGGRGFDY 1 1 1 1_1 4 x -48% 
ARDSSGGFAY 2 3 4 2_1 70 x -70% 
ARGGYEGY 5 2 8 3_1 4 x -67% 
ARYGNYEGYAMDY 3 4 2       









Advancements in next-generation sequencing technology have revolutionized the 
field of genomics[107]. NextGen sequencing has also been instrumental in the 
determination of the repertoire of immune receptors encoded by B and T cells[11], [71], 
[108].  In this study, we sought to examine features of the VH repertoire encoded by 
antibody secreting B cells within each of the major spleen, lymph node and bone marrow 
lymphoid tissues of the mouse model. We generated approximately 2.8x105 full-length VH 
gene sequences and have applied a variety of rigorous statistical analysis methods to 
compare features of these large datasets. We observed that the lymph node VH repertoires 
appears to be dominated by a few highly expanded clones. As a result the measurement of 
first order true diversity in the lymph node repertoire was significantly lower than that of 
the spleen and bone marrow.   It should be noted that we were able to collect approximately 
50% of the lymph nodes from each animal.  Lymph nodes are difficult to localize 
anatomically which makes it extremely difficult to exhaustively extract all the lymph nodes 
from an animal.  Because of this caveat we cannot formally rule out the possibility that the 
lower degree of diversity reported here might be a consequence of under sampling the 
lymph node compartment.  However the possibility that the repertoire of B cells in the 
remaining lymph nodes was substantially different in a manner that would alter the 
conclusion above is remote.    
Results of our statistical analyses suggest that the VH repertoires in bone marrow 
and spleen tissues are highly similar.  Pairwise comparison of lymphoid tissues with lymph 
node VH repertoire appeared to be variable across different mouse individuals.  In mouse 
23, however, we find a strong convergence of the VH repertoires from all three analyzed 




against the HEL antigen.  We postulate that this association is not a coincidence and that 
the higher titer is likely to be a consequence of the synergistic contributions from all the 
antigen-specific B cell clonotypes located in all three lymphoid tissues. This hypothesis 
was confirmed with the recombinant expression of the highly correlated antibody 
sequences to show antigen-specific binding with ELISA.  It would be informative to 
investigate whether this convergence is common in most immunized mice that generate a 
strong immune response against the antigen of interest.  A converging repertoire in multiple 
tissues may be an ideal data-mining set for antigen specific antibody sequences.  This study 
is one of the few studies that demonstrate the use of high throughput sequencing technology 
to quantify and compare the immune repertoires of mice after immunization.  Further study 
of B cell trafficking will greatly benefit from greater sequencing depth at decreased costs.  
However, as sequence depth continues to increase, novel analytical methods will be 






Chapter 3:  Rapid germline VH gene assignment of immunoglobulin 
sequences using Fast Fourier Transform techniques 
 
INTRODUCTION  
Antibody diversity is generated by the recombination of the germline V, D, and J 
genetic elements followed by somatic hypermutation of the BCR nucleotide sequence.  
Characterization of these genetic diversification processes is essential for addressing key 
aims in the study of immunology such as elucidating the true diversity of antibodies 
generated after antigen challenge.  Furthermore, the recognition of anomalies in V(D)J 
recombination and SHM can be indicative of disease states and of an individual’s ability 
to mount an effective immune response against various antigens.  For example, bias in 
germline gene usage and somatic hypermutation has been linked to the development of 
multiple types of autoimmune disease and lymphomas [109]–[112].  To answer such 
questions, the first step in the analysis of immunoglobulin sequences is typically the 
assignment an antibody sequence to a corresponding V, D, and J germline gene segment, 
and analysis of mutations introduced in the segments during differentiation.      
However, V(D)J assignment is not straightforward for a number of reasons.  1) 
human antibodies are derived from more than 250 VH, 20 JH, and 30 DH germline genes 
and alleles [28].  2) V, D, and J segments display a high degree of sequence homology.  3) 
The formation of the CDR3 via random nucleotide addition and deletion at the V-D and 
D-J junction, and the somatic hypermutation at random nucleotide positions along the 
variable gene segment result in considerable variation of the recombined V, D, and J gene 
segments. (4)  Finally, the incorporation of non-biological sequencing error must be 




sequence to the correct germline gene segment from a large collection of homologous 
nucleotide sequences.  
Numerous algorithms have been developed for immunoglobulin annotation [67], 
[68], [113]–[115].  The most widely used algorithm for germline V gene annotation is 
provided by the IMGT High V quest tool[67].  However, this algorithm is closed-source, 
researchers must submit their requests to an online queue, and it restricts analysis to only 
500,000 sequences per request.  Using this online queue to analyze very large datasets can 
often take several days for data to be returned.  On the other hand, many open sourced 
stand-alone algorithms, such as iHMMune Align and Soda2, which depend upon Hidden 
Markov Models, can be computationally expensive[113], [114].  Because of the high 
computational expense, these algorithms are not suitable for processing the amount of data 
generated by using next generation sequencing (NGS) technologies[116].  Currently, next 
generation sequencers can produce more than 106 reads per sequence run; this throughput 
continues to grow at an exponential rate.  Thus there is a need for more efficient open 
source tools for germline V gene annotation of very large datasets[117].   
Here, we took advantage of Fast Fourier Transform algorithms to develop a method 
to rapidly perform gapless alignments of immunoglobulin sequences to a database of all 
possible VH germline genes.  Similar to the FASTA alignment algorithm [118], the initial 
gapless alignment step identifies the best regions of similarity between two sequences 
without allowing for insertions or deletions.  However, in contrast to a FASTA or BLAST 
alignment, this method is not restricted to finding regions that have an exact (or highly 
similar) match between both sequences.  In the event that multiple regions of similarity are 




local alignment[119] is used to resolve any insertions or deletions between pairwise 
sequences.   
While this algorithm focusses on human VH gene assignment, the methods 
described can be applied to any other set of somatically encoded genes.  We show that the 
algorithm can align more than 106 immunoglobulin sequences to their respective germline 
genes in less than 3 hours on an average desktop computer.  Most importantly, comparison 
to IMGT analysis demonstrates that this method was able to accurately annotate the VH 
germline genes of immunoglobulin sequences isolated from NGS immunoglobulin 
repertoire datasets.  This tool for rapidly aligning immunoglobulin sequences to their 




Hardware and software  
All analysis was performed on a standard desktop computer operated by an intel i5 
core processor and 8 GB RAM.  The IgBlast stand-alone program [68] was installed on a 
Linux operating system.  The modified Smith-Waterman alignment algorithm was first 
written in Matlab, and then rewritten in c++.  The Fourier Germline Assignment was 
written using Matlab operated by a Windows operating system.  The Fourier Germline 
Assignment program used both the Matlab and the c++ versions of the modified Smith-
Waterman alignment.  Matlab uses the FFTW3 software package (written in c) for Fast 
Fourier Transformations [120].  IMGT analysis was performed using the web-based IMGT 
High V-Quest tool [67].  Matlab was used to compare the results of VH Gene assignments 




Gapless alignment description and design 
The goal of immunoglobulin annotation is to identify the germline VH gene that 
aligns best to the sequence of interest.  One of the simplest methods for aligning two 
sequences is a gapless alignment.  During gapless alignment, a target sequence (i.e. VH 
germline gene) is shifted translationally along the query sequence (i.e. VH sequence read).  
The alignment between the two sequences is calculated at each translational shift along the 
query (Figure 3.1).   
In Figure 3.1, the alignment score between the sequence pair is calculated by 
scoring matching base-pairs between the query and target sequence by 1 (m=1) and 
penalizing complementary base-pair mismatches (i.e. A-T) by a penalty of -1 (mm = 1) 
(Equation 3.1).  The position along the query sequence (translational shift) that results in 
the highest alignment score is considered to be the best region of similarity between the 
target and query sequence.   
Figure 3.1: Gapless alignment between a target and query sequence 
A) Alignment between a target and query sequence is calculated at each position 
along query. Matching nucleotides are scored by +1, mismatched 
complementary nucleotides are penalized by -1.  The shift of the target along 
the query is referred to as the diagonal. B) Score-matrix of gapless alignment.  
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The alignment scoring scheme of Equation 3.1 results in a maximum alignment 
between the query sequence and target sequence at a “diagonal” of 3 where the 4th 
nucleotide of the query sequence is aligned to the 1st base of the target.  Graphically, this 
alignment can be illustrated using a scoring matrix (Figure 3.1B).  The rows of the matrix 
correspond to the nucleotide bases of the query sequence whereas the columns correspond 
to the nucleotide bases of the target sequence.  Finally, another method for visualizing 
gapless alignments is a scatter plot which plots alignment score between two sequences as 
a function (Equation 3.1) of the current diagonal between the query and target sequence 
(Figure 3.1C).  The gapless local alignment of full length sequences requires a significant 
number of computational operations.  For example, assuming that the query and target 
sequences are the same length, N, then N2 nucleotide comparisons are required to identify 
the best alignment.  Thus, this method is rarely considered a computationally efficient 




Gapless alignment in Fourier space 
Because local and global alignments using dynamic programming are impractical 
for aligning many sequences, heuristic algorithms, such as BLAST, which balance both 
speed and accuracy of nucleotide alignment [118], [121], have been developed and are 
widely used.  One such method takes advantage of applying Fast Fourier Transforms to 
nucleotide alignment[122]–[124].  While, Fourier transform techniques have been for 
DNA sequence alignment, they have never been applied to immunoglobulin VH gene 
assignment.  The simplest calculation of the gapless alignment at every diagonal requires 
N2 operations.  However, representing DNA sequences as Fourier series can perform a 
gapless alignment between two sequences that scales by only NLog(N) operations (Figure 
3.2).   
As discussed above, Equation 3.1 describes the gapless local alignment score (S) 
as a function of the diagonal (d) between pairwise sequences.  The conversion of each 
Figure 3.2: Comparison of gapless nucleotide alignment using Fast Fourier Transform 
Top right section of the square (triangle A) represents the number of 
computations required for nucleotide alignment as a function of sequence length 
(O(N2)).  The bottom left section (triangle B) shows the same operation using 
FFT (O(NlogN)).  The dotted circle and square represent the average alignment 




nucleotide (A,T,C,G) into a system of complex integers (1j,-1j,1,-1)[123] enables a 
variation of Equation 3.1 to be rewritten as the dot product between the complex integer 
representation of the query sequence and the conjugate of the complex integer 
representation of the target sequence (Equation 3.2).  Using this scheme to represent DNA 
sequences, the alignment of matching nucleotides at each position along a diagonal (i.e. A-
A) are given a score of 1, alignment of complementary bases (i.e. A-T) are given a penalty 
score of -1, and alignment of non-complementary bases (i.e. A-C) are not scored.  
Variations of this scheme can be used to weight nucleotide matches and mismatches 
similarly (Appendix C).  Equation 3.2 shows that the calculation of the alignment score 
(Sc(d)) at every diagonal, d, is simply the discrete cross-correlation between two complex 
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Interestingly, according to the cross-correlation and convolution theorem, the 
Fourier transformation of the cross-correlation between two functions is equal to the point-
wise product of each function’s Fourier series coefficients (derivation in Appendix 
C)[125].  In other words, rather than requiring N2 operations as shown in equation 3.2, the 




be calculated using only N multiplication operations in the Frequency domain (Equation 
3.3).   
 
Let F[] represent the fourier transform of a function, Then 
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Additionally, using the Fast Fourier Transform (FFT), both discrete functions can 
be transformed into their respective Fourier series in NLogN operations[126].  Thus, by 
representing each nucleotide sequence as a discrete complex function (A=1j,T=-
1j,C=1,G=-1), the combination of the Fast Fourier Transform with the cross-correlation 
theorem can be used for the accurate gapless alignment between two DNA sequences 
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4 Point-wise multiplication between 
each Fourier series coefficient  
N Fourier of cross-
correlation (Eq 3.3)  
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Other mismatch(A-C): 0 
Alignment score parameters 
The alignment between pairwise sequences was calculated using four parameters. 
(1) The match score is a positive value specifying the score assigned to matching 
nucleotides in a pairwise alignment.  (2) The mismatch score is a negative value specifying 
the penalty for aligning mismatching nucleotides.  (3) The gap-open penalty specifies the 
negative value for introducing an insertion or deletion (in-dels) in a pairwise alignment.  
(4) The gap-extension penalty specifies the negative value for extending insertions or 
deletions using affine gaps.  Affine gap penalties are used when there are consecutive 
insertions or deletions in an alignment.  Table 3.2 summarizes the values assigned to these 
















Match score 1 5 
Mismatch score: Non-complementary 
bases (i.e A-C, T-G) 
0 -4 
Mismatch score: Complimentary 
bases (i.e. A-T, C-G) 
-1 -4 
Gap open penalty -10 -20 
Gap-extension penalty -2 10 
Clustering VH germline genes 
In the germline assignment algorithm discussed in the results below, the set of VH 
germline genes are first grouped into clusters based on nucleotide sequence identity.  In 
this regard, we first calculated the pairwise alignment for all 257 human VH germline genes 
(downloaded from the IMGT germline database (Giudicelli et al., 2005) ) using Smith-
Waterman (SW) local alignment.  The scoring parameters of the alignment are defined 
above in Table 3.2.  Agglomerative average-linkage hierarchical clustering 
(UPGMA[127]) of the VH genes was performed using the Euclidean distance between 
pairwise alignment scores.  From the hierarchical cluster, we selected a threshold cutoff 




that clustered of VH germline genes with at least 90% pairwise nucleotide identity (Figure 
3.3). 
Each cluster is represented by a consensus nucleotide sequence derived from the 
multiple alignment of every VH gene within the cluster.  For each cluster, we performed a 
second Smith-Waterman pairwise in which every VH gene was aligned to the nucleotide 
consensus sequence.  Any VH gene that contained an insertion or deletion when aligned to 
the consensus cluster sequence was removed from the cluster and placed into a new cluster 
group.  This process was repeated until every VH gene grouped into a cluster did not have 
any insertions or deletions when aligned to its respective cluster consensus sequence.  In 
total, all 257 VH germline genes were clustered into 19 groups containing germline genes 
Figure 3.3: Hierarchical clustering of IGHV germline.   
 
Human germline VH genes were hierarchically clustered using the Smith-
Waterman pairwise alignment score as a distance matrix.  The figure shows the 
results of the hierarchical clustering.  Branches of the tree are colored by VH 




with 90% pairwise similarity and no insertions or deletions relative to the consensus 
sequence (Table C.1).  
 
RESULTS 
Proof of concept: immunoglobulin sequence alignment using Fourier transforms  
Somatic hypermutation, a biological process in which random nucleotide 
substitutions are introduced into an immunoglobulin sequence, is the principle source of 
variation between a full length immunoglobulin sequence and its corresponding germline 
gene.  Insertions and deletions are rarely introduced by somatic hypermutation and it was 
reported that less than 10% of circulating B cells encode antibodies with identifiable 
insertion or deletion mutations (in-dels) when aligned to their respective germline genes 
[128], [129].  Thus, the use of gapless alignment techniques using the Fast Fourier 
Transformation posed a promising method for accurately identifying the correct VH 
germline gene from a known set of full length gene segments (Figure 3.4).  
First, we wanted to show that gapless alignment is an accurate method for 
annotating immunoglobulin sequences.  As a proof of concept, we tested the effectiveness 




of the algorithm described in Table 3.1 using NGS data from both a mouse repertoire study 
(mouse_test_10k; 10,000 reads total) and from a human repertoire study (hum_testset_10k; 
10,000 reads total).  First the respective database of all VH germline genes was downloaded 
from the IMGT germline database [130].  At the time this work was performed, the 
database included 257 unique alleles for the humans and 350 alleles for mice (IMGT 
version 3.0).  In Equations 3.2 and 3.3, each real coefficient resulting from the discrete 
inverse Fourier transform represents the alignment score at different diagonals between the 
pairwise sequences.  The maximum value of real coefficients represents the best possible 
gapless alignment between the pair; the position of the maximum value represents the 
diagonal with the best alignment between the sequence read and that specific germline 
allele.  In other words, the position of the maximum alignment corresponds to the most 
probable position along the sequence read where the VH germline gene starts.   
Each sequence read was assigned to the germline gene that showed the best 
maximum alignment to either the forward or reverse complement of the sequence read.  
We then compared the results of a gapless alignment method to gene assignments 
determined by the IMGT high V-quest analysis [67].  We found that, using the FFT gapless 
alignment, 9752/10000 (~97%) sequences from the mouse dataset and 9608/10000 (~96%) 
sequences from human dataset had identical germline-gene assignment as compared to 
results from the IMGT analysis.  Such high similarity with IMGT showed that, without any 
significant optimization of the algorithm, a FFT based alignment could be an effective and 
rapid method for gene annotation.    
We investigated the sequence reads that were annotated differently from IMGT 
analysis.  We focused our efforts on identifying the differences in the human data set, 




between the two annotation methods (IMGT and FFT).  Importantly, the minor 
discrepancies between these sequences did not bias the total distribution of VH gene usage 
reported by IMGT and FFT analysis (Figure 3.5A).  The absence of a systematic bias 
suggests that the FFT alignment algorithm is able to identify sequence reads derived from 
all possible VH genes in the database.  Instead, inaccuracy in the assignment was most 
likely due to unexpected and infrequent mutations in the V(D)J rearranged 
immunoglobulin sequence read.   
Smith-Waterman (SW) local gapped alignment was used to determine the correct 
germline gene assignment for these 392 sequence reads.  Using Smith-Waterman, each 
problematic sequence read was aligned to both of the predicted “best-aligning” germline 
gene annotated by IMGT and the FFT alignment method.  The correct germline call was 
then assigned to the gene segment with the highest gapped alignment score determined by 
Smith-Waterman.  For the majority of mismatch calls (278/392), alignment to either of the 
two predicted germline genes had the same Smith-Waterman alignment score.  That is, the 
sequence read aligned equally well to both predicted gene segment sequences and, thus, it 
was not possible to determine which gene annotation was correct.  Furthermore, Smith-
Waterman alignment indicated that, for a very select number of sequences (21/392), the 
FFT predicted germline gene had a better alignment score to the sequence read as compared 
to the IMGT predicted germline gene.  Further inspection revealed that this discrepancy 
was most likely a result of IMGT annotation showing bias for gene alignments with 
insertion and deletion mutations in the CDR region as compared to nucleotide mismatch 
errors.  For example, in one specific situation, IMGT predicted that the best germline gene 
for a sequence read was IGHV3-NL1, whereas the other alignment methods (FFT and SW) 




IGHV3-NL1 with the sequence read resulted in the deletion of three nucleotides in the 
CDR2 region, while, alignment of the sequence with IGHV3-66 did not contain in-del 
mutations but instead had an additional 5 base-pair mutations in the CDR1 region (Figure 
C.1).  We did not further investigate these rare occasions in which the true gene assignment 
was unclear.   
Smith-Waterman analysis supported IMGT annotation for the remaining 92 
sequences.  We looked at the most common types of annotation errors identified in these 
92 sequences.  Figure 3.5 B plots the distribution of genes incorrectly assigned by the FFT 
gapless alignment method.  Each row of the matrix represents a germline gene correctly 
identified by IMGT but not by FFT; for each row, each column represents the resulting 
Figure 3.5: Comparison of IMGT VH annotation to FFT gapless alignment annotation 
A)  Distribution of VH gene usage in hum_testset_10k.  Black bars represent VH 
genes annotated by IMGT.  White bars represent VH genes annotated by gapless 
FFT alignment method.  B) VH genes annotated incorrectly by gapless FFT 
alignment.   Rows represent the VH gene annotation determined by IMGT.  
Columns represent the FFT assignment for that VH gene.  Color of boxes 
represents the frequency each specific inaccurate assignment.  The boxes along 
the dashed-red diagonal line represent sequences correctly annotated by both 
algorithms.  The three most miscalled assignments was IGHV3-48 mistaken for 




gene predicted by gapless alignment.  It is evident from Figure 3.5B that no germline VH 
gene is consistently annotated incorrectly.  IGHV3-48 was the most commonly miss-
annotated germline gene where, for approximately 5% of the sequences in the dataset, 
sequences supposedly derived from IGHV3-48 were assigned to either IGHV3-66 or 
IGHV3-13.  Smith-Waterman analysis revealed that inaccurate assignment of IGHV3-66 
or IGHV3-13 was due to the inability to account for insertions and deletions between 
pairwise sequences.  When accounting for insertions and deletions, IGHV3-48 was a better 
alignment to the sequence read than either IGHV3-66 or IGHV3-13 (Figures C.2 and C.3).      
Insertion-Deletion correction using a variation of the Smith-Waterman local 
alignment algorithm 
The above FFT alignment method was very effective at locating the position or 
diagonal between pairwise sequences that resulted in the best gapless alignment.  However, 
using only the maximum alignment along this diagonal will not yield the maximum global 
alignment and may result in potential errors when annotating immunoglobulin sequences 
containing insertion and deletion mutations.  Figure 3.6 illustrates this potential drawback 
to using gapless alignments.  In figure 3.6, an immunoglobulin sequence from a NextGen 
experiment is aligned to both IGHV3-66 (Figure 3.6A) and IGHV3-48 (Figure 3.6B) using 
gapless alignments.  The position resulting in the maximum alignment between both 
germline genes is at diagonal 11; at that diagonal, however, the germline gene IGHV3-66 
shows a better alignment to the read with a max alignment score of 252 as compared to 
IGHV3-48 with a max alignment score of 160.  This result differs from a Smith-Waterman 
alignment in which IGHV3-48 shows a better alignment.  The SW local alignment 




to the IGHV3-48 germline (Figure C.3).  This deletion is depicted in Figure 3.6B where 
gapless alignment results in a second non-random alignment at diagonal 8.      
The detection of multiple non-random nucleotide alignments is an indication that 
insertions or deletions must be present in the pairwise alignment. Therefore, we used the 
position of each non-random alignment (defined in Appendix C) to guide a more accurate 
algorithm that could account for gaps between sequences.  Rather than using the canonical 
smith-waterman alignment that compares all N2 space between pairwise sequences, we 
only considered the alignment space between nucleotides within a predefined distance from 
the maximum alignment diagonal.  This diagonal was identified from the position of the 
Figure 3.6: FFT alignment of a NextGen sequence read to two possible germline gene 
sequences  
A) Scatter plot of gapless alignment to IGHV3-66. Alignment to this germline 
does not have insertions or deletions and results in only one maximum alignment 
score of 252.  B) Scatter plot of gapless alignment to IGHV3-48.  SW optimal 
alignment to this germline includes a deletion of 3 base-pairs in the sequence.  
As a result, two peaks above background are detected at diagonals 8 and 11.  
The maximum alignment, 160, is lower than the alignment to IGHV3-66.  
However, summation of both alignments at positions 8 and 11 would results in 





maximum peak in a gapless alignment, and the maximum allowed search distance from the 
diagonal is determined by the distance between additional non-random alignment scores.  
Figure 3.7 illustrates how this method can be applied to the alignment of the test sequence 
to IGHV3-48 in which two non-random scores, separated by three base-pairs, were 
detected.  Starting at the maximum diagonal, 11, and considering only alignment paths 
separated by 3 base-pairs, the optimal alignment path between the sequences was found in 
(3+1)*N steps (Figure 3.7B).  For comparison, using dynamic programming where all N2 
alignment paths are considered, results in the same optimal alignment path between the 
sequences (Figure 3.7 A).  These initial benchmarks and analyses show that gapless 
alignment can be used to accurately align heavy chain sequences to the germline.  
Therefore, these methods were combined into one algorithm for germline gene assignment.   
Figure 3.7: Dot plot illustration of the modified local Smith-Waterman alignment 
A) Scoring matrix resulting from the canonical SW. SW considers all possible 
alignment paths between sequences B) Modified scoring matrix.  Alignment 
starts at maximum diagonal alignment position 11, and only considers paths 
that are separated by an additional 3 base pairs from this maximum diagonal 




Germline assignment algorithm 
Figure 3.8: Fourier Germline Assignment Algorithm 
A) VH germline genes are clustered by pairwise nucleotide similarity. B) Each 
cluster consensus sequence is aligned to immunoglobulin sequence using FFT. 
In-del mutations are fixed using the modified SW method. C) The germline 
genes best aligning clusters are aligned to sequence at the identified maximum 




The algorithm for annotating the IGHV genes of human immunoglobulin 
repertoires is organized into three principal steps (Figure 3.8).  First, the set of VH germline 
genes are grouped into clusters based on pairwise identity.  Second, each sequence read is 
aligned to each consensus cluster sequence using the Fourier series gapless alignment 
method.  The optimal alignment path in sequences which contain insertions and deletions 
when compared to the cluster sequence is determined using the modified Smith-Waterman 
gapless alignment.  Finally, after selection of clusters which best align to the germline 
sequence, each VH gene segment within the cluster is aligned to the sequence at the proper 
diagonal. 
Clustering VH germline genes   
The goal of Fourier analysis for each sequence read was to (1) identify the position 
(alignment diagonal) where the immunoglobulin sequence begins relative to a germline 
gene, and (2) determine whether the modified smith-waterman method would be needed to 
optimize the alignment path in regions containing insertions and deletions.  Accounting for 
these objectives and given the intrinsic nucleotide similarity between germline genes, 
performing Fourier analysis on every germline gene segment is unnecessary.  For example, 
when aligning a sequence read to the germline, the diagonal resulting in a maximum 
gapless alignment does not vary significantly between most germline genes (Figure 3.9).  
In this example illustrated by figure 3.9, more than half of the germline genes aligned to 
the NextGen sequence show a maximum alignment at diagonal 11.  We only need to 
perform the FFT alignment step on a select number of germline genes to predict this 
maximum alignment position.  Therefore, as described in the methods, we grouped together 
VH germline genes with more than 90% pairwise identity at the nucleotide level and no 




criteria, all 257 germline genes were grouped into 19 clusters, and a consensus nucleotide 
sequence was determined for each cluster.  
Fourier alignment to consensus sequences  
As outlined in Figure 3.8B, each sequence read was aligned to the consensus 
sequences of the individual 19 clusters.  The forward and reverse complement of each 
sequence read were aligned to each cluster consensus sequence using the Fast Fourier 
Transform.  The direction, forward or reverse complement, containing the immunoglobulin 
sequence was determined by the summation of the maximum alignments in every cluster.  
We selected the direction (forward or reverse complement) which had the highest 
alignment score to each cluster.  The diagonal of maximum alignment in the determined 
direction was recorded for each cluster.  Additional peaks near the maximum diagonal were 
identified based on having an alignment score at least three standard deviations above the 
expected binomial distribution of alignment score between random nucleotide sequences 
Figure 3.9: Diagonal of maximum alignment between NextGen sequence and VH 
germline 
Distribution of the predicted starting alignment position of each germline gene 




(Appendix C).  Finally, the presence of insertions and deletions near the ends of the 
sequence read, which would be below the sensitivity of the Fourier analysis, were also 
determined. 
For sequences containing no identifiable insertions or deletions, a final cluster 
alignment score is calculated where all base pair matches at the best alignment diagonal 
are given a score of +5, and all base pair mismatches are given a penalty of -4.  The 
modified Smith-Waterman method is applied to alignments predicted to have in-del 
mutations.  For gapped alignments, gap openings are penalized with a score of -20 and gap 
extensions are penalized with a score of -10; similarly to gapless alignments, base pair 
matches are scored +5 and base pair mismatches are penalized by -4.  The output of the 
gapped alignment reports both an alignment score and a “gap-corrected” immunoglobulin 
sequence read where insertions and deletions to the cluster have been removed.  After 
alignment to each consensus sequence, only clusters containing an alignment score within 
85% of the maximum cluster alignment score are selected for further analysis.    
Final alignment to germline clusters 
In the preceding step, the Fourier and SW analysis report (1) whether the NextGen 
sequence read refers to the forward or reverse complement of an immunoglobulin 
sequence, (2) a list of cluster consensus sequences that best align to the sequence, (3) the 
diagonal of best alignment, (4) and the position and number of any insertions or deletions 
in the alignment of the sequence to the cluster consensus sequences.  We can assume that 
each VH gene within a cluster will align to the sequence read at the same position as its 
corresponding cluster consensus sequence.  Moreover, because all of VH germline 
segments within a cluster do not have any insertion or deletion mutations when aligned to 




not have insertions or deletions with respect to the “gap-corrected” immunoglobulin 
sequence read.  Using this information, each germline gene within a cluster is aligned to 
the modified sequence without allowing for any gaps at the diagonal defined by the 
consensus sequence (Figure 3.8C).  A gap penalty is introduced in the finalized alignment 
scores of germline genes whose consensus sequence had in-del mutations when compared 
to the original sequence read.  Germline genes with the top five best alignment scores to 
the sequence read are selected as the most likely VH gene used during VDJ recombination 
of the heavy chain.    
Implementation of the germline assignment algorithm 
The germline assignment algorithm was written using Matlab.  The effectiveness 
of the program was first tested on the previously analyzed hum_testset_10k NGS dataset.  
The results of the alignment was compared to an IgBlast analysis.  IgBlast, which relies 
upon the BLAST alignment algorithm, is a well-validated open-source software tool for 
annotating immunoglobulin sequence data [68].     Analysis of hum_testset_10k using our 
germline assignment method took 2 minutes.  Gene assignment was found to be 99.5% 
identical to IMGT annotation (Figure 3.10).    More importantly, using the Smith-
Waterman method to account for insertions and deletions corrected the initial problems 
where IGHV3-48 was incorrectly assigned to IGHV3-13 or to IGHV3-66.  By comparison, 
the c++ optimized IgBlast analysis of 10,000 sample sequences took 10.5 minutes.  IgBlast 
analysis also had a VH gene assignment accuracy greater than 99% as compared to IMGT.   
Our germline assignment algorithm, namely the addition of a Smith-Waterman 
alignment, was designed around correcting for annotation errors we initially noticed when 
aligning the VH germline gene segments to hum_testset_10K using only the FFT algorithm.  




That is, we wanted to see if, in the process of designing the germline assignment algorithm, 
we only addressed problems we specifically encountered in the hum_testset_10k.  To 
investigate whether this algorithm was indeed a robust method for annotating VH NextGen 
data, we collected another set of 20,000 sequences randomly selected from a second human 
repertoire project, hum_testset_20k.  Analysis of these sequences took 3.5 minutes and 
again resulted in VH annotation with greater than 99% accuracy as compared to IMGT 
analysis.  Therefore, we show that this algorithm is a robust method for annotation of the 
VH gene segment of an immunoglobulin. Given the rate of analysis for this novel method, 
it is projected that, using this non-optimized code in Matlab, 1,000,000 sequences can be 
analyzed, with greater than 99% accuracy, in under 3.5 hours.  From previous experience, 
we project that optimization of this code using c++ would most likely improve this rate by 
three fold.    
 
A minority (5%) of sequences in hum_testset_20k could not be annotated using the 
IMGT software.  These reads most likely represented either non-heavy chain 




immunoglobulin sequences or highly mutated sequences that could not be aligned to the 
germline.  We wanted to investigate whether our germline assignment program could also 
predict these sequences as non-immunoglobulins.  For each sequence read, we analyzed 
the maximum possible gapless alignment score between the cluster consensus sequences.  
Expectedly, the average score of maximum alignment for these sequence reads, 44, was 
much lower than the average score of sequence reads with a significant alignment to 
germline, 253 (Figure 3.11A).   
 
Receiver operating characteristic (ROC) analysis of these sequences versus 
sequences with identifiable VH germline genes illustrates the performance of the algorithm 
as a classifier for immunoglobulin sequence reads with a full length VH gene segment.  
Figure 3.11B shows that using a cutoff maximum alignment score of 90 can filter out all 
false positive alignments yet still identify more than 99.8% of the reads with the correct 
Figure 3.11: Selectivity of the germline assignment algorithm 
A) Distribution of the maximum alignment score for non-immunoglobulin 
sequences (red and immunoglobulin sequences (blue).  B) ROC curve 




assignment.  In conclusion, we have shown that this method is a very robust method for 
the rapid annotation of sequence reads to their respective germline. 
  
FUTURE TECHNIQUES: APPLICATION OF SPARSE FFT METHODS 
 
Figure 3.12: Illustration of sparse functions and the sparse FFT 
A) Performance of the germline assignment algorithm is limited by the final 
inverse FFT step (thick red arrow). B) Example of a function whose Fourier 
series is sparse but required NLogN operations C) Simplified example of a 
sparse FFT.  SparseFFT can accurately estimate the sparse Fourier coefficients 
in O(klogN) operations.  D) Analogous example of the application of a sparse 




The primary purpose of the Fourier method is to align a query sequence to each 
potential germline and identify the starting alignment position of the germline along the 
sequence.  One of the rate limiting steps in this effort is the transformation of the cross 
correlation Fourier series back to the time domain (Figure 3.12A).  For example, the 
alignment of a dataset containing Sx sequences to 19 consensus cluster sequences requires 
2*Sx*19 inverse Fourier transforms.  One area of improvement is the ability to enhance the 
speed of this essential inverse transformation step.   
Many novel algorithms have arisen in recent years which further optimize and 
improve upon the speed of Fourier transforms.  One method gaining recently popularity is 
the development of sparse FFT algorithms [131].  A sparse function can be considered as 
a large vector of complex integers but only contains K non-zero coefficients (Figure 
3.12B).  The use of a sparse FFT arises when a non-sparse complex function has a 
corresponding Fourier series that is sparse and vice-versa.   
For example, the original function in in figure 3.12 B has 1000 coefficients or 
discrete data points, and yet its Fourier transform has only 3 non-zero coefficients.  With 
respect to the canonical Fourier transform function, we have to take the inverse transform 
of all original 1000 data points to identify the three non-zero Fourier series coefficients 
(1000*Log(1000) computations are required).  The sparse FFT, on the other hand, is 
designed to estimate those k=3 sparse Fourier coefficients in Ο(k*Log(N)) computations 
(Figure 3.12 C) .   In summation, given a discrete function (length N) whose corresponding 
Fourier transform contains K non-zeroes coefficients, the sparse FFT is designed to 
estimate the value of these K-largest coefficients without taking the Fourier transform on 
all N data points [131]. With respect to DNA sequence alignments, the cross-correlation or 




identifying the position resulting in the maximum alignment score between pairwise 
sequences.  The remaining “coefficients” in the cross-correlation only correspond to scores 
caused by alignment of random nucleotide sequences. 
Thus, the sparse FFT can be an intriguing method for improving the Fourier 
germline assignment algorithm.  Specifically, we can apply the sparse FFT method in the 
final rate limiting final step where we take the inverse transformation of the cross-
correlation Fourier series.  As an example, the application of the sparse FFT method has 
already been shown  to improve the challenge of identifying GPS signals from satellites 
[132]; this process is highly analogous to our method of gapless nucleotide alignment in 
Fourier space (Figure 3.12D).  Appendix C provides an example algorithm for performing 
a sparse FFT where we only identify the position of the maximum alignment peak.  Figure 
3.13 B shows how this technique can be used to identify the maximum alignment position 
between an immunoglobulin read and its corresponding germline.  Application of this 
algorithm could improve the speed of the inverse transform by tenfold.   
Although, a promising technique, there are significant areas for optimization.  
Sparse FFT algorithms take advantage of a property known as aliasing in which 
coefficients are binned together before taking the Fourier transform.  This method of 
binning coefficients allows one to take the Fourier transform of a function smaller than N.  
Binning is not problematic for theoretically sparse functions in which almost every 
coefficient is zero.  However, in the case of nucleotide alignments, the sparse function has 
many noisy (non-zero) coefficients arising from the random alignment of nucleotide bases.  
The effect of binning too many coefficients to improve performance will significantly 
decrease the signal-to-noise ratio of a true alignment from a series of random alignments 




by the binomial variance of noise caused from random alignments.  In order to fully take 
advantage of the sparse FFT algorithms, it will be necessary to develop solutions for 
decreasing the noise of cross-correlation function or improved sparse FFT algorithms 
which are less sensitive to small non-zero coefficients.    
Figure 3.13: Sparse FFT for nucleotide alignments 
A) Taking inverse FFT of the cross-correlation Fourier series results in the 
accurate alignment score at each diagonal. The maximum alignment score is 
identified at a diagonal 392. B) Taking the inverse of a subsample of the original 
cross-correlation function results in binning alignment scores from multiple 
diagonals together.  The theory behind the sparse FFT is that binning the 
maximum alignment score will always result in the maximum peak within the 
bins.  The only alignment score binned into the 7th and 72nd coefficient of the 16-
subsampled and 11-subsampled functions, respectively, is the alignment at 392.  
Maximum alignment can be assumed to be at 392.  However, binning together 






We have presented a novel algorithm for the accurate VH gene assignment of 
immunoglobulin sequence reads isolated from human B cells.  Most importantly, we show 
that, using a normal desktop computer, this algorithm can analyze data produced by NGS 
within a few hours.  Although we have shown this to be a very promising technique, there 
are still areas for improvement.  Future efforts will focus on adapting this method for the 
annotation of other species and extensions to JH gene assignment.   Furthermore, the 
benchmark comparisons indicate that there may still be areas where accuracy can be 
improved.  Finally, optimization of this algorithm using c++ would further enhance 
performance.  
The main advantage of this algorithm is its ability to perform rapid gapless 
alignment of very long sequences.  One limitation of this algorithm is that it was designed 
to only analyze full length VH genes from immunoglobulin sequences. For example, this 
method will not accurately predict events such as gene conversion of VH genes which have 
been observed in rabbits [1].  Other alignment algorithms such as BLAST rely instead upon 
gapless alignments of very small sequences.  Consequently, one advantage of the BLAST 
algorithms, is the ability to both predict gaps in large sequences and predict unexpected 
recombination events.  Gene conversion, however, has not been commonly observed in 
human and mice repertoires.  Thus, this method is suitable for the analysis of most 
repertoire studies.   
In addition, it should be stressed that the primary focus of the algorithm is to rapidly 
identify a small subset of most likely derived VH genes from a large database of germline 
genes.  This germline assignment method should act as supplement for downstream 




identified germline gene using accurate models which can predict hot spots mutations and 
experimental error.  In conclusion, we have shown that this method is indeed a powerful 
technique for gene assignment and that it can continue to be improved especially in the 





Chapter 4: ImmunoGReP on APPSOMA: A cloud based 




The vast amount of information gained from deep sequencing of the 
immunoglobulin repertoire offers a newfound ability to detect genetic disorders in B cells, 
quantify the efficacy of an immune response, and discover antigen specific antibodies.  As 
a result, this promising technology for high resolution analysis of the humoral immune 
response is becoming widespread throughout immunology.  However, the potential of next 
generation sequencing is exceedingly reliant upon computational tools that can highlight 
biologically relevant features against a backdrop of millions of sequence transcripts.  Our 
dependency on computation will only intensify as the throughput of NextGen sequencing 
continues to increase.  The requirement for robust computational tools is further burdened 
in repertoire analysis because of the discrepancy between immunologists with limited 
computational backgrounds and bioinformaticians with limited knowledge of 
immunologically relevant analyses[133].  There has been significant effort in immunology 
to close this gap between technical skills, and produce established methods for the analysis 
of antibody repertoires[8], [134], [135].  For example, novel analytical methods are 
currently available for V(D)J assignments, CDR3 spectratyping, multiple sequence 
alignment and clustering of clonally related antibodies, statistical analyses of antibody 
diversity, and visualization of relevant biological features[67], [68], [113], [117], [136]–




informatics, their value to immunologists is limited by their ability to provide these 
algorithms in a simple, openly accessible, and reproducible manner[139]–[141].   
Moreover, many algorithms are stand-alone programs that were written in diverse 
programming languages and only address a small fraction of analyses required for standard 
repertoire studies (Table 4.1).  This limitation forces immunologists to develop in-house 
bioinformatics pipelines where multiple tools are combined together in an analysis chain.  
Few research labs have the capability and computational expertise required for designing 
such analytical pipelines which entail installing foreign operating systems and 
programming languages, understanding which algorithms are best suited for specific 
experiments, and benchmarking the accuracy of results[141], [142].  These isolated 
analytical pipelines will not be viable options as the field of repertoire sequencing 
continues to expand and there is a greater demand for meta-analyses of previously 
published studies.  Instead, there must be a centralized source of easily accessible analytical 
tools directed towards immunological repertoire research [8, p. 2014], [143].   
As with all life sciences heavily dependent on computational techniques, this 
collection of analytics must provide scientists, having limited computational experience, 
with 1) novel algorithms that yield reproducible results 2) access to previously published 
sequence data, 3) the ability to benchmark performance of various informatics, and 4) the 
ability to combine multiple tools together into an analysis chain.  Most importantly, as our 
understanding of humoral immunity progresses, it is essential that any bioinformatics 
pipeline is easily adaptable to new techniques and methods.  There have been many recent 
initiatives to provide the scientific community with platforms which allow for the 
development of such open-sourced, reproducible, and standardized software suites[139], 




for sharing collaborative research and the development of novel computational 
methods[144].  In addition, APPSOMA allows bioinformaticians to deploy novel 
algorithms as “APPs” which allow non-computational users the ability to run these 
programs from any computer via a simple user interface.  
We have used APPSOMA to design an ImmunoGenetic Repertoire analysis 
Pipeline (ImmunoGReP).  ImmunoGReP provides access to algorithms for standard 
methods in bioinformatic analyses of antibody repertoires.  Specifically, we offer programs 
for CDR3 spectratyping, IgBlast immunoglobulin analysis, and statistical methods for the 
comparison of repertoires.  Most importantly, these programs are designed to run 
completely within the APPSOMA environment, and without the hassle of software 
installation or working in the often cumbersome Linux environment.  Finally, in an effort 
to address problems in replication, transparency and curation of repertoire studies, we have 
also developed a database designed specifically for the storage of immunological sequence 












METHODS AND DESIGN 
Hardware and APPSOMA installation 
APPSOMA must first be installed on computers which will serve as “executive 

































Web based only 
IgBlast[68] C++ BLAST based 
iHMMune 
Align[113] 
Java Hidden Markov Model 
















JAVA 454 sequencing error correction 
ClonalRelate[148] JAVA 
 Agglomerative Hierarchical 
clustering 









Lack of accessible databases for HTS 
of antibody repertoires 
Table 4.1: Summary of programs commonly used for repertoire analysis 
Repertoire analysis is comprised of three principal stages: Data annotation of 
sequence data into its relevant V(D)J gene segments and identification of the 
CDR 1, 2, and 3; Analysis of sequence data (i.e. multiple sequence alignment, 
and statistical analyses); Methods for storing sequence data and analysis.  The 
above table illustrates some methods for performing these tasks.  These 
programs are written in a variety of programming languages, perform only one 
task, and may require some computational background.  Most importantly, there 




the executive nodes.  The name of the temporary storage folder is called the “scratch” 
folder. Every APPSOMA user who has access the executive node will have their own 
unique scratch folder, and be able to store their data independently from other users.  For 
permanent storage solutions, APPSOMA provides functions for downloading and 
uploading information to warehouses.  These warehouses must also be set-up and installed 
by the administrators of the executive nodes.   
APPSOMA was installed on two executive nodes assigned to the University of 
Texas, termed UTexas1 and UTexas2.  Each node has approximately 200 GB memory and 
650 GB hard disk space.  All University of Texas employees have access to these nodes.  
APPSOMA also offers open access to three more nodes: node-0, node-1, and node-2; 
however, these nodes have very little RAM and available hard disk space, and, thus, are 
not suitable for running most scripts.  
Precompiled software packages required for ImmunoGReP 
The python module, pymongo, is required to run scripts that depend on functions 
which access the immunological database.  For example, any script that queries sequences 
from an experiment would use the pymongo module.  In order to use these functions, an 
administrator must install pymongo onto the executive nodes that will host and run these 
scripts specific to the database.   However, this module is not required for other programs 
we offer which are not dependent on the database such as IgBlast analysis.   
All other programs we offer do not need to be installed onto an executive node by 
an administrator.  Instead, we provide scripts that will automatically install any necessary 
programs before running an ImmunoGReP APP.  For example running the IgBlast APP 
will automatically download and install files and programs to the executive node that are 




automatically installed onto the executive node when running scripts offered by 
ImmunoGReP: IgBlast[68], Circos[150], flash[151], and iCommands. 
File handling and file formats in ImmunoGReP 
The pathname and file location of any file created within an ImmunoGReP script 
follows a standardized set of rules.  This standardization ensures that the user interfaces we 
design for running analysis APPs can easily locate files created within ImmunoGReP and 
exclude any file created by other APPSOMA programs.  The following illustrates how files 
are organized in ImmunoGReP:  
 
                                   
UserData/
        scratch/ 
             immunogrep/
                    Exp_00001_Date_UserDefined
                    Exp_00002_Date_UserDefined/
                                     FastaFile.fna
                                     FastaFile.imgt.annotation
                                     FastaFile.imgt.query
                                     FastaCorrelation.png
  
Specifically, all files are stored in a subfolder, called immunogrep, which exists 
within a user’s main folder called the scratch folder (location in APPSOMA: 
~/scratch/immunogrep).  For every new analysis, a new experiment folder within 
immunogrep is created.  This experiment folder will be automatically named by the current 
date and number of total experiments folders present in immunogrep; the last part of the 
folder name can be defined by the user.  All files generated for a specific analysis, including 
figures, will be stored within this experiment folder. Finally, we also require that 




filenames.  Result files created using immunoglobulin annotation programs such as CDR3 
Spectratyping or IgBlast V(D)J assignment are always given a *.annotation extension file 
name.  In addition, sequences that were queried from the database are saved to a file with 
a *.query extension filename.        
Scripts within ImmunoGReP can handle the following file formats:  fastq raw data 
files containing sequence quality scores returned by NextGen sequencers and (*.fastq), 
standard fasta file (*.fasta or *.fna), standard text-tab-delimited file (*.txt), and files written 
in JavaScript Object Notation[152] (*.JSON file).  We have written functions which allow 
users to inter-convert their files between these four types.  The JSON file format serves as 
the intermediate file format in all of our analysis scripts.  That is, unless specified by the 
user, all scripts will by default output results file using the JSON file format.  JSON file 
notation makes it simple to analyze multiple files that do not have the same structure.  For 
example, in a text-tab-delimited file, each column name refers to a specific field in the file.  
That is, in a sample file, column 1 may refer to the CDR3 length, column 2 may refer to 
the CDR3, and column 3 may refer to the CDR3 frequency.  Any script which requires this 
file must know that the CDR3 and its frequency are found in columns 2 and 3, respectively.  
However, this would not be a restriction if using a JSON file format.  JSON files have no 
columns or column names; instead they use strings to refer to field names.  The JSON 
structure for this file would be: {”Length”:6”,”CDR3”:”CARAEW”,”Frequency”:0.01} 
(Figure D.1).  Because strings are used instead of standard column names, fields can be 
organized in any order.  Therefore, we found a JSON file format to be the most amenable 




Bioinformatics analysis scripts offered by ImmunoGReP  
ImmunoGReP is a compilation of scripts and programs written in tandem with the 
following users: Kam Hon Hoi, Benjamin Goetz, Andrew Horton, and Sebastian Schaetzle.  
The following sections below describe bioinformatics APPs that we currently offer for 
sequence annotation. In addition, appendix D contains a list of all scripts and APPs we 
have written for running ImmunoGReP.  Scripts are openly available from the APPSOMA 
website (https://appsoma.austin.utexas.edu/ or https://appsoma.com/home).  Finally, we 
have designed APPs, written in HTML, that provide a simple user interface for the 
following functions: 1) CDR3 spectratyping, 2) IgBlast analysis, 3) Comparing sequences 
across multiple datasets, and 4) querying the database for a list of sequences from an 
experiment.   
CDR3 spectratyping 
The CDR3 Spectratyping algorithm is based on a program written by a former 
member of our lab, Xin Ge (unpublished data).  It has been modified, rewritten in python, 
and adapted for use in APPSOMA by Kam Hon Hoi.  The CDR3 of an antibody is 
identified using conserved motifs in the framework 3 (FR3) and framework 4 (FR4) 
flanking regions of the CDR3. The motifs were identified using multiple sequence 
alignment of immunoglobulin sequences collected from the Kabat database, and followed 
by analysis of the conserved regions in the alignment that are directly upstream (FR3 motif) 
and downstream (FR4 motif) of the CDR3.  For CDR3 spectratyping, both flanking motifs 
are converted into a probability weight matrix, V (20xN where N represents the length of 
the motif).   Each column of the matrix corresponds to a specific amino acid position in the 
motif; each row corresponds to an amino acid.  The values of the matrix, V(row,column), 




position along the motif (column).  Using this probability matrix a position specific 
sequence matching (PSSM) algorithm is used to identify the region along the sequence 
read that best aligns to the motif of interest.  Because the motif is defined at the amino acid 
level, all six frames of the sequence are aligned to both motifs.  The algorithm only 
identifies a CDR3 when 1) both motifs are found above a threshold score and 2) both motifs 
are found on the same frame.   
Isotype identification 
The constant region or isotype of a NGS sequence is determined by the 
identification of a small oligonucleotide sequence, or barcode, found within the constant 
region of each isotype gene segment.  Table D.2 lists the barcodes used to identify each 
sequence isotype.  This script can only detect the isotype of immunoglobulin sequences 
whose cDNA, prior to sequencing, was amplified using primers that annealed downstream 
of the barcode sequence.   The algorithm performs a simple gapless alignment between the 
sequence read and each possible barcode.  An isotype is assigned to a sequence only if it 
aligns to the bar code in a region that has more than 80% pairwise nucleotide identity with 
the barcode.  
IgBlast analysis 
IgBlast analysis on APPSOMA runs the stand-alone IgBlast (verison 1.3.0) 
executable that was downloaded from the NCBI website.  When running IgBlast analysis 
for the first time, it will automatically download the “internal data” folder from NCBI to 
the user’s scratch folder.  This folder is essential for IgBlast to run.  Next, IgBlast analysis 
will run the standalone program using parameters defined by the user in the IgBlast user 




Results from IgBlast analysis are output using the BLAST output format 7 
parameter.  A python script was written to parse the output file and identify the following 
immunological features:  
1) V, D, and J assigned germline gene segments 
2) The sequence chain type (heavy or light) 
3) The positions of the framework regions 1-4, CDR1, and CDR2 
4) The prediction of the V-D and D-J junctions (CDR3 position) 
5) The Number of mutations, insertions, and deletions in the sequence 
6) The sequence alignment between the sequence and the predicted germline 
The user has the option to output the parsed results file in either a text-tab-delimited file 
format or a JSON file format.  JSON serves as the default file format.   
Database schema 
The database was designed around the Mongo NoSQL database language.  A 
NoSQL database was chosen for two reasons.  First, a significant advantage of NoSQL 
databases is that they scale with size efficiently by “scaling-out”.  This scaling means that 
a NoSQL database can be distributed or “sharded” across many computers or “nodes”.  
When a database reaches full capacity and runs out of storage space, then another computer, 
of similar performance, is simply appended to the database cluster as a new “node”.  A 
second appealing aspect of a NoSQL database is its adaptability in that the schema of the 
database can be easily modified.  Therefore, because we expect that this database will 
rapidly expand in size due to NGS, and that the relevant information we want to store will 
fluctuate greatly, a NoSQL database was a promising design.  In a NoSQL database, data 
is stored in individual files called “documents”.  “Documents” are grouped together into 




transcript “documents”.  We store specific pieces of information for each transcript 
“document” such as “CDR3” and “assigned VH gene”.   
 
The immunological database consists of four separate collections (Table 4.2): 
A) Species collection:  The species collection stores information regarding every 
species that has been analyzed.  For each species we store 1) the species name, 2) 
its respective genus name, and 3) the NCBI assigned numeric ontology for that 
species.   
B) Germline collection (Table D.5): The germline collection was created using 
information downloaded from the IMGT database of germline gene segments 
(version 3.0) [130].  Each document within this collection refers to a specific gene 
locus within the germline (i.e all genes composing VH gene segment of humans).  
For each gene locus we store 1) the species name, 2) the germline locus (V[H,κ/λ], 
DH, or J[H,κ/λ]), 3) the source of the gene segment information (i..e IMGT), and 4) a 
subdocument which contains all of the information regarding every allele within 
the gene locus.  This subdocument for each germline gene stores: i) the gene name, 
ii) the allelic name, iii) and its corresponding nucleotide sequence.    
C) Experiments collection (Table D.3): The experiments collection stores all 
experimental information regarding next generation sequencing experiments that 
were added into the database.  Specifically, the collection stores all of the metadata 
for an experiment (Table D.1).  The following fields are indexed to support 
querying the experiment collection: Project_ID_INDEX, Experiment_Id_Index, 




Isotype_Index, Chain_Types_Sequenced, Cell_Type_Indexed, 
Write_Access_Index, Species, and Publications_Index.    
D) Sequences collection (Table D.2): Each document in the sequence collection 
refers to a specific DNA amplicon that was sequenced via NGS.  Figure 4.4 
describes what information is stored for each amplicon.  To support queries, the 
following fields have been indexed in the sequences collection: 
Mongo_Experiment_ID, Paired_ID, Write_Access, Read_Access, Productive, 
chain type, CDR1, CDR2, CDR3, V genes, D genes, and J genes.  The Paired_ID 
field will be used linking documents within a collection that refer to a biological 
heavy-light chain antibody.  Read and write access define which members in 
APPSOMA have permission to read and update information for that specific 
sequence or document.   The Mongo_Experiment_ID links the sequence to an 





 APPSOMA: A PLATFORM FOR CLOUD COMPUTING AND SCIENTIFIC DISCOVERY 
 
One of the biggest challenges in designing novel algorithms for a scientific 
community is the balance between ease-of-use and ease-of-customization.  That is, if one 
wants to create a tool that is highly customizable with many features then users will be 
required to have some computational background.  In contrast, if one wants to make a 
program with a simple user interface that is easy for anyone to use, then the program must 
come precompiled and cannot be modified.  APPSOMA[144] was created to alleviate such 
difficulties.   
APPSOMA is a web-based platform where programmers can design source code 
from a remote computer and subsequently deploy their finalized programs as interactive 
Figure 4.1: Description of APPSOMA  
A) Users run algorithms on remote computers called “Executive Nodes” from a 
web browser B) Within APPSOMA, developers can program scripts in multiple 
languages and subsequently combine them into a bioinformatics pipeline.  This 
pipeline can be made into an APP that has a graphical interface so that users, 




APPs.  These programs and interactive APPs are run from remote computers referred to as 
“executive nodes” (Figure 1A).  APPSOMA enables four intriguing properties for building 
a bioinformatics pipeline (Figure 1B): 1) centralized set of computation resources, 2) 
support for multiple programming languages, 3) collaborative hub of developers, 4) and 
APP deployment.  First, because APPSOMA is installed on executive nodes, users can run 
these programs remotely from any computer with internet access.  Second, APPSOMA is 
considered “language agnostic” in that it supports programs written in Python, Perl, R 
statistical programming, Bash, Ruby, and javascript.  This support for languages 
commonly employed in bioinformatics, makes it easy to, not only import well validated 
programs, but also build analytical pipelines of programs written in a variety of languages.    
Third, APPSOMA allows easy collaboration between scientists.  Users can be granted 
access to read, modify, and or run code written by fellow collaborators.  Finally, the ability 
to convert programs into interactive APPs allows easy and reproducible access to published 
algorithms.  In summary, these features provided an ideal platform for creating a 
centralized and open-sourced immunological analysis platform. 
RUNNING IMMUNOGREP ON APPSOMA 
The analysis of immunoglobulin repertoires often involves three principal steps: 1) 
annotation of sequencing data such as V(D)J assignment, 2) analysis and comparison of 
NGS experiments, 3) and the storage of sequencing data and results.  The following discuss 
how ImmunoGReP was designed to provide solutions for each feature.  
Solutions for analysis of NGS immunological data 
One of the most important features of ImmunoGReP is that the analysis pipeline is 




algorithms serve different needs, we wanted to provide users with the ability to choose 
between algorithms.  Most programs we offer are designed to be “modular” in that they 
perform highly specific tasks, but can also be easily chained together into functional 
bioinformatics pipelines.  Therefore, this modular structure within APPSOMA, enables us 
to insert any new combinations of techniques within an analysis pipeline regardless of 
upstream or downstream processes. 
APPS for Immunoglobulin Annotation 
First, we offer users the ability to analyze sequencing data using the well-
established and validated IgBlast algorithm for annotating B and T cell receptors  
sequenced from human, mouse, rabbit, and sheep repertoires[68].  IgBlast analysis will 
align each immunological sequence read to its predicted V, D, and J germline gene 
segments.  In addition, IgBlast predicts the framework regions, the CDR regions, and the 
number of nucleotide mutations (SHM) present when aligned to its assigned germline gene.  
 Running the stand-alone IgBlast program on a local computer is not exceptionally 
easy for non-computationalists.  Researchers must first make sure they have installed a 
Linux operating system that contains the proper environment settings and all the necessary 
packages for running the IgBlast source code.  Another source of difficulty is that the output 
file of an IgBlast analysis is written in the BLAST output format.  Because this format does 
not store sequence information using delimiter-separated values (i.e. tab delimited file), the 
results cannot be presented in a tabular format using spreadsheet programs such as Excel.  
This file format can be problematic for downstream analysis because most scripts rely on 
using simple delimiter values to separate the annotated features (i.e. CDR1 and CDR2) 
from each sequence read into individual columns for impending analysis.  Thus, after 




file, identify the features of interest to the researcher, and output the result in recognizable 
formats such as tab-delimited files.   
The IgBlast stand-alone program has been repackaged into scripts hosted on 
APPSOMA.  These scripts address all of the extraneous processes associated with the 
stand-alone IgBlast analysis.  Users can run IgBlast from a graphical user interface that 
works within the ImmunoGReP pipeline (Figure 4.2).  When users run the APP, IgBlast 
will be automatically installed on the executive node running the program, then run IgBlast 
with the necessary settings, and finally report the IgBlast results in an appropriate format 
defined by the user.   
 
Although IgBlast is a highly useful and powerful tool, it is not designed for all types 
of repertoire analysis studies.  First, IgBlast analysis cannot always handle, in a reasonable 
time, the quantity of sequence information associated with contemporary repertoire studies.  
More importantly, IgBlast does not accurately predict the V-D and D-J junctions that form 




the CDR3 ends of a recombined immunoglobulin sequence.  This poses a problem for 
researchers that rely on CDR3 analysis rather than germline assignment.  For example, 
CDR3 sequence spectratyping has been important for both clustering sequences into unique 
clonotypes and for identifying antibodies at the proteomic level via mass spectrometry[9], 
[10].   
Therefore, in addition to IgBlast analysis, we also provide a program for extracting 
only the CDR3 sequence from sequencing data.  This script, based on a previously designed 
in-house algorithm, relies on the identification of CDR3 flanking motifs found in the 
framework 3 and 4 regions of an antibody.  Importantly, the motif we have selected is 
common to all germline V and J gene segments within a gene locus.  Therefore, the CDR3 
can be identified regardless of its respective V and J germline gene segments.  Similarly to 
IgBlast on APPSOMA, we have designed this program with a highly customizable user 
interface for the simple analysis of NGS data.  The CDR3 spectratyping algorithm is 
currently designed for the identification of the heavy and light chain CDR3s from multiple 
species including human and mouse.  Additionally, because users are allowed to upload a 
custom motif table, the APP can be easily extended to the analysis of even more species, 
or other regions of the antibody, such as the CDR1.   
The programs described above annotate the variable heavy and light chains of an 
antibody.  In an effort to provide a complete and comprehensive analysis of sequence data, 
we also provide a program for determining the isotype of a sequence.  The program aligns 
sequences to small barcodes which correspond to the constant regions of an IgG, IgM, IgA, 
IgK, or IgL antibody isotype.  The correct isotype is assigned to a sequence containing 




APPs for repertoire analysis and visualization  
Prepackaged programs such as IMGT and IgBlast only annotate sequence 
information.  However, researchers often struggle the most with post-annotation analysis 
because they do not know how to analyze their data or run the relevant statistical tests.  
Therefore, we include programs which accept output files from either IgBlast, IMGT, or 
CDR3 spectratyping annotation and generate “descriptive statistics” of the repertoire of 
interest.  These statistics, such as CDR3 length distribution, V and J gene segment usage, 
and CDR3 diversity, are common methods for characterizing the adaptive immune 
response.  In addition, we designed an APP which will compare the overlap between 
sequences shared across multiple experiments and subsequently calculate the pairwise 
correlation between datasets.  These programs will also generate plots, such as histograms, 
heat maps, and circus plots,  which summarize the analyses (Figure 4.3)[137].  It is 
important to stress that because all analysis APPs are provided within the APPSOMA 
environment, the user can both annotate and analyze sequence data in one entire step.  
Without such a pipeline, a researcher without any computational background would be 
forced to first annotate sequence data using IMGT or IgBlast, export the results, convert 
the file into a file format that is compatible with a downstream analysis program, run the 
Figure 4.3: Examples of output from analysis APPs 




second analysis on the annotated sequences, and finally plot the results of the analysis using 
a third program.    
Solutions for data storage 
Systems for data curation and storage are equally as important as systems for 
analyzing data.  We aimed to create solutions which address proper curation of 
experimental data, long term storage of raw data, and storage of annotated NGS 
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Standardization of experimental info for raw data 
Data processing and analysis is dependent upon the experimental methods used 
before sequencing.  Factors such as the number of immunoglobulin cells analyzed, the 




cellular markers used to isolate specific cell subsets, and the inclusion of barcodes or 
replicate samples affect how sequencing data should be analyzed and interpreted 
downstream.  We wanted a system that stored both the raw sequencing data for an NGS 
experiment and information describing the experimental process.  The online data 
management tool termed integrated Rule Oriented Data System, or iRODS, is an ideal tool 
for such a system[153].  
iRODS emphasizes secure backup solutions for research groups and easy 
distribution of data across collaborators.  Moreover, files uploaded to iRODS can be tagged 
with an unlimited number of fields, called metadata, which can be subsequently used in 
queries for specific experiments.  For every NGS repertoire study, we stored the following 
files in iRODS: 1) all raw files generated from NGS, 2) quality filtered FASTA files, 3) 
and any sequence annotation results obtained from analyses performed outside of 
APPSOMA such as IMGT analysis of immunoglobulin sequences.  We also enforced 
descriptive fields that must be included when uploading a sequencing dataset.  These fields 
include, but are not limited to, 1) the project name and description, 2) number of cells 
analyzed, 3) relevant cell markers, 4) sequencing platform used, 5) and lists of members 
who have read and write access to the experimental data (Table D.1).  Regardless of any 
changes we make to the ImmunoGReP database or analysis tools, iRODs presents a safe 




An immunological HTS database 
The iRODS system discussed above cannot store detailed information provided by 
annotation tools such as IMGT and IgBlast.  Instead, it is necessary to organize analyzed 
data into a defined database openly available to the community.   For example, a future 
meta-analysis study may search for previous experiments which contained 
immunoglobulin sequences with a specific CDR3 amino acid sequence.  We aimed to 
create a database that could facilitate such prospective endeavors.   
Figure 4.4: Simplified database schema for the sequences and experiments collections 
A) Each NGS sequence read is stored as an individual document in sequences 
collection.  Each document contains information about the sequence and the 
experiment it belongs to B) Condensed experiment collection that only contains 
information on each repertoire study.  C) For every sequence read, analysis 
information is stored within the sequences collection.  Analysis from different 




Figure 4.4 illustrates a simplified schema of how our database is currently 
organized.   In summary, the database is organized across two collections.  The first 
collection is called the experiments collection and stores the experimental information 
stored in iRODS metadata.  Transcript specific information from all experiments is stored 
in a very large collection called the sequences collection.  The sequences collection stores 
information regarding biologically relevant features determined from sequence annotation 
programs such as IMGT.  Such features include the predicted V, D, and J genes, CDR 1, 
2, and 3 sequences, framework regions, and productivity of an immunoglobulin sequence.  
However, different annotation programs will report varied results for the same 
features listed above.  For example, both IMGT and IgBlast use separate nomenclature for 
the set of mouse germline VH genes.  Because of this lack of standardization, the database 
must accurately document which programs were used to analyze sequence data.  
Consequently, for every stored sequence read, we will store annotation generated by 
different algorithms separately within the analysis field (Subdocuments in figure 4.4A).  
That is, sequences analyzed using both IMGT and IgBlast, will contain two different 
analyses that are stored separately within the document.  Using this method, researchers 
can easily compare results reported by IMGT and results reported by IgBlast.  Currently, 
we store information compiled from running IMGT, IgBlast, and our in house CDR3 
spectratyping pipeline.  
All functions for inserting experiments into the database have been implemented 
solely in the APPSOMA platform.  Table 4.3 summarizes the performance of our database 
solution and sample queries.  We currently have 30 million sequences stored in the database 
compiled from 21 experiments.  In total, the size of this database requires 100 GB which 




computer it takes 34 minutes to populate the database with 1 million sequence documents 
and 30 seconds to query the sequences from the database. A query for a CDR3 sequence 
found three times among these 10 million sequences takes under five minutes.    
 
Database Performance 
Time to insert  
in database 
34 minutes 
Time to query from 
database 
0.5 minutes 
Size of inserted 
documents 
3 GB (~3 
KB/document ) 
Table 4.3: Performance of Database Functions 
This table summarizes the time it takes to both insert an analysis file containing 
1 million sequences and subsequently query those documents from the 





The combined pipeline for repertoire analysis:                                                      
annotation, analysis, storage, and validation 
Figure 4.5: Example of repertoire analysis using ImmunoGReP on APPSOMA 
Example analysis pipeline for the lymphoid tissue repertoires (BMPC, LNPC, and 
SPPC) from the mouse 23 NGS datasets described in Chapter 2. Dotted outlines 
represent optional steps; Yellow boxes represent APPs. All data is backed up 
securely in IRODs (A).   APPs report all relevant information for repertoire 
sequence data (B). Analysis from APPSOMA can be stored in the NGS 




Chapter 2 describes the comparison of lymphoid tissue repertoires isolated from 
mice immunized with the HEL antigen.  The analysis for that study was performed using 
IMGT annotation.  Figure 4.5 illustrates how, using all analyses discussed above, the 
ImmunoGReP pipeline can reproduce results from that experiment in less than one hour.  
It should be stressed that this pipeline includes programs written in multiple languages such 
as python, pymongo, c++, and perl.  Users who choose to run the programs from within 
APPSOMA will not need to worry about running analyses using multiple computer 
languages.  Instead, all steps performed within APPSOMA, illustrated by yellow outlines 
in Figure 4.5, can be performed without any computational experience.  Finally, this 
modular pipeline can be easily modified.   
We next demonstrate that the ImmunoGReP pipeline can be used to benchmark 
various algorithms.  Centralization of both immunological data and analysis, enables 
researchers to easily compare multiple algorithms using identical sequence sets and 
computer hardware.  As an example, we can use the LNPC dataset stored in the database 
to compare CDR3 identification using our in-house script or IgBlast to CDR3 sequences 
reported by IMGT.  Using the pipeline, it immediately becomes apparent that IgBlast fails 
when trying to report the heavy chain CDR3 sequence of variable genes (Figure 4.6A).  
Our InHouse CDR3 script on the other hand, shows very strong similarity with respect to 
IMGT (Pearson correlation ~ 0.95) generated results.  Further inspection of the top CDR3 
sequences in each analysis reveals that although IgBlast identifies the start of the CDR3 
correctly, it does not provide the same DJ junction reported by IMGT (Figure 4.6B).  This 
example demonstrates that in order to use IgBlast to provide accurate CDR3 spectratyping, 




Thus, we show that ImmunoGReP provides a centralized source for researchers to evaluate 
algorithms and select those that best meet their research goals.   
 
DISCUSSION 
We have presented the framework of a cloud based tool for analyzing 
immunoglobulin repertoires.  ImmunoGReP is one of the first “suite of programs” designed 
to address all aspects of a repertoire study.  Specifically, we present methods for data 
curation, sequence annotation, data analysis, data visualization, and data storage.  This 
outlined pipeline represents a first stage for ImmunoGReP and demonstrates the utility of 
a centralized source of analysis tools.  The pipeline provides multiple solutions for 
repertoire analysis and can be easily modified to accommodate novel algorithms or 
“modules”.  For the second stage, we want to continue to add to this suite of available 
programs for repertoire study.  For example, we plan to provide accessibility to algorithms 
for clustering, in-silico pairing of heavy and light chains, and additional methods for 
sequence annotation.  In addition, because the database of germline gene segments is 
always changing, the IgBlast germline database may not always provide the most updated 
Figure 4.6: Comparison of CDR3 identification across algorithms 
A)Heatmap of pearson correlations (generated in ImmunoGReP) comparing 
methods for identification of the CDR3 amino acid sequence using the same test 




or comprehensive set of germline gene segments for V(D)J assignment.  Therefore, the 
next version of the APPSOMA based IgBlast APP will also permit the alignment of 
NextGen sequence data against a custom database of germline gene segments defined by 
the user.   
Providing access to a database enables open accessibility and reproducibility of 
repertoire sequencing data.  While we currently only allow users to download sequencing 
data from a previous study, we plan to expand on this functionality and enable advanced 
queries for biologically relevant features (i.e. sequences expressing specific CDR3 amino 
acid sequences).  Finally, a centralized source of analyzes tools connected to a database 
enables researchers to easily benchmark novel algorithms and gauge their effectiveness.     
In lieu of this potential, we also plan to create a gold test set, compiled from repertoire data 
of multiple species, that can used for benchmarking algorithms.  In summary, using the 
APPSOMA platform, we present simple access to a pipeline of algorithms which provide 









Chapter 5:  Conclusion and Future Aims 
METHODS FOR IMMUNOGLOBULIN REPERTOIRE ANALYSIS 
The humoral adaptive immune system is composed of an impressively diverse 
repertoire of antibodies that display varied specificities against unforeseen pathogens.  This 
vast repertoire is attributable to the evolution of an intricate system of genetic 
diversification processes which generate novel defensive elements during the lifetime of 
an individual.  High throughput analysis of the immunological repertoire via next 
generation sequencing has the potential to deconvolute many aspects of adaptive immunity.  
Such advancements can have a profound effect in vaccine development, treatment of 
autoimmune disorders, and antibody discovery.   
Nevertheless, this technology is still in its infancy and, as a result, there are many 
challenges that must be overcome.  One of the largest challenges is that the computational 
and statistical methods needed for the analysis of sequenced repertoires are unfamiliar to 
many researchers in immunology.  In this work we introduce many informatics tools for 
the statistical analysis and visualization of large repertoire datasets.  Additionally, we 
introduce techniques and algorithms that can efficiently process large amounts of data.   
In this work we show that the challenges associated with systems analysis of 
immunological repertoires can be addressed by analogous problems in unrelated fields.  
Identification of such analogous situations could be highly beneficial to the progression of 
immunology research.  One example application is the extension of Fast Fourier Transform 
techniques for V(D)J annotation of immunoglobulin sequences.  Specifically, we show a 
novel use for sparse Fourier transforms in identifying the best regions of alignment between 
an immunoglobulin sequence and its germline gene.  Moreover, statistical methods 




can be also be found in analogous fields.  Statistical methods used in ecology can provide 
a framework for immunoglobulin sequence analysis.  For example, the diversity of 
repertoires can be calculated and compared using numerous indices of diversity previously 
investigated by ecologists.   
In addition, progress in high throughput sequencing of immunological repertoires 
must address how experimental error affects quantification and characterization of an 
immune response.  Our analysis of lymphoid tissues demonstrated that the immunological 
repertoire is highly variable across individuals, and, in addition, we could only identify one 
mouse that presented a strong immune response against the antigen.  While we were able 
to identify statistically robust trends in the global characteristics of lymphoid tissue 
repertoires, it was difficult to ascertain the significance of very minute, yet potentially 
biologically important, differences within the repertoire tissues.  Because there are not 
many quantitative characterizations of potential experimental error and replication, we 
repeatedly exemplified the use of non-parametric statistical analyses in our study of the 
lymphoid tissues.  It is important for future studies to give substantial focus to designing 
controlled experiments which allow for robust statistical analyses of significance and 




INVESTIGATING METHODS FOR ACCURATE DEEP SEQUENCING OF THE CDR3  
The majority of methods described in this work concern the downstream analysis 
of repertoire studies after high throughput sequencing.  However, there are still significant 
areas of improvement in the upstream design of cDNA libraries that would greatly enhance 
the accuracy of sequencing.  This need arises because the majority of repertoire studies 
entail the identification of unique mutations that correspond to specific sequences of the 
BCR.  Such high resolution sequence analysis is difficult in the background of NextGen 
sequencers that have an intrinsic average error rate of 10-2-10-4 mutations per base pair.     
Therefore, a future aim is the design of experimental methods which can mitigate 
non-biological sequencing error.  Our approach will take advantage of a novel method for 
library preparation, termed “circle sequencing”, which corrects sequencing errors 
computationally [154].  In circle sequencing, DNA amplicons from the cDNA library of 
Figure 5.1: Circle Sequencing Protocol 
Circle sequencing is a method for correcting error introduced during NGS. A) 
Circularize library of single stranded DNA B) Perform rolling circle 
amplification (RCA).  This amplification step synthesizes tandem copies of 
circular molecules. C) Perform NGS on the amplicon with tandem repeats. Non-
biological errors are introduced randomly (orange circles) during HTS D) From 
the sequenced read, identify the repeats generated by RCA.  Align each repeat 
from the sequence read and make a consensus sequence, eliminating error 




the immune repertoire are circularized and subsequently replicated using a rolling-circle 
polymerase which creates tandem copies of the sequence that are physically linked on a 
double stranded DNA product (Figure 5.1).  Because each tandem copy is independent, it 
is unlikely to observe the same type of sequencing error introduced across multiple copies.  
Therefore, these tandem copies can be used, post-sequencing, to form a consensus 
sequence and correct for any errors that were introduced by next generation sequencing.  
The application of circle sequencing for sequencing the yeast genome resulted in a decrease 
in error rate by three to four orders of magnitude [154]. 
Figure 5.2: Testing RCA as a method for CDR3 spectratyping 
A)Variant that transcribes control IgM construct from T7  B) Analyze error rate 
of NGS of control IgM using RCA C) Isolate human naïve B cells and extract 
mRNA.  Spike in IgM control, make cDNA, and sequence cDNA library.  Test 




  We will investigate whether circle sequencing can be an accurate method for deep 
sequencing of the CDR3 region, the most diverse region of an antibody sequence.  Figure 
5.2 illustrates the experimental protocol for evaluating circle sequencing.  We want to 
characterize both the accuracy of CDR3 sequencing and the sequencing efficiency when 
using RCA as a method for repertoire analysis.  Sequencing efficiency will refer to the 
fraction of lymphocytes whose CDR3 can be accurately detected and sequenced using 
RCA.  To address both questions, we have made a synthetic construct of a full length IgM 
immunoglobulin whose transcription is regulated by the T7 RNA polymerase promoter 
(Figure 5.2a).  NGS sequencing of the IgM mRNA generated from this construct using 
both conventional and RCA sequencing will demonstrate the accuracy of the RCA method 
(Figure 5.2b).  
Figure 5.3: Quantification of IgM transcript in Naïve B cells  
Scatter plot shows the results from qPCR analysis of the levels of IgM transcript 
in naïve B cells. Naïve B cells were isolated from concentrated leukoctyes using 
MACS isolation kit for CD19+ and CD27- markers expressed on naïve cells.  
The concentration of isolated naïve cells was measured using a countess 
automated cell counter.  mRNA was extracted from samples containing a varied 
number of isolated naïve B cells (3e6 to 1.5e5).  mRNA was converted to cDNA 
and qPCR was subsequently performed on the cDNA samples using primers 




Second, to demonstrate sequencing efficiency, we will spike-in known amounts of 
IgM mRNA into mRNA isolated from naïve B cells.  Subsequent sequencing of this library 
using both conventional and RCA sequencing will determine whether either methods is 
sensitive enough to detect the synthetic CDR3 sequence (Figure 5.2c).  The amount of 
control mRNA IgM spiked-in will be determined using qPCR analysis which will quantify 
the average amount of IgM mRNA expressed by naïve B cells (Figure 5.3). 
EXTENSION OF THE IMMUNOGREP ANALYSIS PIPELINE 
As a final note, there is still a significant amount of work that is required to ensure 
standardized analysis methods in immunology.  This work is dependent upon the efforts 
contributed by the immunology community as a whole.  Consequently, we have introduced 
the ImmunoGReP analysis pipeline.  ImmunoGReP was designed to facilitate 
immunoglobulin repertoire analysis by creating an open source of cloud-based tools. We 
also created a database designed specifically for immunology research.  Some current areas 
of immunoglobulin analysis that we have not yet addressed include 1) the availability of 
novel algorithms for germline annotation such as our in house germline assignment 
program, 2) programs which take advantage of sequence quality scores to correct for 
immunoglobulin sequence error, 3) algorithms for clustering and phylogenetic analysis, 
and finally 4) the integration of an analysis pipeline for proteomic studies. While, our 
pipeline provides non-computationally skilled researchers with easy access to the basic 
tools for analyzing repertoires, it was designed to be continually expanded.   As our 
knowledge of the adaptive immune system continues to develop and change, so will the 
compilation of analytical tools and algorithms.  Access to a constantly updated centralized 




important future prospect for this pipeline is to promote collaboration and integration of 





Additional work: Investigation of E. coli redox chemistry  
PREFACE 
In addition to the study of immunological repertoires, a significant amount of work 
was dedicated to the study of redox homeostasis in E. coli.  Many biological processes are 
closely coupled to redox reactions which transfer electrons from an electron rich source to 
an electron sink compound.  In this regard, E. coli have evolved to tightly regulate electron 
flow using an intricate organization of redox-sensitive proteins and cofactors.  Among 
these molecules, the cofactor, Glutathione, is one of the most essential for redox 
homeostasis in E. coli.  Glutathione (GSH) is a small tripeptide, γ-glutamyl-L-cysteinyl-
glycine whose intracellular concentration in bacteria ranges between 0.1 and 10 mM[155].  
As the most prominent thiol species, GSH acts as a “redox buffer” regulating whether 
oxidative reactions in the cytoplasm are thermodynamically favorable[156].  In addition to 
maintaining a reduced glutaredoxin pool, glutathione has been attributed with protection 
against reactive oxygen species (Figure A.1)[155], [157].  
 
 




  Redox homeostasis is a highly plastic process across organisms and not every 
organism exhibits same dependency on Glutathione.  In fact some organisms have evolved 
in the absence of Glutathione[158].  In such situations, other redox-sensitive proteins such 
as thioredoxins must address oxidative stress created by reactive oxygen species[159], 
[160].  Thus, we have been interested in novel methods in which E. coli would respond to 
selective pressure imposed from the removal of glutathione dependent pathways.  Arsenate 
resistance is an example of a redox mechanism highly dependent on glutathione.  E. coli 
mutants lacking glutathione, glutaredoxins, or arsenate reductase cannot grow in the 
presence of arsenate.  Moreover, not all arsenate reductase enzymes are dependent upon 
glutathione[160].  Thus, the removal of either of these elements provides an effective 
selection pressure for screening novel electron pathways.  The aim was to investigate 
whether these novel pathways could give insight with respect to the evolution of analogous 
arsenate reductase pathways.  Interestingly, while we could not identify pathways 
independent of Glutathione, the results of our genetic screens did result in the identification 
of novel pathways for arsenate resistance.  One of the most promising discoveries from our 
work was the identification of a Glutathione-S-transferase capable of catalyzing the 
reduction of arsenate in the absence of wild type arsenate reductase.  The following study 
discusses the results of this novel finding.  The inability to identify glutathione-independent 
pathways further illustrates that, while redox mechanisms may be a highly plastic process, 






 AN ALTERNATE PATHWAY OF ARSENATE RESISTANCE IN E.COLI 
Introduction 
In nature, the toxic heavy metalloid, arsenic, exists predominately as oxyanions in 
either its pentavalent or trivalent oxidation states[160].  The natural abundance of both 
toxic molecules imposes a strong selection pressure for organisms to evolve arsenic 
detoxification pathways.  Because these pathways have evolved in parallel across many 
organisms, the study of arsenic detoxification is often a topic of interest[160], [161].     
Detoxification of reduced arsenite in-vivo can be achieved via sequestration or efflux from 
arsenite specific transporters[162].  Arsenate, on the other hand, is not immediately 
exported.  Instead, the first step in arsenate detoxification across species has evolved to 
reduce arsenate into arsenite[160], [163], [164].  This reductive step is catalyzed by a 
diverse class of enzymes termed arsenate reductases.     
Five mechanistically and phylogenetically distinct classes of arsenate reductase 
enzymes have been identified so far.  While all families contain a catalytic redox-sensitive 
cysteine residue, the specific mechanism of action can differ significantly between classes 
[160].   Arsenate reductases from Gram-positive bacteria accept electrons from 
thioredoxins which are maintained in the reduced state by the NADPH dependent enzyme 
thioredoxin reductase[165].  These enzymes display structural similarity to mammalian 
tyrosine phosphatase enzymes and exhibit in-vitro phosphatase activity[166] [167].  
Conversely, arsenate reductase enzymes from  Gram-negative bacteria including E. coli 
depend on the glutathione/glutaredoxin reductive pathway [168], [169].  This class of 
reductases does not show evidence for phosphatase activity[170].  Given such a distinct 




plastic process in which multiple unrelated enzymes can evolve to catalyze the essential 
reductive step.  
In an earlier study we used genetic selection approaches to identify alternate 
electron transfer pathways for the reduction of As(V) in E.coli.  Selection for suppressor 
mutations capable of rescuing arsenate sensitivity of a glutathione null E. coli mutant 
(gshA) revealed instead a novel pathway for glutathione synthesis via the proAB operon, 
responsible for proline biosynthesis[171].  Suppressor mutations in proAB resulted in 
accumulation of  -glutamyl phosphate which reacted spontaneously with L-Cysteine to 
form -glutamyl cysteine, the reaction product of GshA.  Thus, the genetic screen resulted 
in the restoration of electron flux towards arsenate reduction[171].    These findings 
underscored the essentiality of the glutaredoxin/glutathione system in providing electron 
equivalents for As(V) reduction by ArsC.    
We investigated whether other E.coli enzymes or pathways are able to confer 
resistance to lethal concentrations of arsenate in the absence of the arsenate reductase 
enzyme, ArsC.  The complete set of E. coli K12 ORF ARCHIVE (ASKA library) can be 
readily used as a powerful screening tool for identifying new enzyme functionalities[172]–
[174].  Using this genetic screen, we found that overexpression of the glutathione S-
transferase B (gstB) gene from a multicopy plasmid enabled E.coli arsC cells to grow in 
the presence of millimollar levels of arsenate.  GstB was previously shown to be involved 
in bromoacetate resistance via a dehalogenation mechanism in which the conjugation of 
bromoacetate and glutathione results in the release of a free bromide[175].  In this study, 
we show that GstB also facilitates a glutathione-dependent arsenate reduction reaction.  
Whereas cysteine plays an essential role in the catalytic mechanism of the much better 




which forming a thioredoxin-like CXXC fold, are dispensable for As(V) reduction[176].  
Instead conserved arginine residues within the active site are critical for binding to 
electrophilic substrates including arsenate.  In vitro and in vivo biochemical studies further 
revealed that GstB directly catalyzes the reduction of arsenate with GSH as the reductant 
in a reaction that does not depend on glutaredoxins.  Thus, our results define an auxiliary, 
mechanism for arsenate resistance in bacteria.   
Materials and methods 
Reagents 
Sodium Arsenate (S9663-50G), Sodium Arsenite (S225I-100G), and MOPS Salts 
(M1254-250G) were purchased from Sigma Aldrich.  Disposable Strata-SAX anion-
exchange columns (8B-S008-HCH) were purchased from Phenomenex.  Isopropyl D-1-
thiogalactopyranoside (206-703-0) was purchased from Fisher Scientific.  All reagents for 
arsenic detection (EZ Arsenic Test Kit Catalog # 280000 ) including arsenic test strips, 
Zinc Sulfate, and Phosphate, were purchased from the Hach Chemicals.  For the NADPH 
coupled assay, Glutathione reductase from Bakers Yeast (060M7405) and Reduced 
Nicotinamide adenine dincucleotide phosphate (N7505-25MG) were purchased from 
Sigma Aldrich.   
Bacterial strains, plasmids, and media 
Cells challenged for arsenate resistance were grown in MOPS minimal growth 
media containing minimal levels of phosphate.  MOPS growth media consisted of MOPS 
Salts, 0.2% Casein Amino Acids, 0.2% Glucose, and 1.32 mM KH2PO4.  When necessary, 
chloramphenicol and/or kanamycin were added to the growth media at a concentration of 




collection, IPTG was added to growth media at a concentration of 0.1 mM.  Cell strains 
used for protein expression were grown in 2xYT rich media containing 33 μg/mL of 
chloramphenicol. 
The details for all E. coli strains are described in Table A.1.  The arsC gene from 
both Jude 1 and DHB4 was replaced with a kanamycin resistance marker using the Wanner 
gene knockout method as previously described[177].  The following genetic elements were 
also knocked out of the chromosome of the DHB4 arsC mutant strain: gstB and the 
arsRBC operon.  Finally, the arsC gene was also removed from the mutant strain 
DHB4ΔgrxAΔgrxBΔgrxC.  For each subsequent knockout, the kanamycin resistance 
marker was first removed using the pcp20 plasmid[177].    
The details for all E. coli constructs are described in Table A.2.  Genetic selection 
was performed using the library of ASKA clones where the GFP tag had been previously 
removed, leaving behind a peptide scar sequence of GLCGR.  We removed the C-terminal 
Scar from pGstB using Quick change PCR.  In addition, using quick change, we made 
variants of GstB with mutations in selected reasons.  Specifically, we made three variants 
in which the CXXC motif was selectively mutated to alanine: pGstBC134A/C137A, pGstBC137A, 
and pGstBC134A.  An additional three mutants were constructed in which the purported 
essential arginine residues were mutated to glutamine: pGstBR111Q/R119Q, pGstBR111Q, and 
pGstBR119Q.  Finally, for GstB crystallization, we constructed another variant pGstBP-WT 
where a Factor XA protease site IDGR was added downstream of the His-Tag and upstream 
of the start codon using overlap extension PCR in the event it was necessary to remove the 





Electrocompetent Jude 1 E. coli arsC mutant strain, EQ217, was transformed with 
the ASKA library.  Transformed cells were rescued in LB media containing 0.1 mM IPTG 
for two hours.  After rescue, cells were plated on MOPS plates containing 
Chloramphenicol, Kanamycin, 0.4 mM Sodium Arsenate, and 0.1 mM IPTG.  Plated cells 
were allowed to grow for two days at 37o degrees Celsius.  After two days, colonies were 
selected and their corresponding pCA24N constructs from the ASKA library were 
sequenced.  
Growth curves 
Selected cell strains were grown overnight in MOPS 1X Minimal Media; 
Chloramphenicol was added to the media of strains containing a pCA24N construct.  The 
following day, strains were sub-cultured at a dilution of 1:100 into 24-well growth culture 
plates.  The total volume of growth media in each well was 20% the total well-volume.  0.1 
mM IPTG and varied concentrations of arsenate from 0 to 2 mM was added to each well.  
Cell growth was monitored for 24 hours at 37ºC using a Synergy HT plate reader at an 
absorbance of 600 nm.  Growth curves were fit to a Gompertz hyperbolic model[178].  
From the model we extracted doubling time, lag time, and saturation absorbance.  
Protein expression and purification 
Both GstB and the GstB inactive variant were purified, as previously 
described[175], from the pGstB and pGstBR111Q/R119Q constructs, respectively.  Cells were 
grown overnight in 2XYT media containing chloramphenicol.  The next day, cells were 
sub-cultured at a dilution of 1:100 in a 500 mL flasks containing 2XYT.  Once cells reached 
an OD of 0.8-1, they were induced with 0.5 mM IPTG for 3 hours at 37ºC.  After induction, 




Cell pellets were resuspended in 30 mL of buffer A containing 50 mM HEPES pH 
7.5, 40 mM imidazole, 2 mM DTT, and 300 mM NaCl.  Cells were lysed by passage twice 
through a French Press; debris from lysed cells was sedimented by centrifugation for 30 
minutes.  GstB was purified from cell lysate using Nickel NTA resin.  Non-specific binding 
to the column was washed using buffer B, which contained Buffer A and 65 mM imidazole.  
GstB was eluted in a solution containing Buffer A and 250 mM imidazole.  Purified GstB 
protein was dialyzed overnight in 4 L of dialysis buffer containing 50 mM HEPES pH 7.5, 
10% glycerol and 10 mM NaCl.  
Measurement of Arsenite in solution 
Solutions of arsenite were separated from arsenate using disposable Strata SAX 
anion exchange columns.  Arsenate, which is negatively charged at a pH > 2.2 binds to the 
positively charged column, whereas arsenite which is uncharged at pH < 9.2 will not bind 
to the column.  Therefore, when a solution containing a mixture of arsenate and arsenite is 
passed through the column, purified arsenite can be collected in the flow through.  The 
levels of arsenite can then be semi-quantitated using the EZ arsenic detection kit provided 
by HACH chemicals.  This kit detects levels of arsenic as low as 50 ppb.  Total arsenic is 
detected by the zinc catalyzed reduction of arsenite to arsine gas which is then captured by 
mercuric bromide strips causing a color change.  Strips that appear dark orange/black 
indicate levels of arsenic above 500 ppb.  
Measurement of Arsenite accumulation in-vivo 
Cell strains grown overnight were sub-cultured at a dilution of 1:100 at 37ºC in 
MOPS media containing the required antibiotic for each respective strain.  When cells 




Once cells reached an OD of 0.6-0.8, 1 mM Arsenate was added to each strain and growth 
was continued for one hour.  After one hour of growth, all cell strains were normalized to 
the same OD, and 5 mLs of cells were pelleted for 10 minutes.  The solution was diluted 
using 45 mLs of water and the amount of arsenite present in each sample was measured 
using the assay described above.  
In-vitro arsenate reduction 
The reaction buffer for in-vitro arsenate reduction was 100 mM HEPES at neutral 
pH 7.  In the non-catalyzed reaction, 1 mM of GSH was incubated with 50 mM sodium 
arsenate.  For the enzyme catalyzed reaction, purified enzyme was added to the mixture at 
a concentration of 0.12 mM.  The total reaction volume was 500 μL and samples were 
incubated for 60 minutes total.  After 30 minutes of incubation, arsenite production was 
measured using half of the mixture; after 60 minutes, arsenite production was measured 
using the remaining half of the mixture.  At each time point, the mixture was diluted to 
3mLs, the pH was subsequently lowered to 4, and, finally, the mixture was separated using 
Strata-SAX anion exchange columns.  The reaction mixture was lowered to 4 to separate 
any As(III)-GSH conjugates known to freely formed in solution.  After separation, the 
flow-through was diluted to a volume of 10 mLs using water before arsenic detection. 
Arsenite in each reaction mixture was semi-quantitated using the arsenite detection assay 
described above.   
GstB bromoacetate activity 
The assay for bromoacetate activity was modified slightly from that described 
previously[175].   Bromoacetate activity was quantified by monitoring the consumption of 




mM bromoacetate and 5 mM GSH was added to the mixture.  To initiate the reaction, 
purified GstB was added to the reaction mixture at a concentration of 0.5 μM. GSH 
consumption was compared to no enzyme controls. The substrates were reacted for varied 
amounts of time, at which point, the reaction was quenched using 30 mM 
monobromobimane which conjugates bimane to any remaining reduced GSH.  The 
remaining GSH conjugated to bimane was quantitated by measuring the absorbance at 338 
nm using HPLC analysis.  Reaction rate kinetics was obtained after subtracting the amount 
of non-catalyzed Glutathione-S-acetate formed.   
GstB activity via NADPH coupled assay 
GstB activity for arsenate reduction was quantified using a similar protocol used 
for arsC activity, in which activity is measured using a NADPH coupled assay[169].  
Briefly, each 100 μL reaction mixture contained the following: 0.3 mM of NAPDH, 1 
μg/mL glutathione reductase, and 1 mM reduced GSH.  If indicated, concentrations of 
As(V) varied between 20 to 150 mM, and purified enzyme was added to the master mixture 
above at a concentration of 0.12 mM.  If indicated, Grx2 was added to the master mixture 
at a concentration of 10 μg/mL.  Reaction kinetics were obtained by measuring the decrease 
in absorbance at 340 nm using a Synergy HT plate reader.  [NAPDH] was determined using 
its extinction coefficient at 340 nm of 6200M-1cm-1 and 0.3 cm path length corresponding 






GstB confers arsenate resistance to E.coli arsC  
 EQ217, a arsC E. coli strain derived from DH10B, is hypersensitive to arsenate 
with complete colony growth inhibition observed on MOPS minimal media agar plates 
containing 0.4 mM sodium arsenate.  EQ217 was transformed with the ASKA library[172] 
and transformants were plated on MOPS minimal media agar plates with  0.4 mM sodium 
arsenate (NaH2AsO4).  Several colonies of varied size arose after two days of incubation 
at 37o Celsius.  Sequencing showed that large colonies encoded for wild type arsC from 
the ASKA vector.  Interestingly, the majority of small colonies randomly picked for 
sequencing were found to encode the glutathione-s-transferase enzyme GstB.  A small 
number of colonies that were sequenced also encoded for the colonic acid biosynthesis 
protein cpsB, and the transcription factors dksA and fruR.  To reconfirm that arsenate 
resistance was caused by gene overexpression, plasmids identified from the genetic screen 
were retransformed in EQ276, a DHB4 arsC mutant strain.  Only multi-copy expression 
of the gstB gene could confer growth on MOPS plates containing more than 1 mM sodium 
arsenate (Figure A.2 A).  Further investigation showed that DHB4 ΔarsC mutants 
transformed with GstB formed good size colonies on plates containing up to 3 mM 
NaH2AsO4, and even formed tiny colonies on plates containing 5 mM sodium arsenate 
(Figure A.2 B).  Every gene expressed from the ASKA collection contains a C terminal 
linker sequence, GLCGA.  Removal of this scar from GstB did not affect arsenate 
resistance in EQ276 mutant cells expressing GstB.  The results of this genetic screen 
suggested that arsenate may serve as an electrophilic substrate for this glutathione-s-




Expectedly, both ArsC and GstB mediated resistance are dependent on glutathione.   
Multicopy expression of GstB or ArsC in glutathione deficient cell strains (WP758) could 
not rescue growth in media containing 0.1 mM sodium arsenate (data not shown).  In 
addition, the arsenate reductase enzyme is dependent on glutaredoxins for the reduction of 
the ArsC-arsenate-glutathione intermediate complex into ArsC-arsenite and a glutathione-
glutaredoxin mixed disulfide[168].  At concentrations above 0.1 mM NaH2AsO4, E.coli 
mutant CC109, carrying a deletion of glutaredoxins A, B, and C as well as arsC,  showed 
increased sensitivity to arsenate relative to the parental strain EQ279 (DHB4arsC).  
Transformation of mutant strain CC109 with pArsC could not restore healthy growth on 
plates containing low millimollar concentrations of arsenate (Figure A.2 B).  In contrast, 




Thus, unlike ArsC, resistance to arsenate by GstB is not dependent on the action of the 
E.coli glutaredoxins.   
ArsC and ArsB together with the trans-acting repressor ArsR comprise the arsenate 
resistance operon arsRBC.  ArsC reduces arsenate to arsenite which is then exported from 
the cell by the ArsB pump [179].  DHB4 containing a complete deletion of the arsRBC 
operon, CC112, could not grow on plates containing more than 0.3 mM arsenate.  This 
phenotype could not be rescued by multi-copy expression of ArsC or GstB (Figure A.2 C).  
Figure A.2: GstB overexpression confers As(V) resistance in arsC knockout 
mutants.   
(A) Only selected arsC mutants overexpressing gstB from the genetic screen 
survived on agar plates containing more than 1 mM arsenate. (B) Selected 
mutant strains were grown on agar plates containing varied arsenate 
concentrations.  GstB overexpression confers growth on plates containing 
between 3-5 mM arsenate.  The growth of glutaredoxin null mutants (grxABC) 
overexpressing GstB indicates that GstB conferred resistance is not dependent 
on glutaredoxins. (C) Both ArsC and GstB conferred resistance are dependent 




Considering that arsR is only required for regulation of ArsC and ArsB transcription, this 
evidence suggests that, in vivo, the arsenite transporter is essential for arsenate 
detoxification facilitated by GstB.   
Residues essential for GstB activity  
GstB contains a canonical thioredoxin-like CXXC motif comprising Cys134 and 
Cys137.  A mutant GstB enzyme in which both cysteine residues had been mutated to 
alanine displayed full arsenate detoxification ability in-vivo.  Specifically, DHB4 arsC 
expressing the double cysteine knockout mutant, GstBC134A/C137A, grew in the presence of 
1 mM sodium arsenate with a doubling time of 200 +/- 10 min compared to  205 +/- 10 
min, for cells expressing wild type GstB.  (Figure A.3 and Supplementary Figure A.7).      
Our efforts to crystallize E.coli GstB led to poor quality crystals that diffracted at 
<3 angstroms but were not solvable due to crystal heterogeneity.  Thus, we referred to the 
recently reported crystal structure of a GstB homolog from Salmonella enterica,  YliJ, in 
complex with GSH [180] (PDB 4KH7).  YliJ shares 83% amino acid identity with the 
E.coli GstB, but contains only one of the two cysteines, Cys137, which constitute the 
CXXC motif.  Consistent with our finding that neither cysteine residue affected arsenate 
detoxification, the crystal structure shows that the homologous cysteine residue in YliJ is 
distant from both the GSH and the putative electrophilic binding site (Figure A.3 A).  We 
observed that in the crystal structure of YliJ three conserved arginine residues, R7, R111, 
and R119, form a patch of positive charge in close proximity near the glutathione binding 
site.  The arginine closest to glutathione, R7, may be involved in glutathione binding.  We 
hypothesized that the two distal arginine residues, R111 and R119, found within the 
electrophilic binding domain of GstB might have a role in positioning anions and 




GstBR111Q, GstBR119Q, and GstBR111Q/R119Q, containing selective mutations of the two 
arginine residues were constructed.  Unlike GstBC134A/C137A , removal of each individual 
arginine residue decreased GstB conferred resistance in the arsenate sensitive strain 
EQ276.  Removal of both arginine residues from GstB, GstBR111Q/R119Q, abolished arsenate 
resistance in EQ276 (Figure A.3 and Supplementary Figure A.7).   
We analyzed whether loss of activity caused by mutagenesis was due to protein 
instability and aggregation.  Both GstB and GstBR111Q/R119Q were expressed and purified to 
near homogeneity using His-tag purification.  Size exclusion chromatography showed an 
identical elution pattern for both wild type GstB and GstBR111Q/R119Q (Supplementary 
Figure A.8).  Differential scanning fluorimetry revealed that the GstBR111Q/R119Q mutant 
Figure A.3: GstB residues Arginine-111 and Arginine-119 are essential for arsenate 
resistance   
(A) Crystal structure of the E. coli GstB homolog in Salmonella (PDB 4KH7).  
Three arginine residues (blue stick models), R-7, R-111, and R-119, form the 
putative electrophilic binding site near GSH (red stick model). (B) Growth of 
arsC mutants expressing either wild type GstB variant (GstBWT), GstB variant 
(GstBR111Q/R119Q), or wild type GstB variant (GstBC134A/C137A) grow in liquid 




even exhibit a slightly increased stability to thermal unfolding (47o  +/- 0.2oC) relative to 
the wild type enzyme (44o +/- 0.4o C) (Supplementary Figure A.10).  Finally, we measured 
whether this GstB variant retained its dehalogenation activity for bromoacetate[175].  In 
vitro activity for bromoacetate was monitored by the measuring the decrease in reduced 
GSH upon the addition of bromoacetate and GstB.  Notably, wild type GstB displayed 
activity towards bromoacetate as previously reported, while GstBR111Q/R119Q, showed no 
activity towards bromoacetate when compared to the non-enzymatic reaction 
(Supplementary Figure A.11). 
GstB catalyzes the reduction of As(V) to As(III) 
The finding that GstB overexpression does not confer arsenate resistance in 
arsRBC cells lacking the arsenite transporter indicates that this enzyme plays a role in the 
reduction of AS(V) to As(III).  We used a straightforward two-step assay to detect the 
accumulation of As(III) in complex biological mixtures such as culture supernatants or cell 
lysates.  This method could distinguish arsenite concentrations varying from 0.05 to 0.5 
mM (Supplementary Figure A.9).  First, As(III) is separated from As(V) in solution using 
anion exchange.  Arsenate, negatively charged at a pH above 2.2, will stay bound to the 
column whereas unionized arsenite passes through the flow through.  The anion exchange 
columns were able to separate arsenite from solutions containing 50 mM sodium arsenate 
(Supplementary Figure A.9).  Separated As(III) in flowthrough is measured using a 
colorimetric assay sensitive to less than 25 ppb total arsenic.  The colorimetric assay 
reduces all arsenic species into arsine gas which subsequently comes into contact with 
strips containing mercuric bromide.  Reaction between arsine gas and mercuric bromide 





                          
 
 
We measured the levels of arsenite that accumulated in supernatant of select E. coli 
strains after incubation with 1 mM sodium arsenate.  Protein expression was induced in 
mid-exponential cells growing in MOPS minimal media using IPTG.  Arsenate was added 
to the media one hour after induction.  After 1 hour of incubation with arsenate the cells 
were pelleted and arsenite levels in the supernatant was determined as described above 
(Figure A.4). No arsenite was detected in the E. coli mutant, WP758, incapable of 
synthesizing GSH.  A very low level of arsenite was detected in the supernatant of the 
E.coli arsCgstB strain EQ301.  This low level of arsenite is presumably due to the slow, 
non-enzymatic reduction of As(V) by intracellular GSH[182].  The presence of arsenite in 
Figure A.4: GstB overexpression results in the reduction of arsenate to arsenite in-
vivo 
Colorimetric tests indicate the level of arsenite accumulation in the supernatant 
of mutant strains cultured in liquid media containing 1 mM As(V).  Detection 
is sensitive to arsenite, not arsenate, in the supernatant (Panel 7).  Glutathione 
null mutant strains cannot reduce As(V) to As(III) (Panel 2).  ArsC null mutants 
overexpressing GstB export significant amounts of As(III) (Panel 6); As(III) 
production is specific to GstB expression and not general GST expression 




this strain as compared to WP758 supports data in which both EQ279 and EQ301 grew on 
plates containing up to 0.4 mM sodium arsenate while WP758 would not grow on plates 
containing 0.1 mM sodium arsenate.   
A low concentration of arsenite in the culture supernatant was also detected in 
DHB4 cells.  This was presumably because exposure to arsenate for 1 hour is not enough 
time to allow a sufficient induction of ArsC synthesis.  In contrast, ArsC expression 
induced from the multicopy plasmid exhibited significant accumulation of extracellular 
arsenite.  A similar result was observed in cells expressing GstB indicating that the 
expression of this glutathione S-transferase directly or indirectly mediates the catalytic 
reduction of arsenate into arsenite (Figure A.4, Panel 6). Finally overexpression of the 
better studied E. coli glutathione S-transferase Gst in EQ301 did not result in significant 
arsenite accumulation (Figure A.4, Panel 5).  
We next sought to evaluate whether GstB directly catalyzes arsenate reduction.  The 
ability of GstB to reduce arsenate was tested using two separate methods.  First, 
accumulation of arsenite was directly measured from in-vitro assays containing purified 
GstB, reduced GSH, and sodium arsenate.  Incubation of 0.12 mM purified GstB in these 
assays significantly increased the levels of arsenite after both 30 and 60 minutes.  
Conversely, incubation with 0.12 mM purified GstBR111Q/R119Q did not increase the levels 
of arsenite produced as compared to the non-enzymatic reaction (Figure A.5 A).  Second, 
the rate of arsenate reduction in the presence of GstB was monitored using a redox coupled 
assay containing NADPH, GOR, GSH, and arsenate[169].  The redox couple assay also 
showed that the rate of arsenate reduction was significantly higher in the presence of GstB, 
but not in the presence of equal amounts of GstBR111Q/R119Q (Figure A.5 B).  The addition 






Finally, GstB activity for arsenate was assayed under saturating glutathione 
concentrations and concentrations varying from 20 mM to 150 mM sodium arsenate.  
Activity was found to be linear at concentrations below 100 mM Arsenate.  Therefore, 
fitting the kinetic data at concentrations below 100 mM, we estimate that GstB has a 
kcat/km of 0.6 (min*M)-1 with respect to arsenate reductase activity (Figure A.5 C).       
DISCUSSION 
By using a genetic screen to identify suppressors of arsenate sensitivity caused by 
the deletion of the native arsC arsenate reductase gene, we identified a glutathione-s-
transferase, GstB, that when overexpressed conferred high levels of arsenate resistance.  
Figure A.5: GstB reduces arsenate to arsenite in-vitro 
(A) Time-course assay for in-vitro conversion of arsenate to arsenite under 
various reaction conditions.  Mixture of 0.12 mM of active GstB with 50 mM 
As(V) and 1 mM GSH results in significant As(III) accumulation (Panel 3) as 
opposed to no enzyme (Panel 2) or inactive GstBR111/119Q (Panel 4) (B) NADPH 
oxidation assay for arsenate reduction in the presence of 0.12 mM active GstB, 
50 mM As(V), and 1 mM GSH.  (C) Reaction kinetics of GstB activity for 




Both in-vivo and in-vitro assays investigating GstB activity, show that this enzyme is 
capable of facilitating the reduction of arsenate into arsenite.  In-vivo, we find that arsenate 
resistance is still dependent upon the presence of ArsB and that overexpression of GstB is 
linked to the accumulation of arsenite in the supernatant.  In vitro, we provide direct 
evidence indicating that GstB accelerates arsenate reduction.  Given this evidence, we 
believe that GstB could support arsenate reduction via two proposed reaction mechanisms 
that do not involve glutaredoxins (Figure A.6).  
In one such schema, GstB could facilitate a rate limiting step in which reduced 
glutathione is first conjugated to arsenate.  Subsequently, another glutathione molecule in 
solution could spontaneously react with the arsenate-glutathione intermediate complex to 
form oxidized glutathione and thereby reduce arsenate to arsenite.  Another plausible 
mechanism given our evidence is that first reduced glutathione conjugates to arsenate in 
solution; GstB then facilitates the reduction of this intermediate complex via glutathione 
bound to the transferase.  While we cannot exclude either mechanism, we believe that the 
former mechanism is more plausible for two reasons.  First, steric collisions around the 
putative GSH binding site of GstB would greatly hinder the ability of a pre-formed GSH-
arsenate complex to interact with the second equivalent of glutathione bound to GstB. 
Second, a nuclear magnetic resonance study of the reaction between glutathione and 
arsenate, in vitro, could not find evidence of an arsenate-GSH complex[182].   Based on 
previous ArsC studies, it is known that such arsenate-thiol complexes form as intermediate 
species in ArsC[168].  The absence of an arsenate-GSH complex in the NMR study 
suggests that the rate limiting step of non-enzymatic arsenate reduction with GSH is the 
putative formation of the arsenate-GSH complex, and that the subsequent binding of a 




correct, GstB would not accelerate the rate of the non-enzymatic reaction as the reduction 
step is not rate limiting. Therefore, it is most likely that GstB catalyzes the formation of an 
arsenate-GSH conjugate, which then leaves the enzyme and encounters a second equivalent 
of GSH, resulting in the reduction of arsenate to arsenite (Figure A.6 Route A).  Given the 
relatively high concentration of GSH in the cytoplasm, millimolar levels, a spontaneous 
encounter between a free GSH and the arsenate-GSH complex would likely be rapid. 
 
To our knowledge GstB is the first known bacterial GST with arsenate reductase 
ability.  However, GstB is not the first instance in which a glutathione-s-transferase has 
been shown to catalyze arsenate reduction[183].  In fact, the human monomethylarsenate 
reductase enzyme, hGSTO1 (PDB 1eem) or MMAV reductase, belongs to the Omega class 
of GSTs [184], [185]. Furthermore, in L. major, the glutathione-s-transferase like enzyme, 
Route A
Route B







Figure A.6: Proposed Mechanisms of GstB conferred As(V) resistance 
Route A.  GstB increases the rate of non-enzymatic reduction of As(V) via 
reduced GSH.  Route B. GstB increases the rate of GSH-As(V) conjugation.  
Once formed, the intermediate undergoes spontaneous reduction to As(III) and 




TDR1 (PDB 4AGS), which shows 29% similarity to hGSTO1 was also shown to have 
reductase activity for both MMAV and As(V)[186], [187, p. 1].  Protein alignment of E. 
coli GstB to both enzymes shows 26% and 28% protein sequence identity to hGSTO1 and 
TDR1, respectively.  One interesting difference between GstB and both TDR1 and 
hGSTO1 is that the later eukaryotic reductase enzymes contain a catalytic cysteine residue 
[184], [186].  Conversely, we did not find any evidence that the cysteine residues in GstB 
contributed significantly to arsenate resistance.  This difference in the catalytic site may 
suggest why GstB shows very poor kinetics for arsenate reduction, and it may be of future 
interest to insert a cysteine into the active site of GstB to elucidate its effect on kinetics.  
Therefore, GstB serves as an intriguing starting point for future directed evolution 
experiments.  It would be interesting to reveal what essential mutations in the active site, 
such as a cysteine, would be necessary to drastically improve its activity towards arsenate, 
and whether these mutations also result in a loss of activity for bromoacetate. Our data 
once again shows the plasticity of arsenate detoxification in biology and that novel 


















DH10B     
Lab 
Collection 
DHB4     
Lab 
Collection 
EQ279 DHB4  ∆arsC Kanamycin This study 
EQ217 JUDE1  ∆arsC Kanamycin This study 
EQ301 EQ279  ∆arsC∆gstB Kanamycin This study 
grxA75
0(del)::





















del)::kan ∆grxA Kanamycin This study 
CC102 DHB4 
grxB734(
del)::kan ∆grxB Kanamycin This study 
CC103 DHB4 
grxC722(
del)::kan ∆grxC Kanamycin This study 
CC104 CC101 CC103 ∆grxA∆grxC Kanamycin This study 
CC105 CC104 CC102 
∆grxA∆grxB∆g
rxC None This study 
CC106 EQ279  ∆arsC∆grxA Kanamycin This study 




CC107 EQ279  ∆arsC∆grxB Kanamycin This study 
CC108 EQ279  ∆arsC∆grxC Kanamycin This study 
CC109 CC105  
∆arsC∆grxA∆g
rxB∆grxC None This study 
CC110 EQ279  ∆arsC∆arsB Kanamycin This study 
CC111 DHB4  ∆arsB Kanamycin This study 
CC112 DHB4  
∆arsR∆arsB∆a
rsC Kanamycin This study 









pGstBASKA - ASKA collection 
pGstASKA - ASKA collection 
pArsCASKA - ASKA collection 
pCpsBASKA - ASKA collection 
pFruRASKA - ASKA collection 
pDksAASKA - ASKA collection 
pGstBWT pGstBASKA This study 
pGstBC134137A pGstBWT This study 
pGstBR111/1119Q pGstBWT This study 
pGstBhomologue  This study 
pGstBP-WT pGstBWT This study 
pGstBP-R111/119Q pGstBR111/1119Q This study 
Table A.1 continued 







Figure A.7: Arsenate resistance conferred by GstB mutant variants 
Growth rate analysis of DHB4 ΔarsC mutant strain expressing selected GstB 
variants.  Analyzed growth in liquid media containing varied concentrations of 
sodium arsenate. 
Figure A.8: Size exclusion of enzyme variants 
[A] GstBP-NS  [B] GstBP-R111/119Q. Arrows represent retention time of protein 






Figure A.9: Two-step semi-quantitative assay for As(III) in solution  
A)Separation of As(III) from As(V) in solution using anion exchange.  As(III) 
comes through the flow through.  B) Sensitivity of colorimetric assays for 
arsenic.   Strips are semi-quantitative for arsenic concentrations between 20 to 
500 ppb.  C) Assay can separate low levels of arsenite (As(III)) from solutions 
containing as much as 50 mM arsenate (As(V)).  D) Separation of As(III) from 
As(V) at pH 4.  Colorimetric assays can distinguish between varied 






Figure A.10: Differential Scanning Fluorometry analysis of GstB active and inactive variant 
Figure A.11: Analysis of in-vitro activity of GstBR111Q/R119Q 
Analysis of bromoacetate acivity with respect to active variant GstB and 
inactive variant GstBR111/119Q.  Reaction was monitored by the reduction in 
reduced GSH over time.  Reduced GSH remaining at the end of the reaction was 





TRUE DIVERSITY AND DIVERSITY INDEX  
In ecology, measurements of diversity are referred to as diversity indices.  The 
simplest type of diversity index is species richness which reports the total number of 
species, S, found within a population.  A more accurate representation of diversity is the 
diversity index, HCDT entropy, which is a function of both species frequency, fi, and the 




( )  [Eq B.1]
(q 1)
:
  x =  HCDT entropy
  q =  The diversity order
  S = The total number of unique species
















In Equation B.1, the diversity order, q, defines the diversity index’s sensitivity to 
species frequency.  For example, analogously to species richness, when using a diversity 
order where q=0, the diversity index (x=Σ(fi)0-1= S-1) only accounts for every unique 
species, S, found within a population, but disregards specie’s frequency (fi).  As a general 
rule, diversity indices where order q<1 tend to give more weight to the diversity contributed 
by rare species.  Diversity indices where order q>1 tend to favor species found at a high 
frequency within the population and ignore diversity contributed by rare species.  Because 
of this bias, the arguably fairest measurement of a diversity index is where q = 1 and the 
frequency of both rare and common species is weighted proportionately[106].  Equation 




Equation B.2.  In fact, when q = 1, the diversity index is identical to Shannon entropy 




lim ( ) ln( ) [Eq B.2]
:
  x =  The diversity index (Equal to shannon entropy)
  q =  The diversity order
  S = The total number of unique species













Each diversity index described above (species richness, HCDT entropy, and 
Shannon entropy) is a monotonic function that is proportional to the diversity of a 
population.  In other words, the larger the index then the more the diverse the population.  
More importantly, we assume that populations with the same measurement of diversity 
index have equal diversity.  However, one caveat is that diversity indices do not scale 
linearly with the population diversity.  A population with a Shannon diversity index of 10 
is not twice as diverse as a population with a Shannon diversity index of 5.  In order to 
compare diversity across populations, the diversity index has to first be normalized such 
that the values for diversity will scale linearly.  The normalized form of a diversity index 
is referred to as “true diversity”[106].  The true diversity is found by noting that diversity 
does scale linearly if the species within the population are represented at an equal 
frequency.  For example, a population containing twenty species represented at an equal 
frequency (5%) is twice as diverse as a population containing ten species represented at an 
equal frequency (10%).  Consequently, the true diversity of a population is calculated by 




at the same frequency [Equation B.3].  The calculated number of species, or “effective 
number of species”, in this theoretical population represents the “true diversity”.  In 
contrast to diversity index, a population with a true diversity of 10 is twice as diverse as a 








Equate diversity index to theoretical population of
equally distributed species:
(1 ) (1 (1/ D ) )
( ) =  
(q 1) (q 1)
 = D *(D ) D
( ) D ( ) [Eq B.3]
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"True diversity"/"effective number of species"
  x =  The diversity index
  q =  The diversity order
  S = The total number of unique species






SUPPLEMENTARY TABLES AND FIGURES 
 
 
Primer Name Primer Sequence
YarivH-FOR 1 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
KGT RMA GCT TCA GGA GTC 
YarivH-FOR 2 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
GGT BCA GCT BCA GCA GTC 
YarivH-FOR 3 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GCA 
GGT GCA GCT GAA GSA STC 
YarivH-FOR 4 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
GGT CCA RCT GCA ACA RTC 
YarivH-FOR 5 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GCA 
GGT YCA GCT BCA GCA RTC 
YarivH-FOR 6 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GCA 
GGT YCA RCT GCA GCA GTC 
YarivH-FOR 7 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GCA 
GGT CCA CGT GAA GCA GTC 
YarivH-FOR 8 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
GGT GAA SST GGT GGA ATC 
YarivH-FOR 9 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
VGT GAW GYT GGT GGA GTC 
YarivH-FOR 10 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
GGT GCA GSK GGT GGA GTC 
YarivH-FOR 11 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
KGT GCA MCT GGT GGA GTC 
YarivH-FOR 12 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
GGT GAA GCT GAT GGA RTC 
YarivH-FOR 13 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
GGT GCA RCT TGT TGA GTC 
YarivH-FOR 14 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
RGT RAA GCT TCT CGA GTC 
YarivH-FOR 15 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
AGT GAA RST TGA GGA GTC 





GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GCA 
GGT TAC TCT RAA AGW GTS TG 
YarivH-FOR 17 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GCA 
GGT CCA ACT VCA GCA RCC 
YarivH-FOR 18 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 
TGT GAA CTT GGA AGT GTC 
YarivH-FOR 19 
GTT ATT GCT AGC GGC TCA GCC GGC AAT GGC GGA 









Titer Mouse 5 Mouse 8 Mouse 9 Mouse 13 Mouse 23 
3125000 0.0615 0.054 0.0505 0.051 0.058 
625000 0.0685 0.068 0.0535 0.0785 0.093 
125000 0.068 0.0825 0.061 0.151 0.19 
25000 0.119 0.1435 0.083 0.477 0.508 
5000 0.2805 0.366 0.153 1.28 1.111 
1000 1.2445 1.534 0.507 2.7955 3.042 
 
 
Primer Name Primer Sequence
YarivH-REV 1 ApaI 
CGA TGG GCCC TTG AAG CTT GCT GAG GAA 
ACG GTG ACC GTG GT 
YarivH-REV 2 ApaI 
CGA TGG GCCC TTG AAG CTT GCT GAG GAG 
ACT GTG AGA GTG GT 
YarivH-REV 3 ApaI 
CGA TGG GCCC TTG AAG CTT GCT GCA GAG 
ACA GTG ACC AGA GT 
YarivH-REV 4 ApaI 
CGA TGG GCCC TTG AAG CTT GCT GAG GAG 
ACG GTG ACT GAG GT 
Table B.1 continued 
Table B.2: 3’ VH primer mix 
Table B.3: Results of serum titer analysis.   
Values represent ELISA absorbance at 450 nm.  Values highlighted in red 








P-Value comparing true 
diversity measurements
First order 
(q = 0) 
First order 
(q = 1) 
BMPC vs LNPC 0.22 0.05 
BMPC vs SPPC 0.69 1 
LNPC vs SPPC 0.22 0.02 
Table B.4:  Mann-Whitney rank test of diversity indexes 
The table shows the p-values of a Mann-Whitney rank test.  The test compared 
diversity between two tissues for all five mice.  Values highlighted in red represent 
tissues whose diversity was statistically significant.  
Figure B.1:  Distribution of VH gene frequency 
A) Box and whisker plot of the number of times we observed a unique VH gene 
sequence (at the nucleotide level). B) Box and whisker plot after unique sequence 





Figure B.2: Scatter plots of clonotype-cluster frequency in pairwise tissues: Mice 5,8, and 23 
Scatter plot illustrating the correlation of clonotype-cluster frequency between pairwise tissues.  Column 1 plots
clonotype-cluster frequency in LNPCvsBMPC; column 2 plots clonotype-cluster frequency in SPPCvsBMPC; column 3
plots clonotype-cluster frequency in SPPC vsLNPC.  Top row, middle row, and bottom row show data for mice 23, 5, 





Figure B.3: Scatter plots of clonotype-cluster count in pairwise tissues: Mice 5,8, and 23 
Scatter plot illustrating the correlation of clonotype-cluster frequency between pairwise tissues.  Column 1 plots
clonotype-cluster frequency in LNPCvsBMPC; column 2 plots clonotype-cluster frequency in SPPCvsBMPC; column 3
plots clonotype-cluster frequency in SPPC vsLNPC.  Top row, middle row, and bottom row show data for mice 23, 9,























Table B.5: Amino acid sequence of synthesized genes 
We tested the top five most predominant clonotype-clusters in the bone marrow, lymph node, and spleen of mouse 23 
for HEL-specificity.  The following lists the amino acid sequences of the genes we synthesized from the top five 
clonotype-clusters.  The CDRH3 of each clonotype-cluster is highlighted in bold.  Specifically we synthesized 5 
variants, 2 variants, 4 variants, 1 variant, and 3 variants of the top 5 ranked clonotype-clusters, respectively  
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Appendix C 









'(t) [ (i)] ( )  [Eq C.1]
:
'(t) represents the Fourier transform of S(i)
 represents frequency
i represents nucleotide position




















'(t) [G(i)](t) G( )  [Eq C.2]
Where
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THRESHOLD SCORE FOR GERMLINE ASSIGNMENT ALGORITHM  
An important step in our germline assignment algorithm is the identification of 
alignment scores that result from non-random nucleotide alignment of the sequence of 
interest to each germline.  Therefore, we need a threshold score that conveys regions of 
non-random alignment between the sequence and germline.  We can model the expected 
number of matching base-pairs in a nucleotide alignment between random sequences using 
the binomial distribution.  The binomial distribution models the probability of observing k 
successes in N trials given a probability of success, p: 
 
k ( )Pr( ) ( ) p (1 )  [Eq C.4]
Where
Pr(X=k) = Probability of observing k successes
n = number of trials
k = number of successes






With respect to nucleotide alignment, a “success” can be thought of as matching 
base pairs and the number of trials can be thought of as the length of the nucleotide 
alignment.  More importantly, the expected number of success in N trials can be modeled 
as follows: 
 
                      
[ ]  [Eq C.4]
[X] np(1 p) [Eq C.5]
Where
E[X] = expected number of successes in n trials
Var[X] = variance in the expected number of successes
n= number of trials








Assuming that nucleotide alignment is completely random, then we would expect the 
probability of “success” is: 
 




 = probability of matching nucleotide pair
P(nt) = Probablity of seeing a specific base = 0.25 (1/4)









Therefore, using these equations, the expected number of random base-pair matches is:  
 
                 
[match] E[comp_mismatch]
[ ] E[comp_mismatch] 0.25*
Var 0.25* (1 0.25)
Where
n = length of alignment
E[match]=Expected number of matching nucleotides








Var=variance in the expected matches
 
 
In our alignment algorithm, the FFT function scores matching nucleotides with a 
+1 score and penalizes mismatching complementary nucleotides by -1.  Therefore, the 
alignment score will just be the sum of two random variables (matching nucleotides) and 
(mismatching nucleotides).  In this case, the expectation of the sum of the two random 
variables will be 0.  However, we are most interested in the variance of the alignment score.  




The variance of the score can be modeled as the variance of the sum of two random variables (x,y):





Var[Sc] ( Var[match]+ Var[comp_mismatch]+2*m*mm*Cov(match,comp_mismatch))
Let 




    m=1
      mm=-1
      p(match and comp_mismatch) 0
Then




Equation C.5 models the expected variance in alignment score as a function of the 
alignment length.  For the average alignment length of 300 base pairs (average length of a 
germline) we expect the standard deviation in the alignment score using equation C.5 to be 
approximately 12.  Therefore, we use Equation C.5 to select our threshold for non-random 
nucleotide alignments as a function of the alignment length.  In the current algorithm, this 




EXAMPLES OF COMPLEX SERIES REPRESENTATIONS OF DNA SEQUENCES 
Before we use the FFT to align nucleotide sequences, we first have to convert the 
nucleotide sequence into a series of complex integers.  In this study, we represented DNA 








 Performing the cross-correlation function on DNA sequences represented as this series 
resulted in the following match and mismatch scores between nucleotides: 
 
 A  C  T  G 
A  (0+1j)*(0‐1j)  (0+1j)*(1‐0j)  (0+1j)*(0+1j)  (0+1j)*(‐1‐0j) 
C  (1+0j)*(0‐1j)  (1+0j)*(1+0j)  (1+0j)*(0+1j)  (1+0j)*(‐1‐0j) 
T  (0‐1j)*(0+1j)  (0‐1j)*(1‐0j)  (0‐1j)*(0+1j)  (0‐1j)*(‐1‐0j) 







Using this representation and excluding imaginary coefficients, all nucleotide matches 
were given a +1 score whereas complimentary (A-T and C-G) mismatches were given a 
penalty of -1.  All other possible combinations such as A-C and T-G were not penalized 
(score = 0).  Although we use the method above for our algorithm, it is not the only allowed 
 A  C  T  G 
A 1  0  ‐1 0 
C  0  1  0  ‐1
T  ‐1 0  1  0 
G 0  ‐1 0  1 
Table of Alignment Scores 
Calculation of Alignment Scores 
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nucleotide transformation for performing nucleotide alignments.  For example, the 




A=[0 + 1j, 1+ 0j]
T=[0 - 1j, 1 + 0j]
C=[1 + 0j, 0 +1j]
G=[-1+ 0j, 0 + 1j]
 
 
In this example, we represent nucleotides as a 2-D vector, or as two different complex 
series.  If we perform the cross-correlation on each vector and then subsequently take the 
sum of the real coefficients we find that all base-pair matches are scored by +2 whereas all 
other combinations are neither scored nor penalized. 
 








































 A  C T  G
A 2 0 0 0 
C  0 2 0 0 
T  0 0 2 0 
G 0 0 0 2 
Table of Alignment Scores 
Calculation of Alignment Scores 
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Finally, we show that representing nucleotides as a 2-D matrix with 5 separate 
complex series functions allows one to define any score for matching nucleotides and any 










T=[0,(m+q) ,0,0,  q ]
C=[0,0,(m+q) ,0,  q ]
G=[0,0,0,(m+q) ,  q ]
 
 
In this example, each nucleotide represents an individual series of complex numbers 
(columns 1-4).  Moreover, the last complex series (column 5) represents the “mismatch 
score” column.  That is, the last column will always refer to the mismatch value we give to 
base-pair mismatches. Given these values for A,C,T, and G, we can calculate the alignment 
between aligning adenine to adenine (A-A) and aligning adenine to thymine (A-T) function 
as follows:  
 
1/2 1/2 1/2 1/2
1/2 1/2 1/2 1/2
A-A Alignment:
[(m+q) *(m+q) ] [0*0] [0*0] [0*0] [q *q ]
(m+q)-q = m
A-T Alignment:
[(m+q) *0] [0*(m+q) ] [0*0] [0*0] [q *q ]
-q = -q
   
   
 
 
The key difference in this example, is that we always subtract the cross-correlation 
calculated in the last column (column 5).  Repeating the steps above for all other possible 
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combinations we show that we the alignment score matrix using the series above will be 







The purpose of these three examples is to illustrate that there are many different 
methods for scoring nucleotide alignments using the cross-correlation function, and thus 
the use of the FFT for nucleotide alignment.   
  
 A  C  T  G 
A m -q -q -q
C  -q m -q -q
T  -q -q m -q
G -q -q -q m
Table of Alignment Scores 
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EXAMPLE OF NUCLEOTIDE ALIGNMENT USING SPARSE FFT  
The following is a simple illustration of how a sparse FFT could be used to identify the 
maximum alignment diagonal between to sequences.  I would like to acknowledge Haitham 
Hassanieh (Dr. Katabi lab, M.I.T) for his assistance in investigating the application of 
SparseFFT for nucleotide alignments 
 
S = seqConvert(seq,3); %convert sequence into a series of complex 
integers=> A=1, T = -1, C = 1i, G = -1i 
S(880,1) = 0; %pad the complex series with zeros; 
seqFFT = fft(seqConvert(seq,3)); %transform the sequence into its 
fourier series using FFTW3 
g = seqConvert(germline,3); %convert the germline VH sequence into a 
series of complex integers 
g(880,1) = 0; %pad the complex series with zeros; 
clusterFFT = fft(g); %transform the sequence into its fourier series 
using FFTW3 
algn = seqFFT.*conj(clusterFFT);% perform cross correlation in fourier 
 
%%Take the FULL inverse FFT of the cross correlation 
alignedSeq1 = (real(ifft(algn)));  
[Val,Shift1] = max(alignedSeq1); 
%%%%%% 
%%The following is an example of a sparseFFT method 
%first sparse alignment.  Take the inverse of the subsampled “algn” 
vector.  Subsample every 16 coefficients. 
Filter1 = real(ifft(algn(1:16:end)));   
 %second spares alignment.  Take another inverse of a new subsampled 
“algn” vector.  Subsample every 11 coefficients this time 
Filter2 = real(ifft(algn(1:11:end)));   
[V1, I1] = max(Filter1); 
[V2, I2] = max(Filter2); 
%The actual position of the maximum alignment is predicted by noting 
the only coefficient that was subsampled in both filters.  This 
equation identifies that coefficient.  
Shift2 = mod(mod(I1,55)*16*31+mod(I2,16)*55*7,880);  
%%%%%% 








Figure C.1: Alignment of NGS read to germline IGHV3-NL1 and IGHV3-66 
In this example, Smith-Waterman alignment shows that the alignment to 
IGHV3-66 is better than the alignment to IGHV3-NL1 because it does not result 
in the addition of in-del mutations in the CDR2 region.  However, aligning the 
sequence to IGH3-66 results in five additional bp mismatch errors in the CDR1 





Figure C.2: Alignment of NGS read to germline IGHV3-48 and IGHV3-13 
The FFT algorithm cannot account for gaps and consequently predicts that 
IGHV3-13 is a better alignment because there are no in-del mutations between 
the NGS read and IGHV3-13. 
Figure C.3: Alignment of NGS read to germline IGHV3-48 and IGHV3-66 
The FFT algorithm cannot account for gaps and consequently predicts that 
IGHV3-66 is a better alignment because there are no in-del mutations between 






















































































































Metadata Description Example 
Experiment ID Descriptive ID that describes the sample Mouse23_IgG_LNPC 
Project ID Project name  MouseTissueProject 
Date Date of sequencing 3/4/2014 
Work Order 
Work order number received from 
GSAF 
JA12345 
NGS Platform Next Generation Sequencing platform 454 
Isotype Isotype of immunoglobulin sequenced IgG 
Keywords project description Mouse23 lymph nodes 
Chain Type 
Immunoglobulin chain sequenced 
(Heavy, Light, Alpha, Beta) 
HEAVY 
Cell Type Cell types present in sample sequences  PC 
Members 




Species Species collected from Human 
Read access List of members with read access to data All 
Reference Publication referring to this study  
Pairing technique 
Technique used to pair heavy and light 
chains, if applicable 
 
Raw data Filenames of raw fastq sequencing data  
IMGT 
Name of the folder containing unzipped 
IMGT files 
IMGT_LNPC 
LAB Name of the research lab GEORGIOU 
Cell markers 
List of cell markers used for positive or 
negative selection 
CD138+ 
Cell number Attempted number of cells sequenced  
















Table D.2: List of barcode sequences for isotype annotation 
Figure D.1: Illustration of the JSON file format 
The JSON file format (B) relies on “strings” to define fields as compared to the 
tab-delimited counterpart (A).   Each “row” of the JSON file does not have to 
output information from each field.  For example, the CDR3 in row two is 
undefined, so the JSON file does not need to include it.  Also, the CDR3 field 
can be located anywhere as compared the table where it must always be in the 




RUNNING IMMUNOGREP ON APPSOMA 
The following provides a detailed analysis of running the immunoglobulin 
repertoire analysis pipeline on APPSOMA.  For this analysis we will use 454 data from the 
data reported in Chapter 2.  Specifically, we have three unprocessed files of sequence data 
for Mouse 23 bone marrow, lymph nodes, and spleen stored in the IRODs system.   
Storing raw data stored on IRODs 
 Our IRODs system stores raw sequencing data compiled from our lab over the last 
three years.  For each experiment we upload the following data to IRODs:  (1) fasta file of 
sequence data (2) fastq files containing sequence quality scores, (3) IMGT analysis for that 
experiment (if performed).  Most importantly, for every experiment file we store metadata 
that describes the sequencing experiment (Table D.1).   
1) The IRODs system comes with an interactive web interface for downloading 
data.  In our file structure framework, each parent folder in the IRODs system 
is defined by the PROJECT_ID that defines a project.  One project can have 
multiple experiments.  Open this parent folder to view subfolders within 
corresponding to experiments 
 
 
2) In this case, the project, MouseTissueProject_DEMO contains three separate 
experiments for each sequencing dataset: Mouse_23_IgG_LNPC, Mouse 
23_IgG_SPPC, and Mouse_23_IgG_BMPC corresponding to 454 data for the 






3) Opening the experiment folder contains subfolders that store 1) FASTA folder 
containing the FASTA file, 2) RAW folder that contains the optional raw fastq 















ImmunoGReP on APPSOMA 
































Steps for querying experiments from the HTS immunoglobulin database using 
































































































































































































































































































































































































































































































ISOTYPE_INDEX: list of strings Same as isotype except removed all white spaces and lower case the string yes
































Locus String Bcell H/L or T cell A/B chain IGH
Sublocus String V, D, or J region J‐REGION
Method String database source IMGT




Germline Family string name of germline family IGHJ1
stat and end position string position along chromosome 723…724
Sequence string actual nucleotide sequence of  gctacgg….
IMGT Accession number string IMGT reference J00256
Exon(s), region names, or 




Germline Gene Name string germline gene name for sequence IGHJ1
Germline Gene Allele Name string allelic name of germline gene IGHJ1*01
Species string species name  Homo sapiens
DATABASE SCHEMA DESCRIPTION





Description of APPSOMA scripts used for developing the ImmunoGReP pipeline 
All code for scripts are openly available on the APPSOMA webpage. The following 
summarize the functions we provide.  
Filename: cchrysostomou_databaseschema.py 
Description: stores all relevant functions for using the database schema. Contains 
functions which report the default structure of the database in the form of a 
dictionary.  
File type: python code 
Functions: 
DB_RequiredFields: List of required fields for inserting into sequences 
database 
 DB_OptionalFields: List of optional fields for inserting documents into 
sequences database 
DB_AnalysisIMGT: List of fields returned by IMGT analysis 
DB_AnalysisIGBLAST: List of fields returned by IgBlast analysis 
DB_AnalysisINHOUSE: List of fields returned by InHouse analysis 
convertDictionaryIntoMongoSequence: Takes a python dictionary of 
terms, usually metadata from IRODs, and formats them so that they are 
properly inserted into the experiments and sequences collection 
convert_metadata_from_irods_to_dic: Takes in a file name 
corresponding to an output from an IRODs query.  This file lists all 
metadata assocated with the query.  This function will convert the text file 
into a python dictionary.  
removeNoneVals: Removes “null” values from dictionary 
extract_DB_INFO: When getting a fasta file from the database, many 
values are appended to the sequence header which correspond to its location 
in the database.  This function, unwraps the database specific variables from 
the sequence header and appends them in another variable.  
removeFileExtension: This function removes the file extension from a 








Description: Most of our scripts use one of the following formats: text tab delimited 
files, JSON formatted files, and FASTA files.  In addition, with each of our file 
formats, we output special “@” symbols which are usually specific for developers 
to know where the files came from and how to handle inserting files back into the 
database.  Therefore, given our unique file formats, we have written a series of 
functions for reading and writing files for ImmunoGReP platform.   
Filetype: python code 
Functions:  
 previewJsonFields: returns a list of all the fields or keys in the json file 
 previewTxtFields: returns a list of the header row from a text file 
 checkFileType: returns whether a file is a txt file, fasta file, or a JSON file 
 TXT_to_JSON: converts a text-tab-delimited file to a JSON file 
 JSON_to_TXT: converts a JSON file to a text-tab-delimited file 
 JSON_to_Dictionary: opens a JSON file as a list of dictionaries in python 
 TXT_to_Dictionary: opens a text file as a list of dictionaries in python 
 Dictionary_to_TXT: converts a python list of dictionaries to a text file 
 Dictionary_to_JSON: converts a python list of dictionaries to a JSON file 
Filename: andrew_ig_tools.py 
Description: This defines a class of functions used to traverse the folder structure 
of ImmunoGReP 
Filetype: python code 
Functions: 
_projName: global variable defining the name of the project folder (i.e. 
immunogrep)  
expDirParams: global variable defining the general structure of folder 
names (currently set as: Exp#####_projectname or date) 
dir_files: lists all files within a parent folder 
get_all_files_recursively: lists all files with all subfolders of a parent folder 
class ExperimentDirs: 
 get_basedir: return the base directory 




make_dir: make a new directory within immunogrep based on the 
structure of folder names 
Filename: cchrysostomou_add_fasta_to_db.py 
Description: Creates a GUI table listing all experiments a user has uploaded to 
IRODs 
Filetype: python and HTML 
Functions:  
GenerateIRODSTable: Generate HTML code that creates a java datatable 
using metadata downloaded from IRODs 
addFastaToDB: 1) Generate the IRODs table, 2) wait for user to select an 
experiment to download, 3) download the fasta file for that selected 
experiment, 4) if present, download the IMGT file for that selected 
experiment, 5) create a file containing both sequence and IMGT 
information, 6) add file to database 
Filename: cchrysostomou_add_seq_irods_to_mongo.py 
Description: Contains functions for adding data to the experiments and sequences 
collections in the database 
Filetype: python 
Functions:  
addSeqToDatabase: Add only a fasta file containing a sequence and 
sequence header to the database 
addNewSeqIMGTToDatabase: If IMGT data is also associated with the 
fasta file, then add both the sequence information in the fasta file and its 
corresponding IMGT information as defined by DB_AnalysisIMGT 
Filename: cchrysostomou_ linkimgttofasta.py 
Description: this is a single function that links sequences within a fasta file to their 
corresponding IMGT analysis.  This does not assume that the row order of  
sequences in the fasta file matches the order of results/sequences reported by 
IMGT.  Instead, it links the sequence header each sequence in a fasta file with the 






Description: In order to use IRODs and parse through stored files, you need to first 
install icommands.  This script automatically installs icommands for you.  
Filetype: bash 
Filename: cchrysostomou_igblast_install.bash 
Description: This script automatically installs both blast, igblast, and any germline 
library files required by igblast to your APPSOMA directory 
Filetype: bash 
Filename: cchrysostomou_run_igblast_command.py 
Description: This script is used to run IgBlast from python. All variables and 
parameters for IgBlast are defined in a python dictionary called 
variable_parameters.  Those values are passed to the IgBlast command.  
Filetype: python 
 Filename: cchrysostomou_parse_igblastfile.py 
Description: This script will first invoke run_igblast_command function and run an 
igblast analysis on a fasta file.  Once igblast is complete, this script will open the 
igblast file and parse it into a easily interpretable tab-delimited, or json output 
containing relevant immunoglobulin features. 
Filetype: python 
Functions:  
Parse_IgBlast_File: actually parses the igblast file (assumes igblast outputs 
-7 file format).  All relevant features such as VGENES and CDR1 are stored 
in a dictionary. This list of dictionary values are written to a text file at the 
end.  
DefaultIgBlastDic: This is the default format for an IgBlast analysis stored 




Write_Seq_JSON: Writes the output results for a sequence to a JSON file 
TABFileHeader: Dictionary that points column names to actual column 
number in a tab delimited file 
DatabaseTranslator: This is an essential function for users who would like 
to update the database with an IgBlast analysis.  This writes a special line 
to the output format that is detected specifically by later functions for 
inserting back into the database.  This gives direction with respect to which 
fields should be inserted and where in the database.  
WriteTABFileHeader: Writes the header row for a tab-delimited output 
result  
GetAlignment: Takes in the alignment between the germline and sequence 
of interest. It translates the sequence of interest into its amino acid sequence.  
If (1) a stop codon is encountered, (2) the user would like to correct stop 
codons, and (3) a gap is detected in the alignment, then the stop codon will 
attempt to be fixed by fixing potential insertions and deletions.  
Fix_Ins_Del: If this function is called, then it will attempt to repair 
insertion/deletions.  Takes the alignment of the germline to the sequence of 
interest and if there is a gap between the sequences, this will remove the 
insertion/deletion error 
Check_Frame: Checks the current frame of the antibody nucleotide 
sequence.  If it is out of frame, i.e. the nucleotide sequence starts at position 
2 rather than 1, it adds, “N’s” to the end to put the sequence back in frame.  
Filename: cchrysostomou_coutnuniquevalues.py 
Description: this function will take either a text file or JSON file and count the 




Description: this function will download all sequences which correspond to a 
specific experiment in the Mongo database.  The sequences are downloaded and 
written to a FASTA file.  
Filetype: python and HTML 
Functions: 
MakeExpTable: Creates an interactive table listing all experiments 




MakeDocResultsTable: Creates an interactive table listing the first 100 
sequences within an experiment  
SaveFile: Saves the result as a new fasta file in the ImmunoGReP folder 
structure.  This file can be used for downstream analyses.   
Filename: kamhonhoi_cdr3.py 
 Description: Runs the PSSM search for DNA motifs that flank the CDR3 
 Filetype: python 
Filename: kamhonhoi_appsoma_cdr3tools.py 




MotifDB2JSON: Download the motif table from the database into a JSON 
file 
MotifTXT2JSON: Convert a text tab delimited file containing a motif into 
a JSON file 
convertMotifTable2Var: converts a motif table into variables used for the 
PSSM search 
Filename: kamhonhoi_taxonomy_tools.py 
Description: This file contains a list of functions for querying the NCBI taxonomy 
ID for selected species within the database 
Filtype: python 
Functions: 
getTaxID: Given a string name for a species, this returns the taxonomy ID 
reported by NCBI 
pushTaxID2DB: update the species collection with a new species 
taxonomy 








Description: this script generates a circus plot given an input file of the correct 
format.  The input format is one text tab delimited file with Nxfour columns for 
each Nxdatasets you would like to compare using a circus plot.  The first three 
columns for each dataset correspond to string you would like to compare such as 
CDR3, count, and frequency.  The fourth column is blank.  The first row of the file 
will containing the name of each dataset separated by tabs.   
Filetype: Perl 
Filename: sschaetzle_comparethingy.py 
Description: This script will compare a certain field such as CDR3 sequence across 
multiple datasets.  First it reports the number of total unique sequences or strings 
observed and the number of times that sequence is observed in each dataset.  Then 
it calculates the pairwise spearman and pearson correlations for each dataset pair.  
Finally, it groups each sequence based on which compartments or datasets it was 
observed in. For example, if comparing 3 datasets, it will group the data into 7 
compartments which represent all possible combinations of overlap. At the end, it 
plots the correlation as a heatmap.  
Filetype: Python 
Filename:  bennigoetz_db_ops.py 









analysis_types: global variable that defines the types of analysis currently 
in the database 
recomb_types: global variable defining either heavy chain (‘VDJ’) or light 
chain (‘VJ’) analyses 
convert_text_to_index_field_text: converts the value for that field in the 
document to a format that is amenable for queries.  For example, it removes 
whitespaces and case-sensitive characters.   
Find_indexed_fields_in_multilevel_dict: Generate dictionaries for 
sequence index subdocument. This is a generator function that recursively 
finds ANALYSIS_TYPE, NT, AA, RECOMB_TYPE and yields a 
dictionary whenever it gathers enough information to fill out a dictionary 
with indexed values. 
generate_indexed_fields_from_sequence_dict: Helper function for the 
indexed_fields generator. The generator spits out the dictionaries for the 
INDEXED_FIELDS field. This function accumulates the output from the 
generator and stores it in a dictionary {'INDEXED_FIELDS': 
subdictionaries} which it returns 
return_nested_values_with_dotted_keys: Search through nested 
dictionary; keep track of nested keys using dot notation (and the custom 
DotAccessible class).  When a non-dictionary value is hit, yield the dotted 
key-value pair. This is a recursive generator function. 
flatten_multilevel_dict_with_dots: Accumulate the one-element 
dictionaries from the return_nested_values_with_dotted_keys generator 
function  into a single dictionary. 
generate_new_subdictionaries: Search through nested dictionary; keep 
track of nested keys using dot notation (and the custom DotAccessible 
class).  When a non-dictionary value is hit, yield the dotted key-value pair. 
This is a recursive generator function. 
find_new_subdictionaries: Accumulate the one-element dictionaries from 
the return_nested_values_with_dotted_keys generator function into a single 
dictionary. 
update_experiments: Updates the experiments collection given the data, 
for either an insert or an update. 
insert_record: Create a new record. This function checks that all required 
fields for a sequence document are present.   It then inserts the "data" 
dictionary into the sequences collection. Then it creates relevant INDEXED 
fields. 
update_record: Given a $oid, this function updates the sequence and 
experiments collections with the given data.  
save_record: Insert and update wrapper. Should return an $oid or a list of 
$oids of records modified/created. If insert=True, it calls insert_record to 




database is replaced. The append argument is only relevant for update 
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